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Thesis Abstract 
There is currently a gap in the use of centrifugal microfluidics in the field environmental 
sensing. The purpose of this thesis was to develop new and innovative centrifugal 
microfluidic platforms, which could enhance current environmental monitoring strategy 
limitations; portability and in-situ capability, cost-effectiveness, generical design for 
multi-analyte detectability, and the minimal required end-user interaction. Included in 
the main body of the thesis will be a review article, providing the theoretical 
perspectives which have been demonstrated for microfluidic applications in other 
domains and recommendations for adaptation towards environmental sensing using 
centrifugal microfluidics, and three novel papers on the staged development of a multi-
toxin detection platform aimed to be incorporated within the fully deployable MariaBox 
(Marine environmental in-situ assessment and monitoring toolBox, co-funded by the 
European Commission: contract no.614088) system. The aspects covered across these 
three original articles includes the development of a centrifugal microfluidic platform 
with complementary fluorescence detection system as an initial test bed for toxin bio-
assay integration on-disc, progression of current centrifugally-automatable pneumatic 
microvalve mechanisms for increased actuation predictability, and the further 
combination of both of these detection and microvalve mechanisms for a complete on-
disc, multi-toxin detection platform which has been designed specifically to be 
compatible with the deployable MariaBox platform. 
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Thesis Foreword 
 
With the ever-increasing demand on our natural environment, environmental sensors 
for monitoring should be considered a high priority. The focus of this thesis is to 
contribute to the field of environmental sensors. 
 
The purpose of this thesis was to develop new and innovative centrifugal microfluidic 
platforms, which could enhance current environmental monitoring strategy limitations; 
portability and in-situ capability, cost-effectiveness, generical design for multi-analyte 
detectability, and the minimal required end-user interaction. Included in the main body 
of the thesis will be a review article, providing the theoretical perspectives which have 
been demonstrated for microfluidic applications in other domains and 
recommendations for adaptation towards environmental sensing using centrifugal 
microfluidics, and four novel papers on the staged development of a multi-toxin 
detection platform aimed to be incorporated within the fully deployable MariaBox 
(Marine environmental in-situ assessment and monitoring toolBox, co-funded by the 
European Commission: contract no.614088) system. The aspects covered across these 
four original articles includes the development of a centrifugal microfluidic platform 
with complementary fluorescence detection system as an initial test bed for toxin bio-
assay integration on-disc, progression of current centrifugally-automatable pneumatic 
microvalve mechanisms for increased actuation predictability, and the further 
combination of both of these detection and microvalve mechanisms for a complete on-
disc, multi-toxin detection platform which has been designed specifically to be 
compatible with the deployable MariaBox platform and the design strategy 
implemented during this development process. During the course of the PhD, a 
reoccurring theme of research was the investigation of the use of centrifugal 
microfluidics for environmental analysis and monitoring. This included the study of 
centrifugal microfluidics for: 
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• Biological studies, such as toxin detection using recombinant antibody 
technologies with future interests in DNA sensors. 
• Chemical studies, using absorbance-based on-disc detection of chromium and 
phosphate. 
• Centrifugal microfluidic disc enhancements for easier assay integration 
including: advanced microvalve development for more reliable assay 
performance (graphite-Wax, pneumatic, hydrophobic), electrification and 
digital-integration of electrical components for on-disc heating, optical and 
electrochemistry detection, wireless disc-to-PC communications for absolute 
assay automation, and investigation into reusable and cost effective centrifugal 
microfluidic solutions. 
 
The PhD programme was funded by the FP7 EU-Funded MARIABOX project, as part of 
the European Union Seventh Framework Program (grant agreement No: 614088), 
whereby the candidate was required to develop a centrifugal microfluidic platform with 
eight separate on-board biosensors (four biological, four chemical). This platform was 
also required to be compatible with a deployable analytical system developed by 
partners, in which contained modules of sample preparation and delivery, disc and 
reagent storage, fluorescent detection capabilities, as well as network communications. 
The project involved the procurement of device components, off-the-shelf chip 
integration, module integration, laboratory testing, field testing and marinization. As 
part of this project, a proof-of-concept, fluorescence-based centrifugal microfluidic 
toxin detection system was also developed and tested. While this platform was 
successful in the use of anti-body technology for 3 separate toxins, current 
investigations are underway for use as a highly portable fluorescence-based DNA 
detector. While MARIABOX was the core project of the PhD, several side-project were 
also investigated. This included the investigation of integrating enhancements into the 
centrifugal microfluidic platform for increased performance and capabilities. One such 
example was the integration of electronic components, in combination with graphite-
paraffin wax, for automated, wirelessly-operated microvalves actuated through melting. 
Another example was the development of highly reliable pneumatic valves which 
opened through increased disc rotational speed, and which was incorporated within the 
MARIABOX 8-analyte discs for synchronised multi-assay execution. A third project 
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included the conversion of a spectrophotometer into a highly portable centrifugal 
microfluidic platform whereby the detection of both chromium and phosphate was 
demonstrated. A final project was the anti-fouling assessment of bio-inspired 
microstructures using a centrifugal microfluidic platform. This included a comprehensive 
surface characterisation of the marine-based species as well as the development of a 
centrifugal microfluidic platform for assessing relative adhesion rates of variant diatom 
species through centrifugation. 
It is hoped that these investigations will not just lead to more complete, cost-effective 
sensors targeting long-term autonomous deployment of marine-based environments, 
as well as being adaptable to other fields due to the generic design and flexibility of the 
centrifugal microfluidic platform. 
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 Introduction to The 
Theory of Pressure-Driven Laminar 
Flow 
 
Chapter Foreword 
A complete understanding of hydrodynamics is essential in developing successful, 
pressure-driven microfluidic systems.(1) Therefore, the theory behind how 
hydrodynamics systems operate must be considered comprehensively, and in 
particularly how they function in microfluidic network-based devices. In this section, 
theoretical fluid flow will be discussed with particular attention to laminar flow in both 
rectangular and circular channels. These theories apply to both Lab-on-a-Chip (LOAC) 
and Lab-on-a-Disc (LOAD) systems, but the additional forces which only occur in LOAD 
platforms will also be discussed. This section will comprehensively cover all the 
important hydrodynamic derivations that must be considered when designing and 
developing of microfluidic technologies. 
 
 Surface tension and cohesion 
Surface tension, often overlooked for being negligible in the world of macrofluidics, 
plays an important role in microfluidics. Surface tension is as a consequence of the force 
of cohesion of the fluids molecules at the free surface. This force is due to the molecules 
being pulled in less directions by molecular forces, such as hydrogen bonding, thus 
resulting in a stronger cohesion at the surface, with respect to the bulk of the liquid 
(Figure 1.1, top). The surface tension of a liquid can be measured by stretching a liquid 
membrane, using a wire edge as shown in liquid (Figure 1.1, bottom), and by where the 
surface tension can be determined using Equation 1.1. 
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Equation 1.1: Determining the Surface tension of a liquid 
     
Where ‘’ is surface tension (N/m), ‘’ is the counteracting force (N) due to surface tension which opposes 
the pulling force   and ‘	’ is the length of the wire (m). (See Figure 1.1, bottom). 
 
Figure 1.1: Graphical illustration of surface tension.  
This phenomenon occurs due to molecular cohesion at the free surface (Top) and how it is measured 
(Bottom). Top: At the surface, there is less hydrogen bond pairs, which would otherwise normalise within 
the bulk of the water, thus resulting in a tighter compacting of the molecules at the free surface. Bottom: 
Surface tension  can be measured by pulling a liquid membrane by a wire of edge length l with the force  which counteracts the overall forces due to surface tension 
    ∑ . (2) 
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 Capillary action and adhesion 
Capillary action is a feature that a liquid possesses by where it can flow through narrow 
passages without the assistance of, and often counteracting, external forces like gravity. 
Capillary action occurs due the intermolecular adhesion forces between the liquid and 
its surrounding solid surface. Its magnitude is inversely proportionally to the cross-
sectional area of the passage, and in combination with surface tension, can actively lift 
the liquid (capillary attraction, see Figure 1.2, Left). Alternatively, if the forces within the 
bulk of the liquid are larger than the combination of the surface tension and adhesion 
forces, capillary action will work in reverse (capillary repulsion, see Figure 1.2, Right). 
Mathematically, this phenomenon can be described as shown in Equation 1.2. 
Equation 1.2: Capillary pressure in a circular tube 
      
Where  is the Capillary pressure,  is the surface tension of the liquid,  is the radius of the tube, and  
is the contact angle between the liquid and the solid surface (perfect wetting occurs at   0, and the 
surface is considered hydrophobic where   90°). 
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Figure 1.2: Graphical illustration of capillary action.  
Left: Capillary attraction occurs between water and a glass capillary tube as the capillary forces are larger 
than the internal forces of the liquid. Right: Capillary repulsion occurs between the mercury and a glass 
capillary tube as the capillary forces are smaller than the internal forces of the liquid.  
 Laminar flow 
Laminar flow is a non-turbulent fluid flow that will occur naturally in microfluidic 
systems.  The fluid movement can be considered similar to multiple sheet-like segments 
of fluid, which travel in the same direction, without mixing occurring with adjacent 
layers. Laminar flow is relatable to fluid viscosity, where the viscosity of a fluid is the 
fluid’s resistance to flow. Laminar flow is often described as non-turbulent streamline 
flow also. In laminar flow, parallel layers are referred to as the lamina. A case of laminar 
flow is demonstrated in Figure 1.3. 
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Figure 1.3: Graphical illustration of laminar flow.  
The graphic demonstrates fluidic movement between a moving plate at velocity ‘V’ and stationary plate. 
With the top plate, of surface area ‘A’, undergoing a force (f), the fluid would resultantly divide into lamina. 
This is due to the fluid resisting against the flow of the above lamina.(3)  
 
 Navier–Stokes equation 
Micro-fluids are considered to be incompressible due to the high surface to volume 
ratio.(4) The Navier–Stokes equation (Equation 1.3) is therefore applicable. The most 
basic scenario of the Navier-Stokes equation for uniform-viscous Newtonian fluids 
(when the viscous stresses of a fluid are proportional to the rate of change of the fluids 
deformation with respect to time), with no additional bodies in sedimentation, is given 
by: 
Equation 1.3: The Navier–Stokes equation: 
                ⃗"                                
#
 ⃗ ∙ % ⃗      &         
#%         &     
'% ⃗ 

()*+ ,- .ℎ)01+ ,- 2,2+0*32      
.,04+.*54+ -,.+  &  
6+773+ -,.+  & 
457.,37 -,.+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‘u’, ‘ρ’, ‘η’ and ‘p’ are the system flow velocity, fluid density, the fluid viscosity, and fluid pressure 
respectively. 
This equation demonstrates that ‘u’, representing the flow velocity (m.s-1) within the 
system, and ‘ρ’, ‘η’ and ‘p’, being the fluid density (kg.m-3), the fluid viscosity (Pa.s) and 
the fluid pressure (Pa) respectively, are all relatable. Viscosity of a fluid is also 
proportional to the fluids temperature. This is a factor that may also need to be 
considered during testing as results may be affected. 
 
 Poiseuille flow 
Poiseuille flow is the case where a flowing, but non-accelerating, laminar and 
unidirectional fluidic motion occurs through a long cylindrical channel. It is described 
mathematically as Equation 1.4: 
Equation 1.4: Basic Poiseuille flow  
%   '% 
Where ‘p’ is pressure, ‘η’ = viscosity and ‘u’ = flow speed. 
Equation 1.4 demonstrates the proportionality between the net pressure of the fluid 
and the net viscosity of the fluid. By applying a boundary condition and using geometric 
simplification (by specifying that u = 0 at r = R, where r = radius of the cylindrical channel, 
see Figure 1.4), then the complete derivation of Poiseuille flow in the case of a pressure 
driven motion within a circular channel of radius ‘R’ (m) is given by: 
 
 
Equation 1.5: Complex Poiseuille flow 
   8 #  9' . ;# <=  >?< @A # 8B 
Cℎ++ >?< 57 *ℎ+ 2)D5232 4+	,.5*E: 89' . ;# <=  ?"   G 
7++ 513+ 1.4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From Equation 1.5, it is evident that at the centre of the circular channel (r=0), the speed 
of the flow (u) will be at a maximum compared to the null value achieved at the channel 
walls (r=R), thus creating parabolic flow conditions (Figure 1.4). 
 
Figure 1.4: Graphical demonstration of Poiseuille flow.  
A fluid flowing at a systematic rate of Q, in the direction of x, is the summation of the individual flow rates 
of the lamina flow rates. Theses individual lamina flow rates, which are proportional to the radial distance 
from the centre to the max distance R (at the boundaries), can be determined from complex Poiseuille flow 
(Equation 1.5).  
 
 Hagen–Poiseuille’s law 
Hagen-Poiseuille law can be derived directly from Poiseuille flow (Equation 1.5) to 
determine the volumetric flow rate (m3.s-1). This scenario only applies where the 
channel used is both perfectly straight and infinitely long channel. To reach this 
derivation, integration of the Poiseuille flow (Equation 1.5), with respect to the flow 
speed of each the lamina with the fluid motion, is required. The degree of volumetric 
flow, in the case of the previously discussed of non-accelerating, pressure-driven fluid 
flow (Equation 1.6), through a circular chamber is given by: 
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Equation 1.6: Hagen-Poiseuille law  
J   K89L' . ;# <= 
Normalisation of (Equation 1.6) using the cross-sectional area will return the area-
normalised flow velocity rate (m.s-1) (see Equation 1.7): 
Equation 1.7: Normalized Hagen-Poiseuille law  
M   JK8   8L' . ;# <= 
By using (Equation 1.7) for channel length ‘L’, certain conditions must be assumed. The 
first assumption that must be made is that the fluid is moving in a fully developed flow 
with the length of the channel ‘L’ being significantly greater than the circular channel 
radius ‘R’. For this to hold true, then (L/R)>>1 and (L/R)>>Re, where Re represents 
Reynolds number (see section 1.7), must be true. The assumption that must be made is 
that the pressure acclivity across the channel wall, in the case of pressure-driven 
microfluidic systems, is constant. This then allows suggestion that ‘dp/dx’ is 
approximately equal to ‘dp/dL’. Taking these assumptions into consideration, (Equation 
1.8) resolves to the following: 
Equation 1.8: Resolved Hagen-Poiseuille law 
J   K89∆O  
With the overall system flow rate ‘Q’ determining direction of system flow (in such that a positive value is 
the equivalent of travel from the inlet to outlet). The hydraulic resistance (see section 1.8) can then be 
further derived from Equation 1.8. 
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Figure 1.5: Graphical demonstration of Hagen-Poiseuille flow with the overall system flow rate ‘Q’. 
The top image illustrates the fluid moving in circular lamina, with the bottom image demonstrating the 
difference in flow speeds from the outer radius to the centre of the channel. This difference in speed is as 
a result of inter-lamina frictional forces, which are highest at the channel boundaries and lowest at channel 
centre. 
 
 Reynolds number 
The Reynolds number (Re), mentioned in the previous section, is the standard 
measurement that determines the turbulence level of a fluid flow. It is defined as the 
quotient of the inertial and viscous forces (Equation 1.9). It has been determined that 
for flow in straight, smooth channels, that laminar flow exists at Re < 2300 with turbulent 
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flow occurring at Re ≥ 2300.(5)  The Re can be described in terms of characteristic length 
‘D’ (m) and the velocity ‘V’ (m.s-1) of flow. This may also be described in terms of the 
area-normalised velocity ‘U’ (Equation 1.7) and the hydraulic diameter (DH). Resultantly, 
the Reynolds number is defined as: 
Equation 1.9: The Reynolds Number  
8P   
QRP"Q? STUP
VQUT STUP   WX' Y MXZ'  
 
 Hydraulic resistance 
By modifying Equation 1.8 further, the simplified Hagen-Poiseuille law can be achieved: 
Equation 1.10: Simplified Hagen-Poiseuille law  
J   ∆8Z  ;  ∆   J8Z 
Where the hydraulic resistance ‘RH’ (Pa.s3.m-1) being defined as: 
Equation 1.11: Hydraulic resistance  
8Z   L'OK89 Y L'OKZ9 
As microfluidic channels are regularly designed to be of rectangular dimensions, 
particularly due to the difficulty with manufacturing circular channels, Equation 1.11 
should be modified to be valid for non-circular channels also. This is achieved by 
exchanging the radius R with the hydraulic radius (rH), or hydraulic diameter DH, being 
twice the hydraulic radius (2rH). The hydraulic radius (rH) can then be defined in this 
scenario as rH = (2A/P), where ‘A’ represents the channel’s cross-sectional area (m2) and 
P is the wetted perimeter (m). This can also be formulated as: 
Equation 1.12:  Simplified Hydraulic resistance of a rectangular channel 
Z    \. ]\ & ]  
This resolves the formula in terms of channel dimensions (channel width ‘w’ and channel 
height ‘h’). This computes a solution to within a 20% error approximation for a square 
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cross section.(6) Solving Poiseuille flow (Equation 1.4) in a rectangular channel is a 
computationally intense task as it normally determined through a Fourier series 
summation (7), and therefore the non-simplified hydraulic resistance can be given by:  
Equation 1.13: Hydraulic resistance of a rectangular channel  
8Z   A'O\]^ @A #  ]\ ;A_K` ∑   A
R # A` "?R ] ;
R # AK\] =aRbc =B
 
Through combining (Equation 1.11, Equation 1.12 & Equation 1.13) and making the 
assumption that the aspect ratio is high in a microfluidic channel 
dCℎ++ (e|gbc 57 *3+ )* hi < 1k, Hagen–Poiseuille’s equation for a rectangle can be 
further generalized as: 
Equation 1.14: Generalised Hagen–Poiseuille’s equation for a rectangle 
∆   J8Z ;  
∆   A'JO\]^  lA #  A_]\K` "?R] dK\] km
nA
 
 
From Equation 1.14, the following conclusions can be drawn: 
a) A Pressure change occurring within a channel will proportionally affect both the 
hydraulic resistance and the volumetric flow rate, especially since the volumetric 
flow is dependent on the variance of the pressure at both the channel inlet and 
outlet.(8) 
b) The Hydraulic resistance of the system is normally of constant value, as it is the 
by-product of the unvarying conditions of the fluid viscosity and cross-sectional 
area of the channel. 
c) The hydraulic resistance will be reciprocal to the channel length. Again, this is 
due to unchanging system conditions. 
These conclusions forge the foundation of microfluidic manipulation and demonstrate 
that fluids can be controlled provided that the system has no unconsidered changes to 
either the pressure or fluid flow of the system. 
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 Extra fluid movement considerations within a rotating 
system 
When working with the Lab-on-a-disc (LOAD) platform, all the forces of the system must 
be considered carefully. A liquid travelling through a system with angular velocity will 
be exposed to the centrifugal force, the Euler force and the Coriolis force of the system 
(Figure 1.6). 
 
Figure 1.6: The forces operating on a rotating LOAD system. 
 A disk, with geometry extruding towards reader, rotating at an angular velocity ‘ω’. Using the radial 
coordinates ‘r’, the channel diameter ‘d’, the absolute length ‘l’ can be discussed in terms of radial positions 
‘r< and r>’. Liquid travelling from r< to r> will be affected by the centrifugal force (Fω) (Equation 1.15), Euler 
force (Fe) (Equation 1.16) and the Coriolis force (Fc) (Equation 1.17) of the system. (9) 
 The centrifugal force is defined as a force which occurs due to the inertia of a body, 
which acts on a body that is travelling in a circular path, causing the body to move away 
from the radial centre of the circular path (Equation 1.15). (9) 
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Equation 1.15: The Centrifugal Force 
So   o 
Where ‘ -p’ represents the centrifugal force (N), ‘ρ’ represents the density of the body (kg.m-3), ‘r’ 
represents the distance (m) from the centre of rotation and ‘ω’ represents the angular velocity (rad.s-1) of 
the system. 
The Euler force is a pseudo-force which a body experiences due to Euler acceleration, 
which acts in a perpendicular direction with respect to centrifugal force and is within 
the plane of rotation. 
Equation 1.16: The Euler force 
SP    o"  
Where ‘ -q’ represents the Eular force (N), ‘ρ’ represents the density of the body (kg.m-3), ‘r’ represents the 
distance (m) from the centre of rotation and  
rprs  represents the angular acceleration (rad.s-2)  of the system. 
The Coriolis force is a force which an angularly moving body experiences, which acts 
perpendicular to the direction of motion and the axis of rotation. 
Equation 1.17: The Coriolis force 
SU   oV 
Where ‘ -t’ represents the Coriolis force (N), ‘ρ’ represents the density of the body (kg.m-3), ‘v’ represents 
the velocity (m.s-1) of the body in the plane and ‘ω’ represents the angular velocity (rad.s-1)  of the system. 
 
 Particle sedimentation through a fluid within a rotating 
system 
A particle present with the liquid will also experience these forces but will also effected 
by the buoyancy and the Stokes drag forces, which counteract the sedimentation of the 
particle through the liquid.(10) This is most evident when the liquid is stationary in the 
system with particles moving through the system. The buoyancy force is an upward 
force that a fluid can exert on a body which opposes the weight of the immersed body. 
(10) 
Equation 1.18: The buoyancy force 
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S>   u>o 
Where ‘Δm’ represents the difference in mass between the bodies, ‘r’ represents the distance from the 
centre of rotation and 'ω' represents the angular velocity of the system. 
 
Figure 1.7: The forces acting on a centrifugally driven particle in a fluid. 
 The particle experiences a centrifugal force (fω) which is counteracted by the drag (fd) and buoyancy (fb) 
forces dependant on holding sample. It also experiences lateral forces in the form of Euler (fE) and Coriolis 
forces (fc), where by the direction of force vector is dependent on the direction of rotation. 
 
The Stokes drag force is a force, by which a fluid can act on a body to the opposite 
direction of fluid flow (10). 
Equation 1.19: The Stokes drag force 
S   vK'8V 
Where ‘η’ represents the viscosity of the fluid, ‘R’ represents the Radius of a spherical particle and ‘v’ 
represents the velocity of the body in the plane. 
 
These formulae are essential to understanding particle-fluid interaction within a rotating 
system. 
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 Literature review: A 
review of centrifugal microfluidics in 
environmental monitoring 
 
Chapter Foreword 
The purpose of this chapter is to identify the current analytes of interest within the 
marine environment and how microfluidic platforms have been utilised to monitor these 
analytes within the required ranges of sensitivity, whilst also illustrating how these 
platforms can be adapted to detect additional analytes through minimal modification.  
Firstly, the reader will be presented with background information about microfluidics 
systems. This will include the origin of microfluidic technologies, currently used 
manufacturing methodologies and the Lab-on-a-Chip and Lab-on-a-Disc dissemination 
history.  Secondly, a demonstration of how to design a centrifugal microfluidic platform 
for mimicking a specific bio-chemical based assay protocol is illustrated to the reader. 
This includes an assay-to-microfeature conversion process as well as illustrating the 
microfeature modifications necessary for tailoring to specific sample/reagent fluidic 
properties, such as viscosity.  Thirdly, the reader is presented with an in-depth 
presentation on the current detection methodologies for monitoring key marine-based 
analytes of interest on both chip- and disc-based microfluidic platforms. This also covers 
a discussion on how different transducing elements can be transferred and 
implemented within centrifugal microfluidic platforms based on the sensitivity and 
selectivity required to detect a specific analyte.  Finally, a brief insight into the author’s 
predictions into the future trends of centrifugal microfluidics and how these 
enhancements will lead to more easily applicable and integrated microfluidic platforms, 
particularly for targeting autonomous, in-situ environmental monitoring. 
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 Abstract 
There is currently a gap in the use of centrifugal microﬂuidics in the ﬁeld of 
environmental sensing. This review provides theoretical perspectives that have been 
demonstrated for applications in other domains and recommends adaptations for 
environmental sensing. Current approaches of centrifugal systems reported are 
primarily in the area of biosensing and electrochemical detection. In the case of current 
environmental monitoring devices discussed, a conversion process for developing 
centrifugal microﬂuidic platforms around currently reported transduction methods will 
be presented, covering design and manufacturing elements required for successful 
platforms. While the success of these reported systems is not in question, there is more 
to be done in advancing both automation, sample-to-detector interaction, simpliﬁcation 
for the end user and portability, to facilitate long term deployable or in situ based 
environmental monitoring. Also included for discussion, are devices that have 
demonstrated the capability of sample processing and reagent mixing, as well as high-
sensitivity sample characterisation with a number of varying detection techniques 
through transducer substitution. While in some cases, necessary sample preparation 
currently involves oﬀ-chip steps (such as cell lysis), others have incorporated these steps 
within the microﬂuidic platform, therefore through combinations of reported sample 
handling and detection strategies, more reﬁned and ﬂexible environmental monitoring 
tools can be achieved on a single platform using centrifugal microﬂuidics. Also 
considered will be the cost-eﬀectiveness of the microﬂuidic platforms with current 
multi-use limitations. In the absence of suitable centrifugal microﬂuidic sensors, 
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alternative chip-based systems, with signiﬁcant relevance to environmental applications 
and which could be easily adapted to a centrifugal platform, are suggested. The primary 
technical challenge of this report is to demonstrate how these current centrifugal 
sensing systems could oﬀer huge potential in the environmental sensing ﬁeld, with 
minimal systematic modiﬁcation, but a myriad of applications. 
 
 Introduction to microfluidics platforms  
Microfluidic systems operate using micro-scale concepts and technologies to develop 
micro-platforms which are aimed at controlling and manipulating fluidic samples. Within 
this, fluidic sample handling holds the key to miniaturising full laboratories onto a single 
microfluidic platform, or Lab-On-A-Chip (LOC).(1) The volumes of fluidic samples often 
range from as large as nano-litres (10-9) to as small as atto-litres (10-18).  A fluidic input 
in this range is highly favourable. With a reduced input sample size, there is a 
corresponding reduction in reagent consumption and required detection time. This 
range also increases the systematic detection resolution and sensitivity, whilst also 
lowering the material quantity required to conduct an experiment. All of these virtues 
collectively decrease the overall cost of microfluidic system advancement, and their 
associated development carbon footprint.(2) 
The origin of microfluidics was due to the requirement for a versatile and highly sought-
after technology which became resultant bi-product of a number of fields; molecular 
biology and analysis, bio-defence and microelectronics.(3) In the 1980s, the evolution of 
genomics accelerated significantly. New analytical methods were therefore required to 
allow better sample processing abilities, such as wider range of detectability with 
greater sensitivity. Other micro-analytical methods at the time, which were based 
around laser optical detection, were also under development, high-performance liquid 
chromatography (HPLC)(4), capillary electrophoresis (CE)(5) and gas chromatography 
(GC)(6). These methods were hugely important for genomics because the methods can 
deliver the required resolution and sensitivity for low sample injection volumes. 
Investigation was then focused into developing new technologies capable of enhancing 
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the performance of these micro-analytical methods for the field of genomics. This was 
the initial step in the development of microfluidics technologies. 
After the cold war, bio-chemical terrorism became a clear threat in the future. 
Therefore, in the 1990s, technology to detect a bio-chemical threat in in-field scenarios 
was investigated. Thus, there was significant developments in microfluidic systems. This 
research was carried out by the ‘Defense Advanced Research Projects Agency’ (DARPA) 
through the support of the US Department of Defence.  (7–9) 
 
Figure 2.1: Manufacturing a NP-based centrifugal microfluidic platform. 
Illustrated here is PhosphaSense platform, which comprises of multiple PMMA and PSA alternating layers 
(10) (Image is authors own) 
 
Microelectromechanical systems (MEMS), which are primarily silicon-based 
microelectronics, became highly successful (11). This was due to the development of 
microfabrication technologies, such as photolithography (12–14), as well as the 
development of other  manufacturing technologies including xurographic and laser 
cutting systems (15–17). These technologies were found to be also applicable in the 
advancing field of microfluidics. While there are a variety of approaches for producing 
centrifugal microfluidic platforms, only two production methods here will be presented: 
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• A non-photolithography(15–17) (NP) method, achieved through assembling 
consecutive layers of poly(methyl methacrylate) (PMMA) and adhesive 
polyethylene terephthalate (PET)(Figure 2.1), also previously reported for 
centrifugal microfluidics environmental applications (10,18).  
 
 
• A photolithography(12–14) (P) method, by where exposed photoresist can be 
used to create microstructures on a silicon wafer (Figure 2.2), upon which 
polymer-based materials, such as polydimethylsiloxane (PDMS), is poured to 
form a mould.  
 
Figure 2.2: The Photolithography process used in constructing P-based platforms. 
This process is used to construct a master construct of the design, on which, PDMS solution is poured to 
form a mould. (Image is authors own) 
 
Both platforms have different strengths and weaknesses without comparing the actual 
materials themselves; a comparative list can be seen in Table 1. While P-based platforms 
can achieve significantly higher resolution in comparison to NP-based platforms, it 
comes at the cost of poor manufacturing time. However, required system resolution is 
usually the deciding factor on which platform was selected. Another important 
consideration was NP-based platforms could be easily constructed into multilayer-
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varying discs, whereas P-based platforms rarely contain above 2 layers due to the 
associated photomask alignment difficulties. 
 
Table 1: Comparative table of the benefits between PMMA- and PDMS- based platforms. 
 
 Microfluidic devices operate primarily through two platforms; the Lab-On-A-Chip (LOC) 
platform (Figure 2.3.Left), which uses pumping forces to drive the sample progression, 
and the Lab-On-A-Disc (LOAD) platform (Figure 2.3.Right), which uses centrifugal forces 
as the primary driving force in the system. As LOC platforms have a number of 
comprehensive review articles to date, as evident by Figure 2.4, also some of specifically 
relevant review also provided (19–21), thus LOC platforms will mostly fall outside the 
scope of this review. Both platforms are constructed from most materials, with Poly 
(methyl methacrylate) (PMMA) with adhesive PET and/or Polydimethylsiloxane (PDMS) 
often used. The LOC (Figure 2.3.Left) utilises an external pumping mechanism as a 
driving force for each chip. The LOAD (Figure 2.3.Right) platform does not have this 
requirement. This is therefore can be an advantage due to ease of use from an end used 
experience. However it is important to note that as LOAD platforms can often designed 
to be for single use scenarios (22), in contrast to LOC platforms which can be used for 
long-term deployment of without replacement (23).   
Benefits of platform NP Method P Method 
Min resolution 500 µm 1 µm 
Cost per disc +++ ++ 
Manufacturing time +++ + 
Equipment for 
manufacturing cost 
++ +++ 
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Figure 2.3: Lab-On-A-Chip (LOC)(left) and Lab-On-A-Disc(LOAD)(right) platforms. 
Left) This Concept (24) demonstrates how LOC platforms are capable of multiplex analysis of complex 
biological samples. Right) This illustration (25) demonstrates a mixing chamber on the LOAD platform. The 
samples are loaded into the inlets and the LOAD is the spun. The centrifugal force f(ω) is applied to the 
system, where ω is the angular rotation of the system. Also, resultantly applied are the Coriolis force f(c) 
and drag force of sample f(d) which all aid in the mixing of samples as required. 
 
Figure 2.4: Keyword publications trends per annum with respect to microfluidic research.  
This included Lab-On-A-Chip and Lab-On-A-Disc platforms, according to Clarivate Analytics’ ‘Web of 
Science’ (26).  
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The inlet of the LOAD can have a sample injected directly into the system. The LOAD is 
then rotated, allowing the sample to be driven through the system by the generated 
centrifugal force. Another advantage of working with LOAD systems is that multiple 
testing mechanisms can be incorporated onto one single disc. This can mean samples 
can either be tested multiple times on a single disc, with the exact testing condition in 
each chamber, or multiple analytes can be detected simultaneous (27–30). This provides 
more statistically accurate and repeatable data. 
 
When designing LOAD systems, there are three primary design criteria to be considered: 
 Laminar flow; 
 
 Micro-architectural design for sample manipulation and; 
 
 Micro-architectural design for air manipulation.  
 
 Laminar flow will occur naturally 
 Due to the flow of such small samples, laminar flow will occur. Laminar flow is a non-
turbulent fluid flow, where the fluid(s) appears to travel in sectional parallel layers, 
known as lamina, with no apparent mixing occurring between layers. (21) However, 
laminar flow may be an undesirable feature as it can prevent sample-reagent mixing. 
Thus, turbulent flow can be introduced through the integration of micro-architectural 
features, such as micro-pillars, to allow sample mixing to occur as required.(31) 
 
 Micro-architectural design for sample manipulation 
 In order to conduct laboratory experiments accurately on chip, the sample must be 
manipulated and controlled to follow a strict and exact experimental protocol or ‘assay’. 
To follow an assay protocol, either physically, biologically or chemically-based, will 
require the addition of micro-architectural structures for example; microchannels for 
sample progression, reservoirs for sample modifications (such as reagent introduction), 
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among others. Stone et al.(21) demonstrate a number of micro-architectural features to 
convert a microfluidic chip to the more desired LOC platform.  
 
 Micro-architectural design for air manipulation 
 The interactions between sample and pre-occupied air become significantly more 
complex due to both fluids being on the micro-scale.(25,32) This means that the 
previous forces acting on both fluids, including buoyancy force and surface tension, 
change significantly with comparison to the macro-scale.(33) Quite often, the surface 
tension can be significantly stronger than the buoyancy force, due to the high surface to 
volume ratio of the fluid, which prevents the pre-occupied air from escaping directly 
through the sample. This means that an air ventilation system must be considered to 
prevent air-locking within microfluidic systems as this can disrupt or even halt assay 
progression. Alternatively, the air ventilation system can also be designed intentionally 
to halt sample progression (34). Whereby, if the assay requires a wait period, indirect 
control of the sample can be achieved by direct control of locked air discharge. These 
three elements, when optimised, allow accurate and controlled fluidic sample handling, 
inclusive of complex samples containing particle-like components.  
 
 Development of centrifugal microfluidics for 
environmental monitoring 
The ideal environmental monitoring tools are expected to be: capable of autonomous 
deployment; robust and capable of providing quantitative and qualitative 
measurements. The requirement for autonomous and/or handheld sensors is essential 
in gaining temporal/timely and qualitative understanding of key environmental 
locations. This can include four core environments; Air (indoor and outdoor air quality, 
etc.), land (agriculture, residential/corporate impact, etc), life (ecology, anthropogeny, 
etc) and water (drinking/leisure water sources, wastewater treatment, etc). Within 
these core environments, where crossover between the core environments is also 
possible, there is also a variety of potential analytes which can be environmentally 
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relevant. In order to develop a centrifugal microfluidic platform for environmental 
monitoring, a number of considerations must be determined; sample/reagent type/size, 
analyte characteristics, sample matrix, assay protocols, transduction method, targeted 
for autonomous/handheld platform, single or multiuse. In this section, a presentation 
of how some of these considerations are used in manufacturing new or modifying 
previous adaptations of centrifugal microfluidic platforms for environmental 
monitoring. This specifically includes the design strategies considered in developing a 
LOAD platform which emphasis on selecting a transducing element. 
 
 Environmental assay integration on a centrifugal 
microfluidic platform  
To determine the optimal approach, a complete breakdown of what laboratory steps 
required to perform the environmental assay are included in the design. This includes 
the specific duties which would be performed on the microfluidic platform. An example 
of a biological assay is demonstrated in Figure 2.5 for toxin detection on a LOAD 
platform. This Figure 2.5 demonstrates the required assay protocol associated for a 
fluorescence-based, inverse-assay toxin detection platform. This case illustrates the 
range of both external inputs and expected outcomes, performed for specific periods of 
time by the microfluidic platform. From this, along with further information about the 
sample (volume, contents, viscosity and surface tension), the required microfluidic 
platform was selected, with fluorescence detection selected for measurement within 
the range of the WHO regulation limit.  
In the example of Figure 2.5, consider a sample input of 50 μL of sea water containing 
targeted, pre-lysed Microcystin-LR toxin. In this case, the platform does not require high 
resolution microstructures (< 500 μm), therefore NP method would be the preferred 
method for producing this platform. Further considering of the adaptation of the assay 
protocol found in Figure 2.5 into a microfluidic platform, adequate 
sample/reagent/complex-sized reservoirs with liquid-transfer and air-ventilation 
microchannel should be designed as required to complete the assay. As the sample 
liquid would then be expected to be passed to each succeeding functionalised reservoir 
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for assay completion (i.e. fluorescent-antibody coating, priming of capture antigen on 
test and control reservoirs, etc.), consideration of the sample-transfer microchannels 
would then be considered.  
 
Figure 2.5: A graphical breakdown of assay protocol conversion to microfluidic features. 
This illustrates the example of a toxin detection assay protocol, with the required external interactions, 
duties expected to be performed by the microfluidic platform (for chosen length of period), and how it can 
be converted to microfluidic features such as reservoirs and microchannels. (Image is authors own) 
 
While the dimensions of the microchannels often are not critically important once a 
standard microfluidic channel dimension is observed, they potentially can be, as then 
sample attributes may need to be taken into consideration. While centrifugal forces are 
viewed as the primary driving forces of the reagents on disc, significantly large rotational 
speeds would be required for sample progression if they were the only acting forces 
available for liquid manipulation. Instead, the system usually minimises the 
microchannel cross-sectional area in order to offer ‘assisting and desisting’ capillary 
action forces, which complements the centrifugal forces generated, thus allow reagent 
actuation with greater ease. Liquids, upon meeting microchannels which have low cross-
sectional areas with respect to length (µm:mm), experience capillary action. The 
capillary action magnitude and direction of flow is dependent on the ratio of molecular 
cohesion force within the reagent, and the adhesion energy between the reagent and 
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containing surface. Thus, if the flow speed of the sample within microchannel was 
important, then refining the optimum channel width and thickness would be required. 
However, this is often not the case and aqueous solutions were able to easily travel 
through microchannels, with a standard thickness of < 200 μm and 500-700 μm channel 
widths, at relatively low rotational speeds (8-15 Hz). In comparison, it can be expected 
that for channel widths >1 mm, aqueous solutions may require rotational speeds of ≥20 
Hz in order to compensate for a reduced capillary action within microchannels of a LOAD 
platform. 
After determining the optimum microchannel dimensions and reservoir locations, the 
next consideration was to set the opening of the microchannel at the lowest tangential 
point of each reservoir, with regards to the radial centrifugal force. This was often 
achieved by filleting the reservoir shape to remove corners. This approach is taken to 
minimise any potential sample loss throughout the microfluidic platform, as shown in 
Figure 2.6. Another important aspect that should be considered was reservoir shape for 
reagent loading and storage.  
Depending on the characteristics of the liquid, for example liquid viscosity, coarser 
reservoir shapes may also be required in order to reduce the liquid-surface attractions, 
as demonstrated by Duffy et al. (18). In this example (18), reservoir shape 
characterisation is demonstrated in Figure 2.6, where the loading of water (72.75 mN/m 
surface tension @ 20°C)(35) with a viscosity of 0.89 mPa.s into a circular reservoir (Figure 
2.6.Circle) was successful, whereas loading methanol (22.95mN/m surface tension @ 
20°C)(35) with a viscosity of 0.543 mPa.s into the same reservoir shape resulted in an 
approximate 50% sample injection reduction. To counteract this, a coarser reservoir 
shape, shown in Figure 2.6.Shield, was also tested. It was expected that the perimeter 
wall wettability would be reduced as the wall shape became coarser (36), which proved 
to be the case (Figure 2.6.Graph). 
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Figure 2.6: Designing reservoirs to avoid sample loss. 
A) This illustration demonstrates the correct reservoir solution, by where the end of the reservoir is the 
lowest tangential point (Tp) with respect to the centrifugal force (FC). A.1-3) confirms that sample loss (S/LA) 
is minimal during sample progression.  B) In contrast to A, this reservoir has tangential points which have 
a larger radial distance than the microfluidic channel’s tangential point. B.1-3) confirms that sample loss 
(S/LB) is occurring during sample progression. (Image is authors own) 
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Figure 2.7: Percentage of reservoir filled before sample leakage occurs vs liquid viscosity. 
This figure illustrates the how reservoir shape can impact the load-ability of a sample. The circular design 
has a uniform perimeter wall in comparison the more random and non-spherical ‘shield’ design. It is 
speculated that the circular reservoir fills too quickly, due to the wettability attraction between the sample 
and perimeter wall at low liquid viscosities, which can lead to air trapping and reduction in maximum liquid 
input. In the case of the shield, the wettability of the coarse perimeter wall is less, (36) therefore reducing 
the shear force acting on the liquid caused by wettability attraction, leading to a reduction in air trapping, 
and thus increasing sample load volume. The liquid viscosities were formed using combinations of acetone, 
glycerol, methanol and water at 25 °C. (Image based on Duffy et al. (36) ) 
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 Detection strategies on centrifugal microfluidic 
platforms for environmental assay integration  
There are a number of microfluidic detection strategies currently employed in the fields 
of biosensing (25) and electrochemical sensing (37), but there is a significant gap with 
regard to LOAD applications for environmental monitoring using these transducing 
strategies. In an effort to determine the significance of this gap, a table produced by 
Rodriguez-Mozaz. et al (38) for identifying environmental applications for LOC 
platforms, was modified to include LOAD microfluidics platforms as shown in Table 2. 
Table 2 is a summary of the reported developments including the transduction element, 
for detection of the relevant environmental compounds and parameters, against known 
integrations of detection on LOAD platforms, or lab-on-a-chip (LOC) platforms if none. 
It is quite clear from Table 2 that if centrifugal microfluidic platforms are to be used in 
environmental monitoring, significantly more study is required. The key in developing 
such a multi-analyte environmental monitor lies within the integration and adaptation 
of new and current transduction elements on LOAD platforms.  
As analytes levels in the environment are often in trace quantities, a low limit of 
detection (LOD) is required by the transducing element. Typically, a pre-concentration 
step would be required in order to move the analyte detection within a suitably sensitive 
linear range of the transducing element. If a pre-concentration step is required, it has 
been previously demonstrated that the pre-concentration step can be integrated within 
the LOAD by using silica-based gel column on a LOAD platform (39), with similar gel 
products found to be successful for LOC platforms also (40). Alternatively, a pre-
concentration step could also be carried out prior to sample injection at a cost of 
reduced simplicity. 
The value of the platform is assessed based on its analytical performance e.g. linear 
dynamic detection range and sensitivity. Therefore, the LOAD system is designed to 
meet current legislation (WHO, WFD etc.). Table 2 can be used to compare current 
detection capabilities of specific detection approaches on a microfluidic system for 
environmental application.  
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 Acoustic transducers 
 Surface acoustic wave (SAW) 
Acoustic waves have been demonstrated as suitable transducing elements for a myriad 
of applications, with one of the more prominent configurations being the surface 
acoustic wave (SAW) format (41–44). SAW-based sensors operate on the premise that 
a pair of piezoelectric (Pe) constructs, where the primary Pe generates acoustic waves 
while the secondary Pe records acoustic wave outputs through a connecting biosensor-
enabled waveguide. Analyte interactions between the waveguide and sample can then 
distort the translating acoustic wave, where a change in total mass on the biosensor 
results in a shift of the wave's phase. Information about the ‘capture’ and ‘release’ rates, 
as well as the stoichiometry of the interaction, can be extrapolated from this phase shift. 
In some cases (42,45,46), antibody biosensor technology was combined with SAW-
based sensors for the determination of the analytes-of-interest presence, analysis of the 
acoustic wave response due to competitive binding. Conformation of the molecules can 
also be derived from variation in the amplitude of the acoustic wave, whereby a 
dampening of the acoustic wave occurs with increased flexibility of the target molecule 
through interaction with the sample. Two examples of SAW-based sensors used on 
microfluidic devices are illustrated in Figure 2.8. A chip-based (Left) design and 
centrifugal cartridge-based (Right) platform are demonstrated. The chip-based 
platform(42) utilises a Al-SiO2 interdigitated transducer (IDT) SAW platform for the 
detection of Escherichia coli with a reported limit of detection of 1.8×10−15 M. The 
centrifugal cartridge-based platform(45) demonstrates a dual IDTs Al-SiO2 SAW 
platform with separate working and reference sensor pairing, achieving a  6.7 pg.mL-1 
limit of detection.  
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Table 2: Current environmentally-aimed transducing elements with corresponding environmental analytes of interest. 
 
Transducing 
element 
Compounds or 
parameters 
Bio-
recognition 
element 
Features 
Reference 
(s) 
Relevant 
LOAD 
referenc
e 
Relevant 
LOC 
reference 
Acoustic (surface 
acoustic wave) 
(SAW) 
 Antibodies 
LOD = 6.7 pg/mL 
 
- [2]  
 
Salmonella 
Typhymurium 
Antibodies 100 cells/mL [3] - [4], [5] 
 Escherichia Coli Antibodies LOD = 1.8×10−15 M [6] - [4], [5] 
Electrochemical 
(amperometric) 
C-reactive 
protein (CRP) 
Antibodies 
LOD = 4.9 pg/mL 
 
- [7]–[9]  
 
Inorganic 
phosphate 
Enzymatic 
(trienzymatic 
configuration
) 
 
LOD: 0.57 mg/L [10] - [11] 
 EDCs 
Enzymatic 
(Tyrosinase) 
- [12] - [13]–[15] 
 
Alkylphenols 
and their 
ethoxylates 
Antibodies LOD: μg/L range [16] - - 
 Nonylphenol Antibodies LOD: 10 μg/L range [17] - [13] 
 
Pesticides 
(Carbofuran 
and/or 
Paraoxon 
Enzyme 
(AChE) 
Discrimination 
between different 
AChE inhibitors by 
neuronal networks 
LOD: 0.2 μg/L 
[18] - - 
 BOD Multispecies 
culture 
Minimum measurable 
BOD=0.088 mg/L O2; 
(biosensor 
BOD/BOD5) ratio=0.80 
[19] - [20] 
 Organophospho
rus compounds 
Enzyme 
(organophosp
horus 
hydrolase) 
Modified carbon 
nanotube 
[21] - [22] 
 Phenols 
Enzymatic 
(cellobiose 
dehydrogena
se and 
quinoprotein
dependent 
glucose 
dehydrogena
se) 
In-field measurements 
LOD: 0.8 μg/L 
[23] - [24] 
 Surfactants 
Pseudomonas 
and 
Achromobact
er (plasmid 
for anionic 
surfactant 
degradation) 
LOD: 0.25 mg/L (SDS) [25], [26] - [27] 
 
Oxygen 
reduction 
reaction (ORR) 
 
- 
micro-electrochemical 
Chip 
- - [28] 
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Table 2: (Cont.) Current environmentally-aimed transducing elements with corresponding environmental analytes of 
interest. 
Transducing 
element 
Compounds or 
parameters 
Bio-
recognition 
element 
Features 
Reference 
(s) 
Relevant 
LOAD 
reference 
Relevant 
LOC 
reference 
 LAS 
Trichosporon 
cutaneum 
(LAS-
degrading 
bacteria) 
In-situ 
measurement LOD: 
0.2 mg/L 
[29] - - 
Electrochemical 
(chrono-
potentiometric) 
Electrolytes 
- 
 
Gold sensing micro-
electrodes; Cation 
exchange 
membrane (CEM) 
 
- - [30] 
 
Chlamydia 
trachomatis 
(DNA) 
DNA 
(hybridisation
) 
Previous PCR 
amplification LOD: 
0.2 mg/L 
 
[31] - [32] 
 Daunomycin 
PCBs, Aflatoxin 
DNA 
LOD: 0.3 mg/L, LOD: 
0.2 mg/L, LOD: 10 
mg/L 
[31], [33] - [32] 
Electrochemical 
(potentiometric) 
Nitrate ion 
NO3- ion-
selective 
membrane 
NO3- ion recovery: 
97-105% 
- - [34] 
 Escherichia Coli Antibodies 10 cells/mL [35] - [36] 
Electrochemical, 
optical and mass 
signal 
(combination) 
- - - - - - 
 
Cadmium, 
copper and 
mercury 
Enzyme 
(AChE and 
urease) 
Array biosensor for 
the measurement of 
pH, urea, heavy 
metals and AChE 
[37] - - 
Electrochemical 
and sonochemical 
(combination) 
- - - - - - 
 
Dichlorvos, 
parathion, 
anzinphos 
(organophosph
orus pesticides) 
Enzyme 
(AChE) 
Array of 
microelectrodes 
[38] - [38] 
Optical 
(fluorescence) 
Multiple 
compounds 
Antibodies 
multiplexed bead-
based fluorescence 
immunoassays 
- [39]–[42] - 
 EDCs Recombinant 
yeast 
- [43] - [44] 
 
Isoproturon, 
diuron simazine 
 
Chlorella 
vulgaris 
(Algae cells) 
0.025 μg/L, 0.5 μg/L [45] - - 
 PCBs Antibodies LOD: 0.1 ng/L [46] - [47] 
 Bisphenol A Antibodies Monitoring in a 
waterworks 
[48] [49] - 
 
Naphthalene 
and 
phenanthrene 
DNA Sol–gel array [50] - - 
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Table 2: (Cont.) Current environmentally-aimed transducing elements with corresponding environmental analytes of 
interest. 
Transducing element 
Compound
s or 
parameters 
Bio-
recognition 
element 
Features 
Reference 
(s) 
Relevant 
LOAD 
reference 
Relevant 
LOC 
reference 
 Nitrate 
Recombinant 
Escherichia 
coli 
Without 
interference of 
phosphate, chloride 
or nitrite 
[51] [52] - 
 
Antibiotics Antibodies - [53] - - 
 
Propanil Antibodies 0.6 ng/L [54] - - 
 Pesticides 
and 
estrone 
Antibodies 
Natural water 
samples 
[55]–[57] [58] - 
 
Hormones 
(estrone, 
progestero
ne, 
testosteron
e) 
Antibodies LOD: sub-ng/L [59]–[61] - - 
 
Hormones 
(estrone, 
progestero
ne, 
testosteron
e) 
Antibodies LOD: sub-ng/L [59]–[61] - - 
Optical 
(luminescence) 
- 
 
- - - [62], [63] - 
 
Dioxin and 
dioxin-like 
chemicals 
 
Recombinant 
hepatoma 
cells 
LOD: 10 pM [64] - - 
 
Benzene 
and its 
derivatives 
Recombinant 
Escherichia 
coli 
Air determination 
LOD: 0.5 mg/L, LOD: 
0.5 mg/L 
[65] - - 
 
Genotoxicit
y 
 
Recombinant 
Escherichia 
coli 
- [66] - [67] 
 Toxicity 
Recombinant 
bioluminesce
nt bacteria 
Cell array to classify 
toxicity 
[68] - [69] 
 
Mercury 
arsenite 
 
 
Pseudomonas 
fluorescence 
(with sensors 
plasmids) 
0.003 μg/kg, 0.7 
μg/kg 
[70] - - 
 
Heavy 
metals 
Recombinant 
Escherichia 
coli 
Bioavailable fraction 
in soils 
 
[71] - [69] 
 
Chlorophen
ols 
Enzymatic 
(horseradish 
peroxidase) 
 
LOD: 1.4–1975 μg/L [72] - - 
 Toxicity 
Genetically 
engineered 
bioluminesce
nt bacteria 
Portable [73] - [69] 
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Table 2: (Cont.) Current environmentally-aimed transducing elements with corresponding environmental analytes of 
interest. 
Transducing element 
Compound
s or 
parameters 
Bio-
recognition 
element 
Features 
Reference 
(s) 
Relevant 
LOAD 
reference 
Relevant 
LOC 
reference 
Optical (Optic fibre) - - - - [74] - 
 Low BOD 
Pseudomonas 
putida 
Minimum 
measurable 
BOD=0.5 mg/L O2; 
comparison with 
BOD5: R2=0.971 
[75] - - 
Optical (Colourimetric 
absorbance) 
- 
 
- - - - [76], [77] 
 Phosphorus 
blue 
phosphomoly
bdenum 
complex 
LOD: 5 μg/L PO4-P, 
Linear range: 14–
800 μg/L 
Sensitivity of 0.003 
AU.L/μg 
[76] - [76] 
 
Chromium 
(III) 
2,6-pyridine 
dicarboxylic 
acid 
LOD: 21 mg/L 
Linear range: 69–
1000 mg/L 
[77] - [77] 
 
Chromium 
(VI) 
1,5-diphenyl 
carbazide 
(DPC) 
LOD:  4 μg/L 
Linear range: 14–
1000 μg/L 
[77] - [77] 
Optical (SPR) 
immunoglo
bulin A 
(IgA) 
Antibodies 
Gold surface SPR 
detection chamber 
 
 [78] - 
 EDCs 
Estrogen 
receptor 
LOD: 0.1 μg/L 
(estradiol) 
 
[79] - - 
 Salmonella 
enteritidis 
Antibodies 106 cell/mL [80] - - 
 
Carbaryl Antibodies 
Self-assembled 
monolayers LOD: 
1.38 μg/L 
[81] - - 
 
Bisphenol A Antibodies 
SPE prior to analysis 
to improve 
sensitivity 
[82] - - 
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Figure 2.8: Graphical illustrations of Surface acoustic wave (SAW) biosensors. 
Top) A ‘shear horizontal surface acoustic wave’ (SHSAW) biosensor with SiO2 nanoparticles waveguide 
(42); The IDT design parameters (a), Microscope image of the SHSAW fabricated biosensor for E. coli 
O157:H7 detection with APTES (b), HPM and SEM images of the IDTs (c), Microscope image of the whole 
SHSAW biosensor and probe pads (d), AFM image of deposited SiO2 layer (e) and FESEM image of the SiO2 
nanoparticles at 5 kV with 800,000 magnification (f).  
Bottom) A Schematic layout of the dual-type SAW sensor packaged on a printed circuit board (top view) 
(A)(45); A Schematic diagram of the cartridge assembly for the integration of the SAW immunosensor (B) 
and  image of the assembled cartridge ﬁlled with reagents and sample for troponin I (cTnI) cardiac marker 
analysis (C); white lines indicate the direction of ﬂow for the implementation of the applied assay, and the 
dotted line indicates the ﬂow direction for plasma puriﬁcation and metering. Each reagent is transported 
according to the alphanumeric sequence. Picture of the centrifugal cartridge operating system (D). 
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 Electrochemical transducers 
Electrochemical transducers are the branch of sensors which utilises electricity as a 
quantitative phenomenon to investigate chemical or biological reactions(120). This is 
achieved through the measurement of electrical charge interactions between the 
electrodes and electrolytes (or ionic species in a solution). Electrochemical transducers 
usually consist of two or more electrodes for detection, with preference on latter for 
specific electrochemical studies as the collected data is more explicit and definable due 
to the presence of a reference electrode(120,121). Electrochemical sensors can be 
widely classified as two predominant categories; biosensors and chemical sensors. 
 Biosensor-based electrodes relate to platforms which specialise in the sensing of 
present biological compounds such as Proteins, nucleotides and tissues(122–124). 
Examples of biosensor-based electrodes in microfluidic platforms, including Lab-on-a-
disc(125), Lab-on-a-Chip(126) and paper-fluidics(127), has become prevalent. 
Chemical-based electrodes can be used as a catalyst for biochemical/chemical 
compound reactions, either through oxidisation or reduction(128,129). Examples of 
chemical-based electrodes in microfluidic platforms, including Lab-on-a-disc(10,18), 
Lab-on-a-Chip(130) and paper-fluidics(131), has become prevalent. 
Through the combined efforts of these classifications, often referred to as an 
‘electrochemical biosensor’, individual and highly selective electrochemical analysis can 
be achieved, including the ‘capture’ and ‘release’ rates of target analytes(132–134). Two 
forms of electrochemical studies will be presented here; amperometry and 
potentiometry.  
 
 Amperometry 
Amperometry involves a step electrical potential applied to a ‘working electrode’, which 
causes the electroactive species to generate a current. This current is then measured 
across the working electrode and the counter electrode. The generated current is 
proportional to the concentration of the electroactive species in solution and 
exponentially decays with respect to time. The function of this phenomenon is described 
by the Cottrell equation. 
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Figure 2.9: Amperometric-based electrochemical detection on a LOAD platform (49). 
Left) 1) schematic of the microfluidic disc design with integrated miniaturized gold electrodes, labelled as 
the working (W.E.), reference (R.E.) and counter (C.E.) electrodes. (2) Image of the fabricated disc loaded 
with coloured water to aid visualization. (3) Setup for the on-disc electrochemical measurements. This 
setup includes an electrical slip-ring mounted onto a motor, a stationary potentiostat, and a PCB 
component that makes electrical contact with the electrodes embedded within the microfluidic disc. 
Right) Stroboscopic images of the critical operational steps. For visual aid, coloured water was utilized. (a) 
Purified sample from the Sample Collection Chamber mixes for 10 s with a solution containing detection 
antibodies. (b) The mixed solution is transferred to the Reaction Chamber containing polystyrene beads 
coated with capture antibodies. Here, the solution is incubated for 10 min. (c) Extra solution is transferred 
to the Waste Chamber. (d & e) Two washing steps are applied to the beads. (f) Finally, the substrate 
solution (TMB) is introduced into the Reaction Chamber and is incubated for 5 min. Finally, the incubated 
solution flows over the electrodes in the Detection Chamber for electrochemical detection. (g: i–iv) 
Schematic representing the steps automated on the microfluidic disc: ELISA followed by electrochemical 
detection. (i) Introduction of the sample, containing the CRP antigen, to the capture antibody-coated PS 
beads. The CRP antigen is pre-incubated with the detection antibody. (ii) Washing of PS beads. (iii) 
Introduction of TMB to quantify captured CRP. (iv) Electrochemical measurement of TMB.(49) 
 
An example of amperometry used in environmental monitoring is demonstrated by Shi 
et al.(135), whereby organophosphates, specifically dichlorvos, was reported with a 
detection limit of 10 nM in the simulated seawater during a 15 min inhibiting time. While 
this example only demonstrates the electrode used, development of a centrifugal 
microfluidic platform around this electrode could assist in automation. Another example 
of amperometric-based electrochemical detection on a LOAD platform using antibody 
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technology(49) is illustrated in Figure 2.9. In this example(49), a three-electrode system 
(working, counter and reference), combined with antibody-coated polystyrene (PS) 
beads, was employed for detecting a biomarker for cardiovascular disease (C-reactive 
protein) with a LOD of 4.9 pg.mL-1. While this example is not a demonstration of LOAD 
platforms used in environmental monitoring, it demonstrates the potential for a high-
sensitivity biosensor to be integrated into a LOAD platform, and with the substitution of 
environmental-targeted antibody technologies (as illustrated by Figure 2.9-
biorecognition element), could be used to detect many different environmental 
analytes. 
 
 Potentiometry 
Potentiometry is an electrochemical study in which a constant electrical potential is 
applied to one of the electrodes, referred to as the ‘reference’, causing a change in 
sample composition which can then be assessed by the second ‘indicator’ electrode 
(120). This quantification of change is based on the potential difference between the 
two electrodes. As potentiometry is a passive measurement of the solution, it is also 
considered a non-destructive measurement, under the assumption that both the 
material of the electrode and the solution can equilibrate. It is common practise that 
indicator electrodes, which have been designed to be specifically ion-selective 
electrodes (ISE), are used in potentiometric studies. This is because the potential is solely 
dependent on the activity of the target ion-of-interest; an example is described by, 
where a nitrite ion-selective membrane was used (75). The sensitivity and accuracy of 
the platform is determined by the time to reach equilibrium between the solution and 
the electrode. This is therefore an ideal type of detection that could be performed on 
LOAD based platform. In aquatic environments, platinum is regularly utilised as an 
electrode due to its high electron transfer kinetics (136), but a combination of metals 
can also be used for further enhancing electron transfer kinetics (137). 
Chronopotentiometry is a variant of potentiometry, first initiated by the work of 
Weber(138), in which measurement of electric potential as a function of time are 
performed whilst a constant current is being maintained. An example by Gabig-Ciminska 
et al. (77), also shown in Figure 2.10, demonstrates how potentiometric measurement 
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of a targeted enzyme product can be achieved. In this example, a silicon chip-based 
electric detector was coupled with bead-based sandwich hybridization (BBSH) to 
perform rapid analysis of specific nucleic acids, which also included characterisation of 
the platform using in vitro synthesized RNA oligonucleotides, followed by analysis of 16S 
rRNA in Escherichia coli extract. In the analysis of the synthesized mRNA, 200 fmol 
(corresponding to 1011 target molecules) was detected, with suggestions made on 
further optimisations which could further improve the detection limit to 109–106 target 
molecules.  
 
Figure 2.10: Potentiometric-based electrochemical detection on a LOC platform (77).  
Top) Principle of the electric chip-based nucleic acids assay (panel A) and the redox recycling scheme (panel 
B).  
Bottom) Top view of detailed interdigitated electrodes on the chip (left). The schematic diagram of the 
integrated fluidic system (right) (77). 
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 Optical transducers 
Optical detection is one of the most successful and common forms of detection on 
microfluidic platforms, primarily due to the wide availability of cheap, low-energy 
consumption and simplistic integration requirements, which evident by the significant 
number of review articles over the past decade (139). One of the most common forms 
of optical transducers used are electro-optic transducers. Electro-optic transducers, 
usually consisting of a light source, photodiode and integrated circuit, operate through 
the conversion of electrical potential into light radiation. The generated light interacts 
with a sample, and the reemitted light is recorded and converted back to electrical 
signals. These electrical signals are used to quantify the sample-light interaction, 
dependent on the selected choice of optical arrangement. For optical transducer 
platforms, due to the abundance of widely available light-emitting-diodes (LEDs) and 
photodiodes types, detection of on-chip assay can be easily tailored to achieve optimum 
detectability. Three reoccurring optical arrangements which will be discussed include 
absorbance, fluorescently and surface plasma resonance (SPR). 
 
 Absorbance spectroscopy 
Absorbance-based optical detection is a common technique used in laboratory 
environments in the form of a photo-spectrometer. This approach employs the use of a 
set wavelength, or spectrum, to characterise and analyse a sample. In this approach, 
both the light source and photodiode detect are set to detect only the loss in the emitted 
light source wavelength through sample absorption.  Several sample characteristics can 
be determined from this approach, depending on the quanta of light used, including 
sample identification and quantification of component concentrations. Absorbance 
spectroscopic studies are relative measurements, whereby an assessed sample is 
contrasted against a known standard of similar composition, or blank sample. 
Absorbance spectroscopy on LOAD platforms has been reported for the detection of 
phosphate(10) and chromium (III & VI)(18), with a generalised example illustrated in 
Figure 2.11. In the case of the phosphate detection system(10), the ascorbic acid 
colourimetric absorbance assay, adapted from Clesceri et al.(140), was incorporated on 
a LOAD platform for determining phosphate with a reported sensitivity and limit of 
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detection of 0.003 AU L μg−1 and 5 μg L−1 PO4-P respectively. In a LOAD system chromium 
(III) and (VI) were measured using 2,6-pyridine dicarboxylic acid and 1,5-diphenyl 
carbazide (DPC) respectively, forming complexes that were measured at 535 nm. The 
LOD for trivalent and hexavalent chromium using this device were 21 mg L−1 and 4 μg 
L−1, respectively. The sensitivity was found to be 0.0012 AU L μg−1 for Cr(III) and 0.0017 
AU L μg−1 for Cr (VI).(18).  
 
 
Figure 2.11: Absorbance-based optical detection on LOAD based platforms. 
This LOAD platform has been designed to measure sample light absorbance through an optical 
pathway(10,18).  
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 Fluorescence spectroscopy 
Fluorescence-based optical makes use of either a particular light excitation wavelength, 
to interact with targeted molecules (fluorophores), which convert and reemit an 
emission wavelength, therefore determining the quantity of fluorophores present. 
Fluorophores can be easily integrated to more specific and sensitive molecules such as 
antibodies(141–143), proteins(144,145) and ligands(146,147) for high affinity capture 
targeted biological or chemical complexes in samples such as toxins,  antibiotics(92), 
propanil(93), pesticides and estrone(94–96), naphthalene(89) and phenanthrene(89) 
and heavy metals(148,149). In these cases, fluorescence detection in the ng L-1 range is 
common, where in the case of PCB detection, a limit of detection as low as 0.1 ng L-1 was 
reported (86). Fluorescence is a form of luminescence, whereby luminescence occurs 
due to a reaction with excitation photons (photoluminescence), but luminescence can 
occur through other means; such as electrical(150), chemical(151), electrochemical(152) 
and bioluminescence(106,109,153). Figure 2.12.A illustrate how an immune complex 
can be formed and assessed, using a targeted antigen and fluorescently enabled 
antibody, with Figure 2.12.B demonstrating how heavy metals can be captured for 
assessment using a DNA-ligand binding. An example of how possible fluorescent 
detection can be integrated on a LOAD platform is illustrated in Figure 2.12.C. 
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Figure 2.12: Analyte capture and optical detection. 
 A) Antibody technology can be used if an anti-analyte can be constructed, such as a toxin. The anti-analyte 
can also be fluorescently enabled to allow optical detection. B) Deoxyribonucleic acid (DNA) can be 
modified to collect analytes, in this case, to collect mercury(154). C) A graphical illustration of how 
fluorescent spectroscopy can be carried out on a LOAD platform. With the capture analyte bound to 
optically responsive fluorescent label, upon excitation, the emission can be recorded. This set-up can be 
modified for a luminescent set-up also by replacing the label and removing the laser/light source. 
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 Surface plasmon resonance (SPR) 
Surface plasmon resonance (SPR) is a label-free optical detection technique in which a 
reflective substrate, such as gold or silver, is coated with ligand or antibody technology 
and used to assess analyte-to-substrate binding rates, specificity, affinity, kinetics and 
analyte concentration. This is assessed by changes in the angle of reflected light, as the 
refractive index of the substrate is proportional to the change in surface mass, thus 
allowing highly sensitive quantification of analytes of interest. An example of SPR 
through antibody-based detection on a LOAD platform is demonstrated by Hemmi et al 
(115)(Figure 2.13). Using this device as an example, it is reasonable to expect that similar 
results could be obtained through substitution of the IgG antibodies with alternative 
ligand/antibody technology. As previously reported, SPR has been used in the detection 
of Salmonella enteritidis (117), carbaryl (118) and bisphenol A (119). While the limits of 
detection reported by these examples are as low as < 2 μg.L-1, which is significantly 
higher than the reported fluorescence-based limit of detection of 0.1 ng.L-1, its key 
advantages are the multiple characteristics which can also be quantified. SPR has been 
demonstrated in the detection of domoic acid in marine sensing applications (155).  
 
Figure 2.13: SPR optical detection on LOAD based platforms, as described by Hemmi et al (115). 
 This illustration demonstrates a particular reservoir of the microfluidic disc which has a gold grating lined 
in the reservoir, on which analyte-surface interactions can be analysed. This occurs due to a change on the 
surface’s mass modifying the trajectory of the optical rays due to a change in refraction index.  
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 Opportunity for LOAD modifications in environmental 
monitoring 
The success of a LOAD system is dependent on its ability to mimic the specific laboratory 
protocols with which are required to conduct sample-to-answer analysis, and to achieve 
this, electrical integration is key. This would offer capability for sample treatments 
including sample handling and manipulation (such as mixing and separation), sample 
modification (including heating and redox reactions), as well as reaction detection (such 
as optical, electrochemical, or as required by user) on the device. Therefore, it is 
important to maximise the LOAD capabilities and make it would be a more attractive 
platform.  
 
Currently, by comparison of the varying transducers, it is evident that electrochemical 
and optical integration on LOAD platforms offer a myriad of detection possibilities with 
minor modifications of previously successful platforms. However, electrochemical LOAD 
systems have been slower to be adopted due to difficulties in integration of the 
electrodes with external electrochemical connections. This initially requires the disc to 
be stationary for electrochemical detection to occur, as demonstrated by Nwankire et 
al(156). While this stopped-measurement is a less complex solution, it may not always 
be feasible. The inputted sample may need to be measured during electrode-
passthrough, perhaps to conduct kinetic studies or identify other sample traits 
obtainable through SPR, or as per assay requirements. Many methods have been 
proposed to date to overcome the issues and allow sample-in-motion electrochemical 
studies, and as well as more integrated optical studies, to occur.  Wireless induction-
powered programable integrated circuits with expandable capabilities through module 
stacking(157) (Figure 2.14.A),  slip-ring based connection to external potentiostat(49,50) 
have been described Figure 2.14.B), or alternatively using an on-disc, battery-powered 
plug-and-play electrochemical system (Figure 2.14.C). Each system has its advantage 
and disadvantage. While the wireless power transfer system offers a constant power 
solution, similar to the slip ring solution and unlike the battery powered solution, it 
comes with the added weight provided by induction coil. As the slip-ring solution does 
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not require the induction coil, it can however add significant electrical noise to the 
system, a feature that is undesirable for electrochemical studies. The battery-based 
option is expected to be the most electrically stable solution, but battery longevity for 
long-term deployment is a major issue. A solution may be a combination of all the 
systems, perhaps with a battery-based system with slip-ring or wireless charging 
solution.  
 
Figure 2.14: Future developments for Lab-On-A-Disc platforms studies.  
A) An example of an induction-based, electrically configurable system, developed by J. Höfflin et al.(157), 
for performing in-motion detection which could be modified to conduct electrochemical studies on LOAD 
platforms. B) An example of a slip-ring based electrical system, designed by Kim et al.(49),  for conducting 
electrochemical analysis while disc is spinning. C) An example of a battery powered system, which can 
perform both optical and electrochemical studies simultaneously. This system is can communicate 
wirelessly to transmit recordings as well as receiving commands. 
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 It is hoped that these additions will pave the way for the next-generation LOAD 
platforms which be more capable of performing environmental analysis activities on a 
disc. Refining and optimisation of these platforms could also aid in the development of 
more generic LOAD platforms which can be used for observing and quantifying current 
environmental problems. These would then offer better environmental data, from 
which more informed decisions can be made. 
 
 Conclusions 
While centrifugal microfluidics is an ever-evolving field, it is important to illustrate how 
Lab-On-A-Disc (LOAD) advances can be very useful in the field of environmental 
monitoring with minimal systematic modification. As with LOC systems the disadvantage 
of LOAD for environmental monitoring include: sample preparation (filtering, lysing, pre-
concentration) currently needs to be done off chip for water samples containing cells or 
particulates. This is due to the potential for clogging of the channels.   
Some key advantages of LOAD sensors identified: 
 Cost-effective support equipment: LOADs use low cost motors as opposed to the 
use of LOC microfluidic pumps.  
 Replacement of damaged equipment would also be minimal for LOAD vs. LOC. 
 Due to the use of a compact disc based design, it has a familiarity of "spin-to-
use" for the end-user/automation process, due to the resemblance of many 
common technology is. Cd drives, DVD players, computer consoles. 
 LOCs utilise a common sample input which is directed through often an assay 
protocol for detection. Due to the nature of the LOAD, incorporation of multiple 
assay iterations can be carried out simultaneously, with separate loaded samples 
if desired, using a motor. This can be compared to a LOC system which would 
require further pumping mechanisms to achieve this. 
 Pumping can cause leakages due to high pressures involved in driving liquids 
through small channels, especially in sandwich-constructed LOC platforms. 
Centrifugal forces which are utilised in LOAD systems are limited both by the 
radius of the disc and the mass of the loaded liquid, therefore the pressures 
required for driving samples is significantly less. 
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This review presents the relevant information for developing new and novel 
environmental sensing systems based on centrifugal microfluidic platforms. The key is 
in identifying the most suitable transducer, for application to the most common 
analytes-of-interest. An environmental sensing LOAD platform is designed around this 
transduction method and the chemical or bio-assay to measure the analyte. The review 
identifies the quite significant gap in the ability to detect certain environmentally 
relevant compounds or parameters for which monitoring is important. LOAD systems 
provide a robust, versatile option to developing such novel sensing systems.  
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 A novel microfluidic 
analytical sensing platform for the 
simultaneous detection of three 
algal toxins in water 
 
Chapter Foreword 
As discussed in the Chapter 2, there is a need for the development of environmental 
sensing platforms. Therefore, the purpose of this chapter is address some of these needs 
through the investigation and development of a hand-held algal toxin detection system 
which uses centrifugal microfluidics. Firstly, the reader will be presented with the 
background information of three high interest algal toxins (microcystin, saxitoxin and 
domoic acid), followed by the current methods of detection. Finally, a novel algal toxin 
centrifugal microfluidic platform, with a complementary detection system, will be 
presented. This generic algal-toxin detection platform uses an inverse-based 
fluorescence assay detection of these three-separate high interest algal toxins with a 
response time after 20 min (Figure 3.1).  
The limit of detection (LOD) of the device was determined to be 7.2 ng/mL, 20 ng/mL 
and 50 ng/mL for microcystin-LR, domoic acid and saxitoxin respectively. The disparity 
between the LODs for each analyte was primarily due to significant more optimisation 
of the microcystin-LR assay and these parameters were then used to detect the other 
analytes without further optimisation. It is believed that further optimisation would 
have improved the detectability of the other analytes. The lower limit of quantification 
was approximated as 2.5 times the limit of detection, with a sigmodal trend, detected 
after 10000 ng/mL, used as the higher limit of quantification.  
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Figure 3.1: The inverse assay toxin detection strategy used in the algal-toxin detection platform. 
Therefore, the dynamic range was identified to be ~18 – 10000 ng/mL. Three notable 
interferences clearly impeded measurements; Optical alignment, electronic 
configuration of the detection system and difficulties in toxin adhesion to the biosensor 
surface. The optical alignment of the disc with the detector proved troublesome initially, 
and required a revamping of the alignment pins used in the disc. This significantly 
increased the repeatability measurements of the disc. The electronic configuration of 
the disc underwent many different orientations and redesigns. Initially a bottom-up 
detector was employed, but due to difficulties with inconsistent transparency after toxin 
adhesion to the biosensor surfaces, the recorded signal became unreliable. Therefore, a 
top-down optical orientation was used which proved more successful. Finally, due to the 
prototyping nature of the electronics controller board incorporated within the system, 
electronic signal saturation occurred. This was rectified by incorporating several 
capacitors within the system to remove external electrical noise.  
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  Abstract 
 Globally, the need for ‘on-site’ algal-toxin monitoring has become increasingly urgent 
due to the amplified demand for fresh-water and for safe, ‘toxin-free’ shellfish and fish 
stocks. Herein, we describe the first reported, Lab-On-A-Disc (LOAD) based-platform 
developed to detect microcystin levels in-situ, with initial detectability of saxitoxin and 
domoic acid also reported. Using recombinant antibody technology, the LOAD platform 
combines immunofluorescence with centrifugally driven microfluidic liquid handling to 
achieve a next-generation disposable device capable of multi-analyte sampling. A low-
complexity ‘LED-Photodiode’ based optical sensing system was tailor-made for the 
platform, which allows the fluorescence signal of the toxin-specific reaction to be 
quantified. This system can rapidly and accurately detect the presence of microcystin-
LR, domoic acid and saxitoxin in 30 mins, with a minimum of less than 5 mins end-user 
interaction for maximum reproducibility. This method provides a robust ‘point of need’ 
diagnostic alternative to the current laborious and costly methods used for qualitative 
toxin monitoring. 
 
 
 
75 | P a g e  
 
 Introduction 
With the rapid incline of population growth, the global demand and pressure for clean 
water supplies has never been more apparent. The resultant anthropogenic 
environmental impacts are predicted to increase freshwater harmful cyanobacterial and 
algal bloom prevalence and duration(1,2). These impacts include both global warming 
and water quality degradation, particularly due to eutrophication. Human, ecological 
and economic health can all be negatively impacted by harmful cyanobacterial and algae 
blooms formed due to eutrophication(3,4). 
Microcystis aeruginosa is one of the most recurrent toxin-producing species of 
freshwater cyanobacteria, and commonly prevails in fresh and brackish water. One of 
the most dangerous toxins produced from harmful algal blooms (HABs) is microcystin-
LR (MC-LR), produced directly by Microcystis aeruginosa, and is shown in Figure 3.2.Left. 
MC-LR can cause significant health issues for both humans and animals(5), particularly 
by inflicting hepatotoxicity and carcinogenesis through ingestion(6). In the EU, 
regulatory levels for MC-LR in water is 1 ng/mL for drinking water and bathing sites, with 
a >20 ng/mL concentration eliciting further action(3). One of the most extreme cases of 
human exposure transpired in Caruaru, Brazil in 1996 in a haemodialysis clinic(7). It was 
reported that 86% of the 116 patients undergoing dialysis in this clinic experienced 
severe MC-LR related symptoms including liver failure, resulting in the death of 52 
patients.  
A second documented marine toxin is domoic acid (DA), also demonstrated in Figure 
3.2.Centre, which is a highly potent neurotoxin. Naturally manufactured by variant 
species of diatom, originating from the genus Pseudonitzschia, it can be responsible for 
eliciting the amnesic shellfish poisoning (ASP) illness(8). Following  human exposure, 
some responses to ASP can include gastrointestinal distress, confusion, disorientation, 
seizures, permanent short-term memory loss, and in the most severe cases death(8,9). 
The earliest documented case of ASP contamination was in 1987 on the eastern coast 
of Prince Edward Island, Canada, where harvested mussels, contaminated with DA, were 
consumed(8–11). This case reported the death of 4 people, with a total of 143 people 
presenting similar ASP illness. Following the Canadian ASP event of 1987, and to protect 
seafood consumers, authorities established an action limit for DA of 20 μg DA/g shellfish 
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tissue(8). As there is no well-defined action limit for free DA in drinking water, a method 
of extraction of DA from shellfish for detection using antibody technology(12), which 
involved a 250-fold dilution step, was used to translate the action limit for free DA to 
approximately 80 ng/mL in water.  
A third highly prevalent marine toxin is saxitoxin (STX), also illustrated in Figure 
3.2.Right, which is another potent neurotoxin. It is most notably responsible for 
paralytic shellfish poisoning (PSP) and is produced by the genus Alexandrium spp. Some 
of the human responses following exposure to PSP can include gastrointestinal 
symptoms, numbness/tingling in mouth, dizziness, headache, fever, ataxia, respiratory 
distress, and death(13). Although there is currently no statutory guideline for STX 
contamination of drinking water, a suggested 3 ng/mL informal guideline concentration 
of for STX is currently used(14). 
These relatively low guideline levels illustrate the importance of continuous 
environmental monitoring, and in particular, on-site algae-toxin monitoring. 
 
 
Figure 3.2: The chemical structures of microcystin-LR (MC-LR), domoic Acid (DA) and saxitoxin (STX) in their 
predominant congener form. 
Currently, there are several in-situ based systems with the potential to monitor toxin 
presence, and in particular MC-LR, where one such case was developed by MacKenzie 
et al. in 2004(15). This approach uses a technique, referred to as solid phase adsorption 
toxin tracking (SPATT), which has since been adapted to allow the detection and 
monitoring of toxic algal blooms and shellfish contamination events(16). This technique, 
while beneficial, does require lab-based liquid chromatography-mass spectrometry (LC-
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MS) analysis on the previously deployed and recovered materials. This limits the 
potential of the analysis system, preventing continuous autonomous analysis. Another 
disadvantage of this method is the low throughput capabilities, as well as the inability 
of real-time data capture, due to a weekly-based deployment and recovery sampling 
regime. These limitations also illustrate the requirement for highly trained technicians 
who are capable of handling and characterising weekly samples, consequently 
increasing the associated costs significantly. These increased costs would also negatively 
impact the ability of this approach to perform multiplexed, high density sampling in sites 
of interest. Other alternative biosensor-based methods, which have been used in the 
detection of MC-LR, have also been limited by this requirement of laboratory-based 
analysis. Chianella et al.(17) detailed a novel molecularly imprinted polymer (MIP)-based 
piezoelectric sensor for MC-LR with a low detection limit for 0.35 nM (0.35 ng/mL) using 
in-laboratory analysis. Similarly, electrochemical biosensors with reported sensitivities 
of 0.1 μg/L (0.1 ng/mL) for MC-LR (18) and 9.0×10−11 M (~0.09 ng/mL) for a MC-LR 
specific gene sequence(19), which again requires the use laboratory-based 
instrumentation. A highly sensitive immunosensor for MC-LR has also been 
demonstrated(20), whereby a graphene–gold nanocomposite/functional conducting 
polymer/gold nanoparticle/ionic liquid composite film with electrodeposition achieved 
MC-LR detection limits of as low as 3.7×10−17 M (~4x10-5 ng/mL). Another immunosensor 
based-method by presented by Queirós et al.(21), demonstrates the use of a Fabry–
Pérot interferometer combined with an optical fibre, coated with a sol–gel imprinted 
sensing membrane, attained a MC-LR detection sensitivity of 12.4 ± 0.7 nm.L/μg (~0.08 
nm-1.(ng/mL)). Finally, a cantilever-based immunosensor was also developed, which 
could assess MC-LR concentrations as low as 1pg/mL (0.001 ng/mL) in varying water 
sources(22). While these methods achieve highly desirable detection sensitivities, they 
all suffer from the common requirement of expensive laboratory equipment, with 
specially trained personnel, in order to perform the analysis. However, an in-situ based 
method has been previously reported by Long and colleagues(23), whereby a 
commercially available portable trace organic pollutant analyser (TOPA) was used to 
detect MC-LR, however the limit of detection of the assay was significantly higher than 
any of the lab-based methods at 0.03 µg.mL−1 (30 ng/mL), which is above the 1 ng/mL, 
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and 20 ng/mL, action limits for MC-LR in drinking water, and bathing sites, 
respectively(3).  
In order to facilitate toxin monitoring at the ‘site of interest’, in-situ toxin detection can 
be alternatively achieved using Lab-On-A-Chip (LOC) technologies. This can be achieved 
through precisely controlling and manipulating of small quantities of liquids contained 
within a LOC platform, in order to process and analyse a sample as if in lab environments, 
even when in-situ. These relatively new technologies are highly customisable and 
commercially-viable alternatives to the current detection methods which have been 
previously employed for environmental monitoring. LOC-based platforms have been 
used to specifically target in-situ environmental monitoring, including the detection of 
phosphate(24–27) and Escherichia coli (E. coli)(28,29),  with the potential to also detect 
polycyclic aromatic hydrocarbons (PAHs), endocrine disruptors (EDCs), inorganic ions 
and heavy metals, by utilising already developed microfluidic techniques(30). Whilst LOC 
platforms are highly convenient, cost-effective and highly adaptive, the pumping 
technologies often required to drive sample progression through a LOC cartridge can be 
expensive. This is primarily due to the high costs associated with precise pumping 
mechanisms. A derivative of the LOC platform, circumventing these externally required 
expenditures is the Lab-On-A-Disc platform (LOAD)(31,32). 
The LOAD centrifugal microfluidic platform replaces these previously required pumping 
mechanisms with a centrifugal driving force, utilising a more cost-effective motor 
system. To date, on-chip water quality assessment systems have been primarily 
developed using LOC systems, with only a few examples reported on centrifugal disc 
(CD) platforms(33,34). There are multiple advantages associated with LOAD platforms 
including; automation of system through precisely-timed sample actuation using 
centrifugal forces, precise liquid handling, control of samples using valves, ability to 
multiplex assays using identical test conditions and a myriad of detection techniques 
compatible on disc, making it an ideal technique for in-situ environmental monitoring. 
In this paper, the first reported multi-analyte LOAD algal toxin sensor is described. The 
purpose of this sensor is to advance the first generation LOAD platform(35), whereby 
multi-toxin detection of a single, pre-lysed sample was confirmed using a fluorescent 
microscope. The novelty of this system includes the use of highly-specific recombinant 
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antibody technology, coupled with highly sensitive immunoaffinity purified antibodies 
from chicken, which have far greater sensitivity than their commercial counterparts. The 
production of specific DA and STX antibodies in chickens allowed for large quantities of 
highly sensitive Immunoglobulin Y (IgY) to be purified with relative ease and minimum 
cost. The LOAD platform combines immunofluorescence with centrifugally driven 
microfluidic liquid handling to achieve a next-generation disposable device for in-situ 
high-throughput sampling. Recombinant antibodies (rAb) were selected over alternative 
antibody technologies. rAb ensure consistent bio-sensing detection, with high purity 
yielded from production and minimal batch-to-batch manufacturing variation. A low-
cost, ‘LED-photodiode’ based optical sensing system was tailor-made for the platform. 
This optical sensing system allows the fluorescence signal of the toxin-specific reaction 
to be quantified. This system can rapidly and accurately detect the presence of the 
targeted toxins in approximately 30 mins, with a maximum of 5 mins of user-interaction 
and high reproducibility. Due to the imminent requirement for a rapid and reliable 
qualitative assessment of waterbodies at the point of need, this sensor has the potential 
to provide an in-situ alternative to the current laborious and laboratory-based methods 
used for multiple toxin detection. 
 
 Results and discussion 
The system design was largely inspired by the limitations of current in-situ 
environmental monitoring techniques. The system itself was specifically designed to 
prioritise some of these limiting factors, such as portability, reliability and ease-of-use, 
where it is envisaged that future assembly line manufacturing will offer further 
reproducibility and cost-effectiveness improvements. This compact, rapid system was 
achieved through small hardware size, simultaneous multi-sample detection in separate 
assay form, and reduced assay runtime through minimal user interaction and incubation 
periods.  
 Microfluidic disc characterisation 
 Reliable fluid manipulation is vital in order to conduct accurate assay protocols. For this 
reason, the on-disc fluidic dynamics were assessed, with the results demonstrated in 
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Figure 3.3 and Supplementary Video1. The manual valve approach demonstrated 
excellent control of liquid, with minimal premature sample leakage between reservoir 
transitions. As this technique indirectly controls sample progression, via direct 
pneumatic air actuation, therefore there was no additional cross-reactivity between 
sample and microvalve material. This phenomenon occurs as the sample, while 
progressing within a microchannel with a ~7.5 × 10-8 m2 cross-sectional area, 
experiences an increased surface tension force. This increased surface tension then 
prevents air-sample pass-through, resulting in an air compression proportional to the 
centrifugal force acting on the sample. Therefore, with the liquid acting as a cap for the 
succeeding reservoir, a pressure release through a valve is required to further sample 
progression. This pneumatic valving strategy can also be future automated, as described 
by Kim et al.(36) It is expected that with the integration of a motor(26,37), sampler(38), 
and multi-disc changer(39–41), long-term autonomous sensor deployment could be 
achievable. 
 
Figure 3.3: Fluid dynamic characterisation of microfluidic disc using a coloured-aqueous solution. 
Sample was initially loaded into the ‘load’ reservoir (1). Once the first valve was manually opened while 
the disc was stationary, spinning of the disc allows sample progression only to the succeeding ‘incubation’ 
reservoir (2), with minimal premature leakage into the test reservoir (3). The second valve was opened 
then for the sample to pass to the test reservoir (4) and halted (5), with the process repeated until the 
sample has passed into the control reservoir (6) and halted for the allocated time (7), where it was then 
moved (8) and stored (9) in the waste chamber. 
                                                      
1 Supplementary video included in publication available at: 
 https://drive.google.com/open?id=16BV2FcXlBdJiAKtJnNN8UWaMn6SjPLS1 
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 Biosensor characterisation 
Due to the potential human health hazard posed by MC-LR, DA and STX (which shall be 
generically referred to as ‘toxin’), and the repercussions associated with a false 
qualitative screening of waterbodies, including human health, fishery, recreational and 
economic impacts, a screening method needs to be capable of detecting toxins with a 
significant degree of confidence. An assessment of the screening data variability or 
coefficients of variation is critical in determining the reproducibility of the assay format. 
Initial experimental design approaches were investigated to evaluate and determine the 
optimal assay parameters for use with the system. 
 Biosensor selection 
In order to attain the low levels of relevant detection (ng/ml), highly sensitive biosensors 
were an essential component in achieving this detectability. All Abs (recombinant for 
MC-LR, and polyclonal for STX and DA) were produced in-house with MC-LR antibody 
fragments assessed (Figure 3.4). In the case of domoic acid, it was also reported that the 
in-house produced scFv performed better that the commercial counterparts (sourced 
by Abcam Ltd.) (Figure 3.5). 
 
  
 
Figure 3.4: The comparison of the performance of the microcystin scFv vs scAb antibody form. 
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Figure 3.5: In-house highly specific recombinant antibody technology vs. commercial counterparts 
(supplied by Abcam Ltd.) 
 
 Assay optimisation studies 
As the detection system was limited to an 11-bit ADC reference readout (in the form of 
‘0-2047’ fluorescence response units’ for the end-user), it was important to identify the 
system’s maximum fluorescent readability threshold. Therefore, the amount of 
fluorescent antibody required for this assay format was investigated by analysing 
varying concentrations of primary antibody to ascertain the dynamic range of the 
system. There are several parameters that primarily influence direct planar assay 
performance; these include antibody/antigen concentration, contact time and flowrate. 
These parameters were evaluated for this assay, with a rotational frequency of 35 Hz 
constant spin rate was used for the final assay procedure. Figure 3.6 illustrates the 
averaged results (n = 3) of a direct binding assay performed on the disc to assess optimal 
antibody concentration and determined by the system via fluorescence at 430 nm.  
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Figure 3.6: Direct binding assay measured by the system. 
A set concentration of MC-LR-BSA coated on the test wells of a disc was probed with varying 
concentrations of the Alexa-430-labelled anti-MC-LR scFv. The scFv were excited fluorescently at 430 nm 
with the emission signal recorded. The system readout was limited to ‘0-2047’ response units (R), therefore 
any dilution factor below 1:75 produced a signal outside of the detectable range. 
 
It was observed that the optimum concentration of anti-MC-LR-Alexa-430 labelled-scFv 
to be used in the assay for MC-LR detection was approximately 40 μg/mL (1/75 dilution), 
as observed in Figure 3.6. This was subsequently calculated to be approx. 12 µg/mL and 
20 µg/mL for anti-DA-Alexa-430 labelled-scFv and STX-Alexa-430 labelled-scFv, 
respectively. These antibodies will be generically referred to as ‘anti-toxin’-Alexa-430 
labelled-scFv to avoid repetition. Once the assay conditions were established, and direct 
binding of the antibody to the surface of the disc was successfully quantified, inter/intra 
assay studies were performed to develop a calibration curve. Method precision and 
accuracy for the assay was evaluated using validation standards in the same complex 
matrix as the study samples; i.e. lake water samples. 
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 Performance studies 
In order to assess the performance of the system with each of the toxins, a number of 
studies were conducted to identify the variation between assays readings on the same 
disc (intra-day) and between separate disc readings on different days (inter-day). Six 
microfluidic discs, with six assay tests per disc, were manufactured for each toxin. Each 
of the six assays were set to be injected with varying toxin concentrate (0, 1, 10, 100, 
1000, and 10000 ng/mL), resulting in triplicate results (over two separate days) for each 
concentration. The PMMA discs were treated and functionalised at the test zone with 
‘toxin’-conjugate, and the control zone with anti-chicken antibody. The incubation zone 
was coated via passive adsorption with ‘anti-toxin-Alexa-430 labelled-antibodies. A 
silanization approach was also deemed the most effective in coating the disc surfaces 
with the detection molecule of interest, namely, a toxin-BSA conjugate. Issues arose 
with the level of background noise observed from the un-coated discs. The background 
noise was circumvented by coating the perimeter of each well with black acrylic paint to 
negate any inherent optical interference generated from the PMMA discs. 
To determine the inter-day variation of results, calibration curves were generated for 
each toxin in the range 0 – 10000 ng/mL. The co-efficients of variation (CV) values 
between the inter-day batches were then calculated via calibration curve analysis. For 
the intra-day studies; lake water aliquots (1 mL) were spiked with toxin at 
concentrations of 0, 1, 10, 100, 1000, and 10000 ng/mL. Sample progression, through 
each assay step (see Figure 3.9), was achieved using the spin cycle approach discussed 
in microfluidic disc characterisation. The sample progression included pass-through of 
the incubation chamber, where the anti-toxin-Alexa-430 labelled-scFv was coated. This 
was resuspended by incubation for 5 min with the toxin sample prior to passage over 
the test chamber, whereby toxin in the sample and immobilized toxin on the disc 
compete for binding to the anti-toxin scFv. Following resuspension of the antibodies at 
the incubation-zone (see Figure 3.9), the sample was centrifuged to propel the sample 
through the test, control and waste chambers respectively.  
Binding was fluorescently observed in both the test and control chamber separately. 
Bound scFv was quantified via fluorescence measurement with a 430 nm excitation LED, 
with the pre-filtered optical range above 475 nm collected, including the emission peak 
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at 545 nm. Fluorescence measurement occurred after assay completion, with each 
single fluorescence value programmed to consist of an averaged (n = 640, with n 
sampled every 8 µs) reading generated every ~0.5 s, with a further averaging of data 
captured over a 30 s run. The signal generated from the bound scFv was found to be 
inversely proportional to the amount of toxin present in the test sample. The sample 
was then passed from the test chamber to the control chamber where scFv was picked 
up by the control anti-chicken antibody. Once signal could be observed in this control 
chamber, it was used as a qualitative measure to ensure that the sample had successfully 
passed through all zones of the disc, thus signifying cessation of the assay. The readings 
generated from assessment of these lake-water spiked standards formed the calibration 
curves for each toxin whereby the system’s performance could be determined. 
To determine the detection capabilities of the system, equal volume lakewater samples 
were spiked with varying concentrations of ‘Toxin’ (0, 1, 10, 100, 1000, and 10000 
ng/mL). The spiked lakewater samples were individually applied and run through the 
pre-functionalised PMMA disc. The fluorescent response units (R) of the system were 
then normalised by dividing the max achievable fluorescence of the blank (0 ng/mL) 
response (R0). The intra-assay analysis of each of the toxins, shown in Figure 3.7, was 
performed in triplicate within the same assay. The observed co-efficients of variation for 
this assay was < 0.05%, proving considerable quantitative agreement between the intra-
assay standards. A best-fit calibration curve was applied to the mean data, with assay 
accuracy determined by comparing the error of predicted concentrations against known 
standards. These results are shown in Table 3.  
The precision analysis shown in Table 3 demonstrates excellent correlation < 20% for 
high concentrations of MC-LR when estimated from the calibration curve. This is evident 
by the estimated concentration error recorded, from use of the calibration curve for 
validation standards, down to as low as 100 ng/mL of MC-LR. However, it was noted that 
assessment of lower levels of MC-LR not as accurate, determined by the larger relative 
standard deviation. This may be due to stearic hindrance effects during the binding 
event, when low or non-competing levels of MC-LR are present, and full capacity binding 
of the antibodies at the test zone is attempted(42). Ng et al. (43) discuss the use of long 
flexible linkers such as polyethyleneimine (PEI) and dextran (DEX) being more 
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favourable for covalent attachment than shorter linkers such as 3-
aminopropyltriethoxysilane (APTES), as the long flexible linkers circumvent problems 
associated with antibody accessibility and steric limitations, which could be a 
contributing factor to the low sensitivity observed within the assay. Taking these 
hindrance effects into consideration, and the lower optimum concentration of anti-
toxin-Alexa-430 labelled-Ab used for the DA and STX assays, an increased averaged 
error correlation (Table 3) of < 26% and < 32% respectively, was not unsurprising.  
Quantitative immunoassays rely on calibration correlations to determine the analyte 
concentration in samples from the strength of the signal produced. Figure 3.8 illustrates 
how the log of analyte concentration is plotted against the percentage antibody bound. 
The latter is the signal level expressed as a normalised function of the total signal 
response units per response in the presence of no competitive agent (R/R0)).  The 
bottom graph shown in Figure 3.8 illustrates the assessment of MC-LR down to 1 ng/mL 
in spiked lake water samples. Intra-day co-efficients of variation (CV) (n= 3) were 
calculated as < 0.1% for replicates within the same assay (Figure 3.7), and the inter-assay 
(Figure 3.8) CV (n=2) were calculated as < 0.27% for the average calibration curve of MC-
LR. These CV values confirm the reproducibility of the assay. The detection capacity of 
this assay as observed from the validated standards is approximately 7.2 ng/mL. 
Table 3: Precision determination of ‘back-calculated’ concentration percentage error extrapolated from 
the calibration curve by estimation of the actual concentrations of free ‘toxin’ (ng/mL). 
Actual toxin 
concentration 
Microcystin recovery 
variance (expected 
value ± reported value 
difference) 
Domoic acid recovery 
variance (expected 
value ± reported value 
difference) 
Saxitoxin recovery 
variance (expected 
value ± reported value 
difference) 
(ng/mL) (ng/mL) (n=3) (ng/mL) (n=3) (ng/mL) (n=3) 
10,000 10,000 ± 1,560 10,000 ± 181 10,000 ± 3,640 
1,000 1,000 ± 192 1,000 ± 221 1,000 ± 350 
100 100 ± 15.5 100 ± 43.6 100 ± 17.6 
10 10 ± 3.28 10 ± 4.69 10 ± 4.2 
1 1 ± 0.368 1 ± 0.131 n/a 
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Figure 3.7: Intra-assay analysis (n=3) for microcystin (MC-LR), domoic acid (DA) and saxitoxin (STX) 
measured on the microfluidic sensor. 
Spiked concentrations of ‘Toxin’ were incubated with anti-toxin-Alexa-430 labelled-scFv. The sample was 
passed to the test zone to interact with coated toxin conjugate. Signal was observed by fluorescent 
measurement at the test zone at 430nm.  
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Figure 3.8: Inter-assay analysis for microcystin (MC-LR), domoic Acid (DA) and saxitoxin (STX measured on 
the microfluidic sensor. 
Lakewater samples spiked with concentrations of DA and STX were incubated with anti-toxin-Alexa-430 
labelled antibody. The sample was passed to the test zone to interact with coated Toxin conjugate. Signal 
was observed by fluorescent measurement at the test zone at 430nm 
 
The limit of detection (LOD) for the system was observed by using Equation 1. The LOD 
was calculated to be 7.2 ng/mL for MC-LR for this assay. This LOD meets the need for an 
early warning system capable of providing an early warning assessment of bathing water 
bodies when MC-LR is present, while it is short of the 1 ng/ml detection limit for drinking 
water currently. The detection limit observed from the inter-day analysis of DA and STX 
using the detection system was found to be approximately 20 ng/mL and 50 ng/mL 
respectively. It was also expected that individual optimisations of the antibody/antigen 
concentration, contact time and flowrate for each of the DA and STX would have further 
reduced the LOD. The co-efficients of variation of the DA and STX assay from the intra-
assay studies (Figure 3.7) were both determined to be less than 0.05 %, with the 
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precision of the assay determined from the inter-assay studies (Figure 3.8) found to be 
within 95% and 90% agreement with actual spiked concentrations respectively. 
Equation 1: Limit of detection of instrument (LOD) 
wxy  z{|}g~ & 3{|}g~  
Where, wxy the concentration of toxin corresponding to the signal intensity, z{|}g~ is the mean signal intensity of 
blank toxin and {|}g~ is the standard deviation of the blank 
 
Recent detection methods described for the detection of MC-LR include biosensor-
based methods (44–47) or ELISA-based methods (48) or even MALDI-TOF (49) analysis. 
These methods suffer from extensive automation requirements or laborious testing via 
specially trained personnel, the methods are also not applicable for testing in-situ at the 
‘point of need’. The qualitative method described herein, illustrates a method for 
routine use as a future-autonomous rapid warning system for water quality, with results 
in 30 mins with minimal end-user interaction. This assay represents several notable 
advantages; firstly, the system is made of inexpensive materials suitable for mass 
replication, and secondly, the simple design offers the potential to become a rapid and 
easy-to-use instrument for direct use in the field at the point of need.  It has a high 
within-assay response-reproducibility and a negligible assay turnaround time. The 
limitations of the proposed assay relate to potential deviations induced to individual 
discs due to each of the discs currently being manufactured and assembled by hand, 
which it is hoped in the future can be produced using industry standard assembly 
lines(50). Also, while the biosensor application within the disc is initially complex, it is 
hoped that through mass production breakthroughs such as automated assembly line 
production, that this platform could become significant faster and more cost-effective 
to produce. This proof of concept system shows detection of low levels of toxins, which 
makes it highly applicable for use as a warning system for the qualitative assessment of 
recreational or fishing waters. Due to the system being designed for detection of ‘free 
toxin’, the addition of a lysing step for extracting toxin from the species for improving 
the sensitivity of the system requires would be beneficial, and has been previously 
demonstrated either on disc(32) or through a pre-loading mechanism(51). The system 
will be coupled with a wireless communications platform, motor and automatic sampler 
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for use as an automated rapid warning, integrated system. This would include 
monitoring, analysing, interpreting, and distribution monitoring data, in which 
continuous real-time detection can be performed for offering generic warning or trigger 
an alarm as required, similar to the deployable MARIABOX system(38). 
 
 Conclusion 
Intoxication events due consumption of contaminated seafood and water supplies due 
to prevailing marine toxins is becoming a global problem. Ideally, the monitoring of 
harmful toxins like microcystin (MC-LR), domoic acid (DA) and saxitoxin (STX) should be 
performed on a device in-situ, which is sensitive enough to perform accurate detection 
toxin outbreaks in a complex aquatic matrix. Currently, there is a high priority for the 
development of an easy-to-use, rapid, robust and non-expensive devices for monitoring 
of the required low action level concentrations of toxins. Herein, a rapid system capable 
of providing an early warning system for the presence of toxic residues in water samples 
in-situ is described. This system is capable of detecting algal toxin residues in lakewater 
matrices using recombinant antibody technology and immuno-affinity purified 
antibodies with fluorescent-labelling. The advantages of the system are the 
incorporation of these elements into a rapid assay for the concurrent detection of three 
algal toxins at the point of need. The antibodies are produced under minimum cost 
conditions and made in very large quantities. The instrument provided reproducible 
dynamic linear ranges and rapid assay times. The rapid fabrication techniques used in 
disc generation offered a platform, whereby tailoring of the prototype’s size, shape, 
reservoir volume and surface structure for rapid assay integration became feasible. This 
allowed facilitation of a fully enclosed platform, specifically optimised for minimal end-
user interaction. In addition, the disposable discs can be mass produced, allowing 
convenient and safe ‘on site’ toxin handling, with future possibilities aimed at fully 
autonomous system deployment. While these toxin analytes were used as a ‘proof of 
concept’ to determine functionality of the system, the system is designed generically to 
allow for future multiplexing and with testing of numerous toxin variants. This method 
could alleviate the costly laboratory procedures associated with frequent toxin 
monitoring. 
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 Materials and methods 
 Chemical and biological reagents used 
 Bis[3-(trimethoxysilyl)propyl]amine (cat no. 413356), Micro90 (cat no. Z281565), 
ethanol, isopropanol and phosphate buffered saline (PBS) were all obtained from Sigma 
Aldrich, Ireland Limited, Arklow, County Wicklow, Ireland. 1-Ethyl-3-(3-
dimethylaminopropyl)carbodiimide bovine serum albumin (Imject EDC BSA) and 1-
Ethyl-3-(3-dimethylaminopropyl)carbodiimide keyhole limpet hemocyanin (Imject EDC 
KLH) spin conjugation kits were obtained from Fisher Scientific (UK). Alexa Fluor 430 
(Alexa-430) fluorescent kit (cat no. A10171) was obtained from Bio-Sciences Ltd., 
Charlemont Terrace, Crofton Rd, Dún Laoghaire, Dublin, Ireland. MC-LR (cat no. ALX-
350-012-M001) was obtained from Enzo life sciences (UK) Ltd. Domoic acid polyclonal 
antibody was obtained from Abcam Ltd. Cambridge, United Kingdom. Donkey anti-
chicken IgY Fab was obtained from Gallus Immunotech (Antibodies-online GMBH). Lake 
water samples were obtained from Leixlip reservoir in Dublin, Ireland and stored in 
RNAse and DNAse free tubes (Fisher Scientific, UK) at 4 degrees. Black acrylic paint 
(obtained from Tiger Direct™) was also used for biosensor signal enhancement.  
 Preparation of conjugates and fluorescent antibodies 
 MC-LR-BSA conjugates and the recombinant anti-MC-LR-Alexa-430 were prepared, as 
per the method by Murphy et al. (52). All animal models used were approved by the 
Department of Health and Children, Ireland licensing authority under the Cruelty to 
Animals Act 1876 as amended, for Dublin City University under license ref no. 
B100/2705. Domoic-Acid and STX conjugates were prepared using an Imject EDC KLH 
spin conjugation kit (Fisher), as per the manufacturer’s instructions. A Leghorn chicken 
was initially immunised sub-cutaneously with of equal parts solution of DA-KLH/STX KLH 
conjugate and Freund’s complete adjuvant. The final concentration of the initial 
immunisation was 200 µg/mL. The first boost (day 14) was then administered using 100 
µg/mL of each conjugate in PBS, mixed in a 1:1 ratio with Freund’s incomplete adjuvant, 
in a final volume of 1 mL. The final 4 boosts that followed (days 36, 52 and 66) all 
contained 100 µg/mL of each conjugate and were administered in the same manner as 
the first boost using incomplete adjuvant. Serum antibodies were isolated from the 
chicken and subsequently labelled with Alexa-430.  
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 Microfluidic disc manufacturing 
The microfluidic disc was designed and developed as a single-assay version of the 
previously reported multi-toxin detection disc (35). The previously reported multi-toxin 
detection disc was fluidically optimised for sample metering between three separate 
assays via pneumatic-based valving with detection performed using a fluorescent-based 
microscope, whereas this single assay format, shown in Figure 3.9, was fabricated 
primarily to fully characterise a toxin detection performance on a microfluidic disc 
platform using an in-house built fluorescence-based complementary system. The 
microfluidic disc platform was manufactured from poly(methyl methacrylate) (PMMA) 
sheets and “pressure sensitive adhesive” (PSA) sheets (ARseal™90880), obtained from 
Radionics™ and Adhesives Research™ respectively. The discs were manufactured 
through assembling consecutive layers of PMMA and PSA(53–55). The roof was 
additionally covered using PSA to act as a manual active microfluidic valve layer. The 
reservoir floor of the biosensor was laser etched to improve binding process (70% 
power, 60% using Epilog Zing 16, Epilog Laser USA) with the surrounding reservoir walls 
painted black, using acrylic paint, before full disc assembly. 
 Preparation of reservoir surface for bio-activation  
The PMMA layers of the disc were thoroughly surface cleaned in a class-1000 clean room 
with the assistance of ultrasonication; A 2% (v/v) solution, consisting of Micro-90™ in 
deionised water was prepared to remove any present oil, grease, resin and any 
biological material on PMMA layers prior to assembly. This solution was placed in a heat-
sealed bag with the all of the PMMA layers and ultrasonicated at 50°C for 30 min. 
Subsequently, the PMMA layers were each rinsed three times, with deionised (DI) water, 
followed by isopropanol. Finally, the PMMA layers were then rinsed a final time with DI 
water and dried using nitrogen. Following this, the PMMA and PSA disc layers were 
assembled as two halves (the lower half (LH) and upper half (UH)), with a centre point 
at the floor of the reservoirs, leaving the reservoir floors exposed on the LH for antibody 
immobilisation treatment. After cleaning and assembly, the two halves of the discs were 
then placed in heat-sealed bags for storage, while the biosensor components were being 
integrated to the LH of the disc. Following this integration, the two halves were then 
combined to form a single disc. 
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 Amine surface functionalisation of biosensor reservoir floor by 
liquid phase 
Following the cleaning process, the LH of several discs were then exposed to a 
microwave-induced O2 plasma, allowing multiple reservoir floor surfaces to be treated 
simultaneously, using the plasma cleaner (Harrick plasma, USA). The O2 gas stream was 
regulated by the integrated mass flow controller until the required operating pressure 
within the chamber adjusted to approximately 1000 mT. The exposure duration of the 
LH of the discs were exposed to the O2 plasma for 10 min on the ‘high setting’. A 3% 
APTES solution was prepared in 98% ethanol to functionalise the PMMA disc reservoirs. 
This solution was then immediately applied to the detection reservoirs (reservoir 3 
“Test” and reservoir 4 “Control”) of the surface-activated discs to provide a binding 
bridge between the surface oxidation of the reservoir floor, and hydroxylation (-OH 
groups) of the toxin conjugates and toxin-specific antibodies. The discs were then 
incubated at room temperature for 1 h in a fumehood in a 15 cm diameter petri dish 
with cover. Following functionalisation, the discs were then cleaned twice, using a 
solution of 98% ethanol under ultrasonication for 15 min. The discs were baked at 60°C 
for 2 h in an oven, where significant cracking of the PMMA discs was noted at high 
temperatures. The discs were then allowed to cool to room temperature, at which point 
the toxin conjugate/antibodies were added to reservoir floor.  
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Figure 3.9: The competitive toxin detection assay protocol represented by functional microfluidic 
reservoirs. 
 A) The microfluidic assay structure consists of five reservoirs (loading, incubation, test, control and waste) 
in radial alignment connected by microchannels, each with separate ventilation systems, and 6 replicates 
per disc respectively. Each reservoir is a single step in the competitive assay protocol (B). This inverse assay 
demonstrates how a loaded sample, containing pre-lysed microcystis, interacts with the reservoir of 
fluorescent (Alexa 430)-anti-MC-LR antibodies (Abs), with the control Abs available for quantification 
through a separate capture site to act as a positive control. 
 
  Microfluidic disc characterisation 
The fluidic motion on the microfluidic discs was assessed using a customised, in-house 
developed “spin stand”(56) (shown in Figure 3.10), as previously demonstrated by Kirby 
et al.(57). Briefly, the centrifugation of the discs was regulated using a computer 
operated spindle motor (Faulhaber Minimotor SA, Switzerland). A highly sensitive, 
short-exposure camera (Pixelfly, PCO, Germany) was combined with a stroboscopic-
programmed light source (Drelloscop 3244, Drello, Germany), which was synchronised 
A 
B
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with the spindle motor using in-house built electronics, for visualising on-disc fluidic 
performance under centrifugation. Furthermore, as the roof was covered using PSA to 
act as a manual active microfluidic valve layer, actuation of the microvalves was attained 
by pin puncture, allowing pneumatic pressure release which had prevented sample 
progression to occur. In summary, the discs were spun at 35 Hz for 30 s to transport 
sample to the subsequent reservoir, followed by halting of the disc for the required 
incubation period per reservoir. After this wait period, the sequential manual microvalve 
was opened. This cycle repeated until the sample had successfully completed the full 
assay protocol. 
 
 
Figure 3.10: The 'Spin stand' used for microfluidic characterisation.  
This observation setup had a triggering mechanism for actuation of camera and pulse light every 2πn 
rotations (whereby n is a natural number and dependant on rotational speed). This give the viewer the 
perspective of a stationary disc with fluidic motion, giving precise liquid characterisation whilst 
simultaneously running assay to be tested in the detection system. 
96 | P a g e  
 
 Optimisation of antibody concentration 
Preliminary studies were performed to determine the optimal labelled-antibody 
concentration for use in the final assay. An optimal antibody concentration will provide 
sufficient signal observation when interacted with the immobilised toxin conjugate on 
the surface, and subsequently measured fluorescently at 430 nm on the system. Varying 
dilutions of each antibody from 1/35, 1/75, 1/150, 1/300 were assessed fluorescently, 
by applying 100 µL of each to the inlet channel on a functionalised disc and spinning the 
disc on a spin stand at 35 Hz for 1 min. A depletion sample which included 10 µg/mL of 
free toxin with 1/75 dilution of antibody at equal volumes was assessed also. The 
amount of bound antibody was determined via fluorescent measurement at 430 nm. 
 Toxin Conjugate and control antibody binding to biosensor 
surfaces 
The Alexa-430 labelled specific Ab’s were coated on the 2nd radially-aligned ‘incubation 
zone’ reservoir (see Figure 3.9) where 100 μL of optimally determined antibody 
concentration was added (40 µg/mL). As this reservoir was not functionalised prior to 
coating, the antibody was passively adsorbed onto the reservoir floor of the incubation 
zone. The sequential release of the sample was then required for antibody resuspension 
within the incubation zone. MC-LR, conjugated to BSA (1 µg/mL) was prepared in a PBS 
solution, where 100 µL was then added to each of the 3rd radially-aligned ‘test’ reservoir 
(see Figure 3.9). 100 µL of a commercially available anti-chicken IgY (H+L), at 
approximately 10 µg/mL (Gallus Immunotech Inc., Canada), was added to each of the 
4th radially-aligned ‘control’ reservoir (see Figure 3.9). The coated discs were stored at 
4°C covered for 12 h. To avoid any non-specific binding from occurring on the biosensor 
reservoir floor, the remaining activated amine sites were then subsequently blocked 
with 200 μL of 3% BSA (in PBS solution) added to each reservoir. The blocking agent was 
left to incubate at 37°C for 1 h, after which it was aspirated. Finally, the disc assembly 
was completed and the prepared disc was ready for toxin determination. 
The exact same procedure to determine the calibration curve for DA was followed as 
was outlined previously for the MC-LR calibration curve. The variables used for DA 
include approximately 12 µg/mL of antibody as assessed via ELISA. The conjugate coated 
on the test well was 1 µg/mL of DA-BSA conjugate prepared in-house in DCU. The control 
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antibody used in the control well was the anti-chicken IgY (H+L) 100 µL, a commercial 
antibody from Gallus Immunotech Inc., Canada. 
Similarly, the exact same procedure to determine the calibration curve for STX was 
followed as was outlined in section for the MC-LR calibration curve. The variables used 
for STX include approximately 20 µg/mL of antibody as assessed via ELISA. The conjugate 
coated on the test well was 1 µg/mL of STX-BSA conjugate prepared in-house in DCU. 
The control antibody used in the control well was the anti-chicken IgY (H+L) 100 µL, a 
commercial antibody from Gallus Immunotech Inc., Canada. 
 Manufacture of the detection platform 
 The detection system shown in Figure 3.11, was 3D-printed from acrylonitrile butadiene 
styrene (ABS), to hold the disc, with an incorporated fluorescent detection apparatus to 
separately capture fluorescence values at both reservoirs three and four on the disc (see 
Figure 3.9). The detection system utilised a top-down detection configuration with a 405 
nm excitation LED (cat no. 713-4898, Radionics Ltd Ireland), a 475 nm long pass filter 
(cat no. 64-617, Edmund Optics Ltd) and a photo-LED emission detector sensitive from 
420–675 nm (cat no. 708-2813, Radionics Ltd Ireland). This in-house developed system 
was controlled by a Pololu Wixel microcontroller (cat no. 785, Cool Components Ltd), 
which transmits communications to a user interface via USB and/or wirelessly (using a 
second Pololu Wixel microcontroller). While this model does not contain a motor, as 
microfluidic characterisation was done using the previously described ‘spin stand’, 
motor incorporation will be done in future models similarly to those described by Duffy 
et al.(26,27,37) 
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Figure 3.11: The Detection system. 
This 3-D printed system was designed to allow in-situ detection of MC-LR applied to the Lab-On-A-Disc 
(LOAD) platform. It is configured for a top-down detection method of the test reservoir (TR) (see reservoir 
three in see Figure 3.9) with a 405 nm (Rex) excitation source (Exs), a 475 nm long pass filter (OF) and a 
photo-LED emission detector (Pd) for collecting the emission radiation (REm). The optical components all 
stored in a swappable ‘Optical Detection Block’ and is adhered to the bottom of the ‘Electronic Component 
Housing’ by screw (S). This in-house developed system is controlled by a Pololu Wixel Microcontroller, 
stored in the ‘Electronic Component Housing’, which can transmit communications to user via USB and/or 
wirelessly (using a second Pololu Wixel). 
 
  Measurement of toxin binding 
The preliminary assay was performed at room temperature in the lab using the 
developed system box connected to a portable laptop facilitating analysis via the Pololu 
Wixel software. The analysis was performed by adding 100µL of the lake water sample 
via pipette to the sample load zone on the disc. When spun at 35 Hz the water sample 
travels from the sample loading zone into the incubation zone. The water sample is 
allowed to interact with the now reconstituted antibody in the incubation zone for ten 
minutes and the disc is spun again at 35 Hz. The water sample with potential toxin and 
resuspended anti-toxin antibody then advanced to the test zone, whereby toxin in the 
water sample and toxin coated on the wells of the test zone compete for binding to the 
fluorophore conjugated antibody. Bound antibody on the wells of the test zone is 
inversely proportional to the amount of toxin present in the water sample. The water 
sample continues through to the control zone, whereby anti-chicken antibodies capture 
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the fluorophore labelled anti-chicken antibodies, this signifies successful transition of 
the water sample from the loading zone through the incubation and test zones and to 
the control zone. The water sample then flows from the control zone to the waste zone, 
and the fluorescent readings are measured. Readings from the system are taken every 
0.5 seconds, these values are exported into excel and an average of 10 measurements 
is taken for each fluorescent analysis.  
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 Supplementary Information 
 Additionally, a Supplementary Video2 is included to demonstrate visualisation 
of fluidic motion on disc platform using the “spin stand’ method 
  
                                                      
2 Supplementary video included in publication available at: 
 https://drive.google.com/open?id=16BV2FcXlBdJiAKtJnNN8UWaMn6SjPLS1 
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 Enabling fluidic 
predictability using a pneumatic valve 
enhancement strategy for highly 
integrated Lab-on-a-disc platforms 
 
Chapter Foreword: 
In order to further build on the toxin detection strategy and make it compatible for 
incorporation within the Marine environmental in-situ assessment and monitoring 
toolBox ‘MARIABOX’ in-situ, there is a need for development of an automation 
mechanism for the centrifugal microfluidic platform. Inclusion of this mechanism would 
additionally benefit non-specialist users for potential on site sampling. Therefore, the 
purpose of this chapter is tackle some of these needs through the investigation of a 
highly reliable, yet low-complexity, autonomous microfluidic valve mechanism. Firstly, 
the reader will be presented with the background information of current microfluidic 
valving mechanisms. This will be followed by an introduction to a novel pneumatic 
microvalve mechanism, and the extensive characterisation process used to develop a 
corresponding rotational valve actuation program. The combination of both these 
elements results in a powerful, easy-to-use microvalve mechanism for automation of 
centrifugal microfluidic platforms. Also, with the requirement of the MARIABOX 
platform for storage and use of manually, mass produced centrifugal microfluidic 
prototypes, this study also investigated the recalibrations required of the disk rotational 
program in order to maximise complete assays due to potential misalignments and 
unintentional variations in pneumatic chamber size. 
It was found that using a standard modelling strategy for liquid state actuation was 
predicted to be unsuccessful for as high as ~48% of the microvalves used. This model 
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was then modified by shifting the model trend based on both the highest averaged and 
raw actuation values observed. This resulted in an improvement of 72% of predictability 
of valves in the case of the averaged data set, with up to 100% improvement using the 
raw data.  
Summary of the nature and extent of candidate’s work present in this chapter: 
First author, initiation, key ideas, disc fabrication (collaboration with Kevin Alazet and 
Niamh Aine Kilcawley), data collection, data analysis (collaboration with Prof. Turlough 
Downes), manuscript development and writing up.  
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  Abstract 
Fluid flow control is key for defining the sequence and timing of liquid handling protocols 
at the backbone of automating bioanalytical protocols for sample preparation and 
detection on Lab-on-a-disc (LOAD) platforms. The requirements on the reliability of the 
valving techniques significantly increases with the degree of functional integration and 
parallelisation of liquid handling steps. During the prototyping stage, simplification of 
microfluidic systems can initially benefit the assay optimisation, but to further improve 
the cost-effectiveness of the system, multi-iteration integration of the desired assay 
protocols is desirable. It would also be advantageous for synchronised multi-assay 
execution to occur in the device as it would reduce the overall runtime duration of 
microsystem protocol. Therefore, achieving a successful highly-integrated microsystem 
with synchronised multi-assay execution, reliable and predictable microfluidic valves are 
essential. We present here a characterisation of the operational inconsistencies of 
microfluidic features, with particular emphasis on a microfluidic pneumatic valve 
strategy, due to rapid-prototyping manufacturing process. In this paper, as part of the 
liquid behavioural model, characterisation of set microfluidic features was conducted 
on a centrifugal platform at varying drive forces and radii from the centre of rotation. 
These were aimed at enhancing current dissolvable film-based microvalve strategies. 
The study involved three liquid phase changes of interest; from ‘loaded liquid’ to 
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‘normalisation’ against a centrifugal force, from ‘normalisation’ of liquid to liquid 
‘passthrough’ in microchannels, and from liquid ‘passthrough’ to a ‘compression’ of a 
pneumatic chamber, where a dissolvable microvalve would be suitably positioned. 
These models were then calibrated to be used as a rotational frequency protocol for 
autonomous use, with demonstration of the MariaBox Platform used as an example. The 
paper shows that the predictability of these liquid phase changes, through a 4.5-7 Hz 
increase in rotational frequency of the liquid phase change base models, can experience 
up to ≈72-100% improvement, respectively. This improvement in reliability will 
significantly enhance the ability of LOAD platform for performing assay protocols in 
autonomous, in-situ environments. This work aims to promote more efficient and 
effective use of LOAD-based platforms as autonomous, reliable and robust detection 
strategies. 
 
 Introduction 
There is significant interest in the development of micron-scale integrated 
chemical/biological analytical devices, also referred to as Lab-on-a-Chip systems(1–3). 
The development history of microfluidic-enabled solutions involves a number of fields 
such as molecular biology and analysis, and microelectronics(4). Microfluidic systems, 
which can perform bio-analytical assays, are generally reported as three primary types 
of platforms; Lab-On-A-Chip (LOC)(5–7), Lab-On-A-Disc (LOAD)(1,2,8,9) (Figure 4.1), and 
paper-fluidic platforms(10–13). The specific role of these devices is to perform a desired 
biological/chemical required to conduct specific assay protocol which would normally 
be conducted within a laboratory environment. This requires the devices to be capable 
of performing experimental functions such as sample transportation(5,8), 
separation(14–16), reagent mixing(17) and storage(18,19), heating(20) and 
detection(9,21). To conduct these experimental functions for the required assay 
duration, integration of protocol-required time delays is essential for the assay success. 
This can be achieved through the addition of reliable pumping and/or valving 
mechanisms.  In bio and chemical assays, these pumping systems can be very complex 
and therefore, extensive efforts have been made to develop simple and reliable micro 
pumping/valving schemes(22) that can be employed in microfluidic systems. There are 
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a number of approaches which can be taken in order to integrate valving onto a 
microfluidic platform, but they can usually be split into two primary categories(22,23), 
active microvalves and passive microvalves. 
 
Figure 4.1: The Lab-On-A-Disc (LOAD) platform concept. 
This illustration demonstrates how the centrifugal force (Fω) increases radially on a disc during 
centrifugation, with constant rotational frequency ω. Microfeatures, such as microchannels and valves 
which are radially positioned on disc, will have a constant activation force based on their physical 
parameters. Therefore, a constant Fω should be acting on the sample during microfeature interaction to 
maintain reliability, which can be tuned by decreasing ω as radius r increases. (Authors own image) 
 
Active microvalves are microfluidic valves which require a physical parameter change by 
external or separate interaction for actuation to occur. The actuation method can be 
mechanical (magnetic(24), electrical(25), piezoelectric(26), thermal(27), bistable(28)), 
non-mechanical (electrochemical(29), phase change(30,31), rheological(32)) and 
external (modular(33), pneumatic(34)).  In the case presented by Gorkin et al.16, similar 
to Figure 4.2.a, an active, non-mechanical and air-tight microvalve, polyvinyl-alcohol-
based water-soluble dissolvable film (DF), undergoes phase change upon liquid contact 
112 | P a g e  
 
by where it dissolves. This is a very useful set-up, as liquid-DF contact will not occur until 
the pneumatic chamber storing the DF valve reaches sufficient compression, which can 
be achieved through a generated centrifugal force, although sample loss is illustrated 
per iteration use of the valve which could prove problematic for largely integrated 
devices.  While KC-35 film (made from SOLUBLON® and sourced from Harke Packpro, 
Germany) was the only used DF material during this report, with a dissolution time of 
approximately 30 s, there are a also number of different materials currently available, 
with a study carried out to determine the dissolution time of each.(35) Another example 
of an active valve was demonstrated by Lee et al.(36) and Park et al.(37), illustrated by  
Figure 4.2.b, whereby microchannels can be closed using a ferrowax microvalve, which 
can be melted using a laser source, allowing further sample progression.  
 
Figure 4.2: Active valving systems integrated into microfluidic platforms. 
A) illustrates the structural design and scale of a dissolvable film (DF) valve. In this case, the valve halts 
sample temporarily often by pneumatic compression, until the liquid solution reaches the DF and dissolves 
the material, thereby releasing any generated air pressure. B) demonstrates how ferro-wax microvalves 
can be also used to prevent pneumatic release, thus halting sample progress, until laser abolition of valve 
creates a vent to release compressed air. (Authors own image) 
 
Passive microvalves refer to valves which don’t require external interaction for actuation 
due to the valve’s natural physical parameters, which can be overcome through sample 
interaction; mechanical (check valve(38)), non-mechanical (capillary(39)). In comparison 
to a standard microchannel (A), three examples of passive microvalves are illustrated in 
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Figure 4.3; capillary valve (B), hydrophobic valve (C) and siphon valve (D). In each case, 
the microvalve can be overcome, without modifying the physical parameters of the 
valve, by increasing the centrifugal force beyond the activation threshold of a particular 
valve. While passive valves are generally easier to integrate into microfluidic systems 
than active microvalve, a usual trade-off is microvalve reliability due to not being 
externally actuated.(22) 
Generally, once a microfluidic platform has been fully characterised to show successful 
assay integration and performance, the subsequent step would be the integration of 
further ‘assays-of-interest’ and/or replication of desired assays for increased sampling 
capabilities per single microfluidic platform. An example of this can be demonstrated 
with the MariaBox microfluidic platform(40), whereby the system was targeting the 
long-term monitoring (up to 6 months), in-situ monitoring of eight separate marine 
analytes. Due to the limited storage specifications on the buoy-based detection system, 
inclusion on the microfluidic platform of multiple multi-assay detection iterations was 
required. The microfluidic system was developed gradually, as described in Figure 4.4, 
whereby initially the development of a single-assay microfluidic platform which 
incorporated an inverse-assay based protocol with manual microvalve actuation, was 
used to fully characterise successful assay integration. Due to the ease of development 
of this platform, large-scale production using current prototyping techniques was 
possible, and thus allowed considerable assay optimisation studies to be rapidly 
conducted.  
However, due to the storage constraints associated within the MariaBox platform, the 
number of assays was required to be increased from 6 (single assay x 6) to 24 (octuple-
assay x 3). Initially, the expansion of the ‘single-analyte disc’ to the ‘triple-analyte disc’ 
was conducted to increase the number of sampling assays to 9, which also utilised a 
single sample loading reservoir which metered the sample between individual assays, 
as well as an enhanced pneumatic microvalve strategy. As each assay experienced the 
same wait periods between each assay step, considerable effort was focused into 
developing this highly reliable valve strategy which could consistently open all of valves 
at the same radial position, allowing synchronised assay execution.  
114 | P a g e  
 
 
 
Figure 4.3: Passive valving solutions for microfluidic platforms. 
 Presented here are three microfluidic valve concepts, with respect to a standard capillary action 
microchannel (a), which require a separate specific force for liquid to overcome either constriction (b), 
hydrophobic (c) or siphon (d) obstacles. (Authors own image) 
 
This format was then further upscaled to the ‘octuple-analyte’ disc, which had four 
assays per loaded sample, as in this specific case(40), there was four biological and four 
chemical analytes of interest with differing preloading treatments required. This 
platform was also made ~20% thicker to allow the same volume of sample (50 μL) per 
assay as previously used with a reduced x-y spatial footprint for increased reservoir 
quantity. 
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Figure 4.4: The development stages of a highly integrated LOAD microfluidic platform summarised as three 
microfluidic platforms.  
Top-left) A microfluidic platform which targets ‘single-analyte assay’ performance characterisation in the 
microfluidic platform with minimal microfluidic features. The simplicity of this platform offered ease-of-
manufacturing, thus allowing mass production of disc for significant assay characterisation studies to be 
conducted both cost- and time-effectively. Top-Right) Expansion of the previous test disc to include triple-
analyte detection with an enhanced pneumatic microvalve incorporated for synchronised assay execution. 
Bottom) Augmentation of the previous test disc, the final MariaBox microfluidic platform(40) incorporated 
the same microvalve strategy for the synchronous detection of eight separate analytes from two loaded 
sample. This platform was also made ~2.5 mm thicker to maintain consistent 50 μl sample-per-assay, as 
per previous test discs. 
 
In this work, a characterisation of the operational inconsistencies of microfluidic 
features due to the rapid-prototyping development process, and with particular 
emphasis on an enhanced microfluidic pneumatic valve strategy, is presented. This 
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includes the design and characterisation of a pneumatic-based microfluidic feature for 
enhancing the previously reported DF microvalve strategy developed by Gorkin et al.16. 
As part of this strategy, intentional rotation of microfeatures, with respect to the radial 
axis, was done to replicate possible misalignments may occur during the manufacturing 
and assembly stages of rapid-prototyping, which can significantly affect the 
predictability of sample-microfeature interactions. Also, as this microfluidic strategy was 
targeting synchronised assay execution with minimal sample loss per microfeature 
iteration, a full characterisation of sample-microfeature interactions at varying radii and 
rotational frequencies was conducted to generate a complementary liquid performance 
model. Therefore, we present here, a non-simulation-based approach for assessing and 
modelling microfeature performance to develop a complementary ‘spin program’ for 
high reliability liquid actuation. It is hoped that this strategy of modelling microfeature 
operational conditions in a non-simulation-based approach will assist in the 
development of more reliable, autonomously-predictable LOAD platforms. 
 
 Results and discussion 
Initially, a reservoir-reservoir-pneumatic-chamber (RRPC) feature (shown in Figure 4.5) 
was specifically used to simultaneously assess the rotational frequencies of the non-
pneumatic ‘passthrough’ of liquid between reservoirs, where low rotational frequencies 
were sufficient, and the compressibility of pneumatic chambers, where high rotational 
frequencies were required. This was then used in determining the required low and high 
disc rotational frequency regimes, with respect to the radial placements of both 
microchannel, for sample progression, and microvalve, for halting sample progression 
temporarily. In effort to increase the error due to rapid-prototype manufacturing as well 
as reduce the effect of liquid driving due centrifugal magnitude growth, a spiral pattern 
was also utilised, whereby the RRCP features became further rotated, with respect to 
the radial axis, as the radius increased (Figure 4.5). It was expected that the operational 
range of required rotational frequencies would resultantly be reduced on the premise 
that the features intentionally became misaligned with the vector of centrifugal force 
with respect to radius, thus reducing the effect of liquid driving by centrifugation, as well 
as replicate the effects due to poor manufacturing and assembly during the rapid 
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prototyping process. It was also predicted that due to the manufacturing techniques 
used, being xurography and laser cutting which work of the premise of an x-y 
coordinate-based system, that the resolution of the microfluidic features would be 
diminished upon rotation. This reduction in resolution was predicted to be in proportion 
to the squared root of the combined squared resolutions in the x and y axis, whereby if 
the resolutions of each axis was identical, then the error would be increased by a factor 
of √2.  
 Disc characterisation 
Once the microfluidic discs were manufactured and assembled, they were continuously 
spun from 2-50 Hz with a liquid settlement period of 10 secs before image capture at 
each incremental increase of 1 Hz. This was to ensure that liquid movement did not 
change between each increment. The RRCP pattern was used to assess three liquid 
phase changes of interest; from ‘loaded liquid’ to ‘normalisation’ against a centrifugal 
force, from ‘normalisation’ of liquid to liquid ‘passthrough’ in microchannels, and from 
liquid ‘passthrough’ to a ‘compression’ of a pneumatic chamber (as demonstrated by 
Figure 4.5). The images for each rotational frequency per disc were then collected and 
analysed to determine the correct rotational frequency required to initiate a liquid 
phase change (as per Figure 4.5). The averaged (n=3) rotational frequency () where 
liquid phase change occurred at radial position () from axis of rotation, is shown in 
Figure 4.6.  
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Figure 4.5: The Microfluidic disc with spiral arraying of reservoir-reservoir-Pneumatic-chamber (RRPC) 
microfluidic features. 
 Top) The assembled microfluidic disc, at rotational frequency of 50hz. Middle) The RRPC pattern 
dimensions and associated liquid phases during centrifugation; ‘Loading’, ‘Normalisation’, ‘Passthrough’ 
and ‘Compression’ of pneumatic valve at 27.5%. Bottom-left) The centrifugal microfluidic platform layers, 
including 2mm thick PMMA (Red) and 150μm thick pressure sensitive adhesive (Green) sheets. Bottom-
middle) The innermost reservoir-reservoir-Pneumatic-chamber (RRPC) pattern initially aligns directly with 
the radial centrifugal force which is arrayed in a spiral pattern. Bottom-right) This results in an intentional 
unalignment of the pattern of the centrifugal force to reduce the effective magnitude of the centrifugal 
force driving the liquid as the placement radius increases, therefore reducing the dynamic range of 
required rotational frequencies for the study, as well as replicate the effects of poor manufacturing and 
assembly during the rapid prototyping process.  
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Figure 4.6: The averaged (n=3) rotational frequency vs positional radius from centre of rotation, whereby 
liquid phase change occurred. 
This graph indicates the occurrence of three distinct liquid phase change models; liquid shape conforms to 
the centrifugal force in the load reservoir (Normalisation), normalised liquid passthrough a microchannel 
with compression (Passthrough) and liquid passes through a microchannel whilst simultaneously 
compresses air by 27.5% (Compression). Also evident is the large error most likely prominent due to the 
manufacturing and manual-assembly process of the discs. 
 
This data reflects the significant unpredictability of liquid phase change due to the 
necessary manual-manufacturing of individual layers, most likely occurring during due 
to assembly misalignments and/or manufacturing inaccuracies. This also emphasises the 
difficulty in transitioning from a prototype device to a fully developed platform, for 
which an automatic fluidic actuation protocol can be easily predicted throughout sample 
progression within a centrifugal microfluidic platform. It is clear from Equation 20, that 
there is be a logarithmic-based proportionality between  and , which was used as a 
base model for assessing the unpredictability, corresponding to the coefficient of 
determination (RSD). 
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Equation 20: Derivation of centrifugal force (t), in the form of rotational frequency (ω) 
t  2. .   .,07*. 
→ t2  .  
→   1 
→   1 
Where t is the required centrifugal force induced, 2 is the mass of the liquid,  is the rotational frequency 
of the disc and  is the radial distance from the centre of rotation. Therefore, there is an inverse logarithmic 
relationship between  and , as depicted by the data in Figure 4.6. 
 Outlier removal 
Due to the poor RSD values indicated (< 0.8), an initial step of outlier removal was 
required in this case to further improve model accuracy. This was achieved by setting a 
maximum standard deviation (STD) error as the threshold for outlier removal. This was 
done using Excel™ solver, where the optimisation of RSD was maximised by changing 
the STD error tolerance threshold, with the requirement of a minimal averaged (n=3) 
sample count of five. The output of these settings is given by Table 4, and illustrated in 
Figure 4.7. 
Table 4: Outlier removal settings using logarithmic regression analysis. 
Liquid Phase 
change 
% STD 
Error 
tolerance 
Sample count 
after outlier 
removal 
RSD 
Normalisation 29 24 0.787 
Passthrough 13 10 0.911 
Compression 7 10 0.878 
121 | P a g e  
 
 
Figure 4.7: Averaged rotational frequency vs positional radius of feature from centre of rotation, whereby 
liquid phase change occurred, with outliers excluded as per settings described in Table 4. 
 
 Initial Model generation 
These data points were then used to assess the specific force required to enact liquid 
phase change. As Equation 20 indicates, a directly proportional relationship between  
and n should occur. However, as the reservoir, microchannel and compression valve 
shape are constant at varying radii throughout the disc, the ‘specific force required to 
induce liquid phase change’ (6) should also be constant. As this model is only based on 
the rotational frequency and radial position parameters, liquid phase change should 
occur as the centrifugal force (t) becomes equal to the force required to initiate liquid 
phase change (). Therefore, as Equation 21 demonstrates, 6 is constant for enacting a 
particular liquid phase change, and is represented by the squared slope of this 
relationship.  This data is illustrated in Figure 4.8 and summarised in Table 5. 
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Equation 21: Derivation of theoretical rotational frequency 
shqqst}| required to generate the force 
of liquid phase change . 
  t  2. 
.   .,07*. 
⟹ 6  t2  
.  
⟹    2 . 1   6  
⟹ ED   
 @1B
  2    6 . 
∴   6  ;ED=

 
Where  is the force required to initiate liquid phase change, t is the required centrifugal force induced, 2 is the mass of the liquid,  is the radial distance from the centre of rotation, 6 is the specific force 
required to initiate liquid phase change of mass 2, which can be determined through linear regression 
analysis between  and the square-rooted inverse of   (as illustrated in Figure 4.8). 
 
Table 5: Specific force of liquid phase change model data using linear regression analysis. 
Liquid Phase 
change 
STD Error 
% tolerance 
Sample count after 
outlier removal 
RSD 
Slope 
m1/2.s-1 
Squared slope 
m1.s-2 or N/Kg 
Y-
intercept 
Normalisation 29 24 0.816 0.995 0.989 1.890 
Passthrough 13 10 0.928 2.484 6.170 4.241 
Compression 7 10 0.888 5.223 27.284 18.630 
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Figure 4.8: The averaged rotational frequency (with outliers excluded) at the inverse square root positional 
radius of feature from centre of rotation, whereby liquid phase change occurred. 
 This graph was used to extrapolate the specific force determined by linear regression (as per Equation 21) 
and used to generate a model representation (as per Equation 22). 
 
It is also important to note that Figure 4.8 does not demonstrate a directly proportional 
relationship between  and  as theoretically postulated, and the addition of the y-
intercept value (tgs can be attributed to the misalignment of the features with 
respect to the radial centrifugal force, disc layer assembly and manufacturing issues and 
unaccounted-for liquid-surface and liquid-air interactions, which should otherwise be 
constant with respect to  and . Therefore, the initial characterisation model (rq| 
was generated as to include both a  
 and tgs element, as demonstrated in 
Equation 22. 
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Equation 22: Characterisation of experimental rotational frequency required for liquid phase change 
rq| 
qqqgs}|   t2 . 1  & .,07*.   6  & 
tgs 
dc→k  lim→aqqqgs}|  lim→a t2 . 1 & tgs  tgs 
∴ rq|   t2 . 1  & .,07*.   
  & tgs 
Where qqqgs}|  is the true experimental rotational frequency at which liquid phase change occurred, t is the required centrifugal force induced, 2 is the mass of the liquid,  is the radial distance from the 
centre of rotation, tgs represents the y-intercept value as ( → ∞, 
 corresponds to the rotational 
frequency of the disc at . 
 
 Spin protocol generation 
As the models determined from Table 5 offer a valid model of liquid phase change, they 
are not yet suitable for use as a guaranteed liquid phase change threshold, as is visible 
in Figure 4.9. Therefore, a shift in the y-intercept was initially conducted using Equation 
23, which is based on using the largest positive y-residual value determined initially from 
the averaged data set, in order to set to maximise liquid phase change successful 
transitions. However, as shown in Figure 4.10, it is again evident that the y-intercept 
shift based on the averaged data (solid) is insufficient, with a significant number of failed 
liquid phase changes likely. Therefore, the y-intercept shift was again repeated to using 
the max raw residual value (dotted).  
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Equation 23: Modification of model to include positive outliers 
rq|    6  & tgs 
q,
   )D 
 #  rq||    
| #  6  & tgs 
Where q, is the maximum positive residual difference of the rotational frequency at  radial position 
between the D dataset [averaged, raw], and the model. 
q, was then used to recalibrate tgs in the 
base model to 
tgs_qt}|{}sqr, by, 

tgs_qt}|{}sqr,    6  . ln
q, #  q, 
With the recalibrations using averaged and raw datasets demonstrated in Figure 4.9 and Figure 4.10, 
respectively. 
 
Figure 4.9: Averaged (n=3) rotational frequency vs positional radius from centre of rotation whereby liquid 
phase change occurred (including outliers) compared to model. 
 Two trends are included in this graph for comparison; the initial liquid phase characterisation model 
(YBase), as per Equation 22, and the recalibrated model using the averaged dataset (YARS), as per Equation 
23. This recalibrated model demonstrates a up to 35% improvement in predictability, corresponding to a 
maximum rotational increase of ~4.5 Hz. 
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Figure 4.10: Raw rotational frequencies of the three discs vs positional radius from centre of rotation 
whereby liquid phase change occurred (including outliers) compared to model. 
 Two trends are included in this graph for comparison; and the recalibrated model using the averaged 
dataset (YARS) and recalibrated model using the raw dataset (YRRS), as per Equation 23. This graph 
demonstrates up to 26% failure of liquid phase change with recalibration using the averaged dataset vs 
the raw dataset, corresponding to a maximum rotational increase of ~7 Hz. 
 Summary 
Table 6 summarises the expectant success of each model variation per liquid phase 
change, based on the original raw data, if used as a ‘spin speed’ protocol. In this table, 
it is evident that a recalibration of the model significantly reduced the failure rate of all 
of the liquid phase change predictions, with a considerable reduction in missed points 
particularly evident with the compression liquid phase change. The recalibration of the 
base model corresponded to ~4.5 Hz and ~7 Hz increase, based on the averaged and raw 
residuals, respectively. While these recalibrations would lead to a higher compression 
percentile in the case of the compression liquid phase change, risking premature 
dissolvable microvalve rupture, a stronger or thicker DF could be incorporated to 
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counteract the excess pressure generated whilst maintaining the lower failure rate. 
Alternatively, as per the setup demonstrated in the MariaBox platform(40,41), an 
additional DF valve can be included to assist in liquid deceleration before compression 
(Figure 4.11). In this case, DF microvalve one was used to prevent premature air 
compression in the pneumatic chamber, while DF microvalve two acted to prevent air 
release until sufficient pneumatic compression is achieved.  
Table 6: Model comparison of the initial model, the modified model based on averaged residual shift and 
the modified model based on the raw residual shift. 
y-intercept 
adjustments 
Liquid phase change 
y-intercept based on initial model 
(Hz) 
Raw 
points 
missed 
(x/75) 
% of raw 
points 
missed 
Initial model 
Liquid normalisation in 
start reservoir 
-2.943 29 38.67 
 Liquid microchannel 
passthrough 
-7.830 25 33.33 
 Air compression by 
27.5% 
6.009 36 48.65 
  y-intercept based on averaged 
data max residual (Hz) 
  
Averaged data 
Liquid normalisation in 
start reservoir 
-2.063 16 21.33 
 Liquid microchannel 
passthrough 
-7.027 20 26.67 
 Air compression by 
27.5% 
8.318 10 13.51 
  y-intercept based on raw data 
max residual (Hz) 
  
Raw data 
Liquid normalisation in 
start reservoir 
0.767 0 0 
 Liquid microchannel 
passthrough 
-3.656 0 0 
 Air compression by 
27.5% 
12.808 0 0 
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Figure 4.11: Ideal dissolvable valve locations. 
1) prevents premature air compression during deceleration of rotational frequency from high frequency 
(‘Compression’) to low frequency (‘Passthrough’). 2) prevents air release, which halts sample progression, 
until sufficient air compression within the pneumatic chamber is achieved, allowing the sample to contact 
and dissolve the microvalve. 
 
Liquid phase changes are essential components in developing a microfluidic platform. 
Understanding and predicting how liquids normalise, travel through microchannels and 
interact with microvalves is key in the success of a microfluidic device. To develop a 
highly reliable autonomous rotational frequency program to run a LOAD assay protocol, 
a characterisation of the specific force required to initiate a liquid phase change should 
be performed and related the liquid driving force, or in the case of the LOAD platform, 
the centrifugal force. There should also be a clear distinction between the specific force 
required to drive a liquid through a microchannel and interact with a microvalve if high 
reliability is to be achieved. In the case of a pneumatic chamber for DF-based 
microvalves, how they are integrated with other microfeatures can largely affect 
actuation performance and efficiency. Larger pneumatic chambers can increase reduce 
the required activation force, making differentiation between microchannel 
passthrough more difficult, while smaller pneumatic chambers would result in larger 
1 
2 
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required actuation forces, therefore tuning of the pneumatic chamber should be 
considered carefully. As is demonstrated in the MariaBox platform(40) (Figure 4.12), the 
combination of the liquid phase change models can then be mapped to the respective 
microfluidic feature, whereby the change between liquid phase changes is determined 
by the individual assays step durations. This program can then be used to autonomous 
LOAD management in-situ. 
 
Figure 4.12: The rotational frequency protocol used for the MariaBox microfluidic platform(40), either by 
varying radius (top) or time (below), based on the normalisation, passthrough and compression models. 
The assay steps in this example are loading and normalisation(i), metering and incubation (ii), test (iii), 
control (iv), and complete disc spin-down (v).  
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With the increased abilities of highly complex microfluidic devices, achieved through an 
increasing the quantity of microfeatures present, there is also a corresponding reduction 
in success rate of the system proportional to the reliability and predictability of the 
utilised, particularly in an autonomous setting. Therefore, it is essential to maximise the 
corresponding actuation model in order to achieve a successful, highly integrated 
microfluidic platform. 
 
 Conclusion 
A characterisation of possible manufacturing errors associated with the rapid-
prototyping of microfluidic platforms and their effects on liquid manipulation has been 
performed. This was achieved through the use of a novel designed 25-iteration 
reservoir-reservoir-pneumatic chamber (RRPC) feature set, joined by microchannels, 
and aligned in a spiral patterning at varying radii. The purpose of this was to identify and 
fully characterise three liquid phase transitions which occur during assay execution; 
from loaded liquid to normalisation against a centrifugal force (Normalisation), from 
normalisation of liquid to liquid passthrough in microchannels (Passthrough), and from 
liquid passthrough to a compression of a pneumatic chamber where a microvalve would 
normally be installed (Compression). These models were used to develop a 
corresponding ‘spin speed’ protocol for increased valve reliability for autonomous use, 
whereby a 4.5-7 Hz increase on microvalve model corresponded to a ≈72-100% 
improvement in successful compression reliability respectively. Within this protocol 
development, a comparative study was conducted between the use of either the 
averaged and raw activation spin speeds to develop spin speed protocols with high 
predictability. These protocols were based on a logarithmic regression model which an 
intercept shift based the maximum residual difference between either the averaged or 
raw data sets. After characterisation, these valves were successfully integrated into both 
the ‘triple-assay’ and fully integrated ‘octuple-assay’ MariaBox microfluidic discs for 
autonomous, in-situ deployment.  
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 Materials and Methods 
 Microfluidic disc manufacturing 
The Microfluidic disc, shown in Figure 4.5, was manufactured from poly(methyl 
methacrylate) (PMMA)  sheets (2 mm for top and bottom, 0.5 mm for pneumatic 
chamber) and “pressure sensitive adhesive” (PSA) sheets (ARseal™90880), sourced from 
Radionics™ and Adhesives Research™ respectively. The discs were manufactured 
through assembling consecutive layers of PMMA and PSA using xurographic and laser-
based rapid prototyping strategies(42–44).  
 Microfluidic disc characterisation 
A “spin stand”(45), as described by Kirby et al (15) was used to characterise liquid motion 
on the microfluidic platform. In short, centrifugation of the discs was controlled via 
computer operated spindle motor (Faulhaber Minimotor SA, Switzerland). A high 
sensitivity, short-exposure time camera (Pixelfly, PCO, Germany) and a stroboscopic 
light source (Drelloscop 3244, Drello, Germany) were combined and synchronized with 
the spindle motor using custom electronics to allow visualisation of hydrodynamic 
performance of the discs during centrifugation. 50 μL of de-ionised water with red food 
colouring added to each load reservoir, images were captured of the liquid phases in 
each of the 25 RRPC patterns (2-50 Hz rotational frequencies, with a 10 S wait period 
before each 1 Hz increment) for 3 separate test discs, as shown in Figure 4.5. The liquid 
phases were then compared to the preset profiles (shown in Figure 4.5.Bottom), 
whereby ‘Loading’ represents liquid shape before spinning, ‘Normalisation’ represents 
the liquid conformity, normal to a centrifugal force, and before progression from 
reservoir to microchannel, ‘Passthrough’ represents a reservoir-to-reservoir liquid 
transfer via microchannels unimpeded by air pneumatics, and ‘Compression’ represents 
the point at which the liquid has entered the larger slot-shaped pneumatic valve causing 
liquid trapping above the microvalve location (Figure 4.5).   
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 A Centrifugal 
Microfluidic-Based Approach for 
Multi-Toxin Detection for Real-Time 
Marine Water-Quality Monitoring 
  
Chapter Foreword: 
Building on the previously presented algal toxin detection system (Chapter 3) and the 
autonomous microvalve mechanism (Chapter 4), the summation of both platforms will 
be presented in this chapter. This will specifically include the furtherment of the single-
toxin detection platform presented in Chapter 3 into a simultaneous multi-toxin 
monitoring platform, achieved through the integration of the autonomous microvalve 
mechanism demonstrated in Chapter 4. This platform was used as stepping-stone to the 
final eight-analyte centrifugal microfluidic platform designed for MariaBox project, 
discussed further in Chapter 6. 
The limit of detection (LOD) of the platform could not be determined due to the larger 
size of the disc being incompatible with the detection system presented in Chapter 3. 
This platform was specifically tailor-made for compatibility with the MARIABOX device, 
and it was hoped that optical detection could have been comprehensively performed 
using this system. Unfortunately, MARIABOX detection platform was not ready in time 
for this study. Therefore, fluorescence microscopy was used to confirm successful assay 
execution after integration of the autonomous microvalve mechanism. 
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up. 
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chapter: 
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        Abstract 
Globally, fresh and brackish water sources are constantly under treat of exposure to 
toxins. Two of the most prevalent toxins from fresh and brackish water blooms are the 
cyclic peptide toxins of the microcystin family, formed from cyanobacterial, and the 
kainic acid analog neurotoxin known as domoic acid. There is therefore a significant 
need for constant and cost-effective ‘on-site’ algal-toxin monitoring to respond to 
constantly increasing demand for safe and ‘toxin-free’ fresh-water, shellfish and fish 
stocks. Herein, we describe a Lab-On-A-Disc (LOAD) platform which was developed to 
assess microcystin and domoic acid concentration levels in-situ. Using recombinant 
antibody technology, the LOAD platform combines immunofluorescence with 
centrifugally driven microfluidic liquid handling to achieve a next-generation disposable 
device for high throughput sampling.   
 
 Introduction 
 Overview of the problem 
To sustain a rapidly increasing of population growth, the global demand for clean, safe 
water supplies has never been more apparent. It has been previously reported, and 
predicted, that anthropogenic environmental impacts will continue to increase the 
prevalence and duration of harmful freshwater cyanobacterial and algae blooms.(1,2) 
Other influences also reported are global warming and water quality degradation, 
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particularly due to eutrophication. Human, ecological and economic health can all be 
negatively impacted by harmful cyanobacterial blooms formed due to eutrophication. 
(3,4) 
 One of the most dangerous toxins documented is the cyclic peptide cyanobacterial toxin 
microcystin-LR (MC-LR), shown in Figure 5.1-Left. MC-LR is the predominant congener 
of the microcystin family which derived from the cyanobacteria microcystis aeruginosa, 
and commonly recorded in fresh and brackish water.  Significant health issues can arise 
through ingestion of MC-LR for humans and animals alike (5), with patients often 
presenting with hepatotoxicity and carcinogenesis (6).  In the EU, concentration limits 
for microcystin which elicit action are regulatory levels for is 1 ng/mL for drinking water 
and 20 ng/mL for bathing sites. (4) One of the most noted cases of human exposure 
occurred in a haemodialysis clinic in Caruaru, Brazil in 1996 (7,8). In this case, it was 
reported that of the 116 patients undergoing dialysis, 89% experienced severe 
symptoms, and 100 of these patients developed liver failure resulting in the death of 52 
patients.  
Another well documented marine toxin is Domoic acid (DA), shown in Figure 5.1-Right, 
which is a highly potent neurotoxin. It is naturally produced by several diatom species 
of the genus Pseudonitzschia, and is responsible for the amnesic shellfish poisoning 
(ASP) illness.(9) Some of the human responses following exposure to ASP include 
gastrointestinal distress, confusion, disorientation, seizures, permanent short-term 
memory loss, and in the most severe cases death.(9,10) The first documented case of 
ASP poisoning was noted in 1987 on the eastern coast of Prince Edward Island, Canada, 
where harvested mussels, contaminated with DA, were consumed.(9–12) This case 
resulted in the death of 4 people of some total 143 reporting similar DA associated 
symptoms. Following the Canadian ASP event of 1987 and to protect seafood 
consumers, authorities established an action limit for DA of 20 mg DA/g shellfish 
tissue.(9) 
These case studies demonstrate not only the importance of continuous environmental 
monitoring, with special regard to on-site algae-toxin monitoring, but also the need for 
a multi-toxin detection platform. Therefore, preceding this will be several both lab- and 
in-situ- based toxin monitoring solutions. 
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Figure 5.1: The chemical structures of microcystin-LR (left) and domoic acid (right) in their predominant 
congener forms 
 
 Current approaches for toxin analysis 
 MC-LR detection solutions 
There is currently multiple in-field based platforms capable of monitoring MC-LR, with 
solution suggested by MacKenzie and colleagues in 2004.(13) This solution is referred to 
as solid phase adsorption toxin tracking (SPATT), and has since been further adapted to 
detect and monitor toxic algal blooms as well as shellfish contamination events (14). 
While this technique is useful, it requires a deployment and recovery process for lab-
based liquid chromatography-mass spectrometry (LC-MS) analysis. This limits it as a 
semi-in-situ analysis system and prevents autonomous continuous monitoring. Another 
limitation of this approach is the relatively low sample rate due to the weekly 
deployment and recovery process, thus impeding the throughput capabilities and 
potential of real-time data capture. These limitations also indicate a requirement for 
trained experts for handling and characterisation of weekly samples, therefore 
increasing associated costs significantly and reducing the ability of rapid, high density 
sampling of sites.  
Other previously reported biosensor-based methods for microcystin detection have 
been limited by the requirement for laboratory-based analysis. Chianella and colleagues 
reported a novel molecularly imprinted polymer (MIP)-based-piezoelectric sensor for 
Microcystin-LR with a low detection limit for 0.35nM for in-laboratory analysis (15). 
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Similarly, electrochemical biosensors with demonstrated sensitivities of 0.1 μg/L-1 for 
microcystin-LR (16) and 9.0×10−11 M for a microcystin specific gene sequence (17) were 
reported, however both of these methods are primarily laboratory-based. A highly 
sensitive immunosensor for microcystin has previously been reported (18), based on 
graphene–gold nanocomposite/functional conducting polymer/gold nanoparticle/ionic 
liquid composite film with electrodeposition with detection limits as low as  3.7×10−17 
M. Another immunosensor based-method by Queirós et al., reported the use of a Fabry–
Pérot interferometer using an optical fibre coated with a sol–gel imprinted sensing 
membrane with a sensitivity of 12.4 ± 0.7 nm/L/μg−1 (19). A cantilever immunosensor 
was reported which tested microcystin concentrations as low as 1pg/mL−1 in varying 
water sources (20). These methods, however sensitive, all suffer from the requirement 
of expensive laboratory equipment and specially trained personnel to perform the 
analysis. An in-situ based method was previously reported by Long and colleagues, who 
used a commercially available portable trace organic pollutant analyser (TOPA) for the 
detection of microcystin, however the limit of detection of the assay was significantly 
higher than any of the lab-based methods at 0.03 µg/mL−1 (21). 
 DA detection solutions 
It has been previously reported that surface plasmon resonance (SPR) (22,23), antibody 
technology (24,25) and optical MIP-based molecular recognition sensors (26) can be 
used in detecting DA. Lotierzo et al and Stevens et al. reported a detection limit of 5 µg.l-
1 and 3 µg.l-1, respectively. (22,23) The antibody-based approaches taken by Zhou et al. 
and Micheli et al. observed a 100 µg.l-1 and 5 µg.l-1 detection limit respectively. (24,25). 
The MIP-based approach, taken by Henry et al. reported a detection limit of 5 µg.l-1 also. 
(26) 
 
 A Lab-On-A-Chip (LOAC) solution to toxin monitoring 
In order to facilitate detection of microcystin at the ‘point of need’ On-site algal toxin 
monitoring can alternatively be achieved using Lab-On-A-Chip (LOAC) technologies. This 
is possible as small volumes of liquids can be precisely controlled and manipulated to 
undergo assessment as if in lab environments, even when in-situ. These relatively new 
technologies are highly customisable and commercially-viable alternatives to the 
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current detection methods employed for environmental monitoring. LOAC-based 
platforms, previously designed for environmental monitoring, are currently capable of 
detecting phosphate(27–29) and E. Coli (30,31), whilst also offering the capabilities of 
detecting polycyclic aromatic hydrocarbons (PAHs), endocrine disruptors (EDCs),  
inorganic ions and heavy metals, by utilising already developed microfluidic techniques 
(32). Whilst LOAC platforms are highly convenient, cost-effective and highly adaptive, 
the pumps often required to drive sample progression through a LOAC cartridge can be 
expensive. This is primarily due to the high costs associated with precise pumping 
mechanisms. A derivative of the LOAC platform, circumventing these externally required 
expenditures is the Lab-On-A-Disc platform (LOAD)(33,34). 
 Proposed Lab-On-A-Disc (LOAD) alternative solution 
The LOAD centrifugal microfluidic platform replaces the previously required pumping 
mechanisms with a centrifugal driving force, utilising a more cost-effective motor 
system. To date, on-chip water quality assessment systems have been primarily 
developed using LOAC systems, with only a few examples reported on centrifugal disc 
(CD) platforms (Czugala et al., 2012; Hwang et al., 2013). There are multiple advantages 
associated with LOAD platforms including; autonomous pumping using centrifugal 
forces, precise liquid handling, control of samples using valves, ability to multiplex assays 
using identical test conditions and a myriad of detection techniques compatible on disc, 
making it an ideal technique for in-situ environmental monitoring. 
In this paper, a novel LOAD-based platform, which has been developed to assess both 
M-LR and DA toxin levels in-situ, with the additional capabilities for deployment as a 
long-term, real-time microcystin monitor will be presented (Figure 5.2-Left). Using 
highly-specific recombinant antibody technology, the LOAD platform combines 
immunofluorescence with centrifugally driven microfluidic liquid handling to achieve a 
next-generation disposable device for high throughput sampling. Recombinant 
antibodies (RAs) were selected over alternative antibody technologies. This was because 
RAs would ensure a consistent bio-sensing detection as the RAs would remain 
homogeneous indefinitely. 
 A stockpile of these LOAD platforms will then be incorporated into the MARIABOX 
deployable system for a targeted deployment of 6 months. This deployable system will 
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incorporate a high sensitivity ‘LED-Photodiode’ based fluorescent detection system 
which was tailor-made for the LOAD platform (Figure 5.2-Right). The optical sensing 
system utilises the fluorescence signal of the toxin-specific reaction to be quantified, 
thus allowing rapid and accurate detection of the presence of M-LR and DA toxins 
simultaneously in less than 15 min with minimum user interaction and maximum 
reproducibility. The LOAD platform was first assessed using a simplified single assay 
detection system a replica electronics configuration stored in handheld 3-D printed 
casing. This method provides a low-cost diagnostic-alternative to the current laborious 
and costly methods used for toxin detection, and can be easily adapted for further 
alternative toxin monitoring.  
 
 
Figure 5.2: The MARIABOX platform and detection. 
 Left) The centrifugal Microfluidic platform with for triplicate triple-toxin detection. Each triplicate has a 
separate load zone, marked as ‘1’, which separates and mixes with the relevant detection antibodies 
located in zone ‘2’. Zones ‘3’, ‘4’ and ‘5’ represent the test detection zone, control detection zone and waste 
collection zone respectively. Right) The fluorescent detection setup which will be incorporated within the 
MARIABOX platform for determining the remainder of fluorescently-enabled anti-body presence after 
toxin conjugate pass-through has occurred. This is will be performed at zones ‘3’ and ‘4’, where toxin 
concentration can be inversely determined based on the recorded fluorescent intensity.  
 Results and discussion 
The LOAD design was largely inspired by the limitations of current environmental 
monitoring techniques. The system itself was therefore designed to overcome some of 
these limiting factors; portability, cost-effectiveness, multiplexed sampling and ease-of-
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use. This was achieved through small system size, low cost per assay with higher sample 
throughput, simultaneous multi-analyte detection in single assay form and reduced 
assay runtime through minimal user interaction and incubation periods. Due to the 
potential human health hazard posed by MC-LR and DA, and the repercussions 
associated with a false qualitative screening of waterbodies, including human health, 
fishery, recreational and economic impacts, a screening method needs to be capable of 
toxin detection with a significant degree of confidence. Therefore, both reliability of 
sampling handling and confirmation of fluorescent presence was required before a full 
calibration of the MARIABOX platform. 
 Characterisation of sample handling 
The microfluidic platform was assessing whilst under centrifugation to confirm reliable 
and consistent sample handling. Figure 5.3 illustrates how close each assay pathway is 
with regards to progression with near synchronise movement occurring. While some 
microvalves did rupture before others, which falls within the expected rupture deviation 
of the Solublon™ material, this was also to be expected due to the manual 
manufacturing process of both the microvalves and LOAD platform which lead to some 
inconsistencies. 
 Fluorescent assessment of microfluidic 
It was important to assess that binding was present before calibration of the MARIABOX 
platform. This was done through fluorescent microscopy. Figure 5.4 demonstrates the 
competitive inverse assay used on the LOAD platform, whereby the larger the toxin 
concentration within the loaded sample, the lower the fluorescent signal detected. This 
was initially compared to the expected thresholds of a reservoir containing the same 
population of fluorescent antibodies which would be used within the assay to determine 
a control high and low. From this, a comparison between a high toxin concentration of 
MC-LR and DA could then be done.  
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Figure 5.3: – Microfluidic disc characterisation. 
1-6) illustrate the sample flow through each of the assay steps, represented by the reservoirs. Each valve 
is opened by pulsing the speed from low to high. This reduces the possibility of premature valve rupturing 
to maintain a consistent time delay in each reservoir. 
 
 Next steps to be taken 
With confirmation of the LOADs reliability and the detectability of the fluorescence at 
varying concentrations of DA and MC-LR, integration and calibration of MARIABOX 
prototype will take place. This will include deployment in Oslo, Norway on the MS Color 
Fantasy in collaboration with NIVA, Oslo. 
 
 Conclusion 
It has been observed that both microcystin and domoic acid can be simultaneously 
detected on a LOAD platform. While this has only been assessed using a fluorescent 
microscope, future work will include a full calibration assessment on the MARIABOX 
platform. Once this complete calibration has been achieved, it is aimed that the 
MARIABOX platform will be deployed for up to six months of autonomous use.  
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Figure 5.4: – Fluorescent microscopy images taken from the test reservoir floors. 
Left) illustrates the fluorescence captured using a fluorescent microscope to assess the competitive assays 
of both microcystin-LR and domoic acid. Right) demonstrates the expected fluorescence levels with a high 
concentration of fluorescently enabled antibodies vs no antibody presence. 
 
 Methods and Materials 
 Chemical and biological reagents used:  
 MC-LR was sourced from Enzo life sciences (UK) Ltd. (cat no. ALX-350-012-M001). Alexa 
Fluor 430 (Alexa-430) fluorescent kit was sourced from Bio-Sciences Ltd., Charlemont 
Terrace, Crofton Rd, Dún Laoghaire, Dublin, Ireland. (cat no. A10171). Bis[3-
(trimethoxysilyl)propyl]amine (cat no. 413356), Micro90 (cat no. Z281565), Ethanol, 
isopropanol  and PBS were all sourced from Sigma Aldrich, Ireland Limited, Arklow, 
County Wicklow, Ireland. Donkey anti-Chicken IgY Fab was sourced from Gallus 
Immunotech (Antibodies-online GMBH). Black acrylic paint (sourced from Tiger Direct™) 
was also used for biosensor signal enhancement. Lake water samples were sourced from 
Leixlip reservoir in Dublin, Ireland. 
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 Preparation of MC-LR and DA conjugates and fluorescent 
antibodies:  
MC-LR and DA conjugates and the recombinant anti-Microcystin-LR-Alexa-430 and anti-
Domoic-Acid-Alexa-430 were prepared, as described by Murphy et al. (35) 
 
 Microfluidic disc manufacturing: 
 The LOAD disc, shown in Figure 5.2-Left, was manufactured from PMMA sheets and PSA 
(ARseal™90880), sourced from Radionics™ and Adhesives Research™ respectively. The 
discs were manufactured through assembling consecutive layers of poly(methyl 
methacrylate) (PMMA) and pressure sensitive adhesive (PSA). (36–38) 
 
 Dissolvable film valves: 
Dissolvable film (DF) valves were manufactured as reported by Gorkin et al. (39) Briefly, 
the DF was arranged on the disc to act as pneumatic valves which would become 
activated upon contact with sample, as shown in Figure 5.5 and Figure 5.6. The DF used, 
referred to as KC-35 film, was supplied by Harke Packpro, Germany. While its 
composition is proprietary, the KC-35 film is formed from SOLUBLON®, a water-soluble 
film based on the synthesis of polyvinyl alcohol (PVA). As the film is non-adhesive, it was 
adhered to PSA to create sticky tabs. One-tab geometry was used for all valves and were 
placed after each reservoir section. A two-valve arrangement both before and in the 
pneumatic valve was utilised to keep all liquids in separate sections of the disc from 
moving in sync with each other through the assay protocol. 
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Figure 5.5: – An illustration to demonstrate how sample progression can be halted for a set period of time 
using a pneumatic stop approach, which was determined by a specific disc spin cycle. 
 A) The pneumatic stop (PS) consists of a narrow-to-wide microchannel with a DF valve (with a 30 secs time 
to dissolved upon contact with sample) located both at the start and midpoint of the PS. The purpose of 
these valves is to have a set volume of trapped air in each case, hence improving reliability of each valve. 
B-C) Once the first DF valve has dissolved, the sample will require an increase of disc spin speed in order to 
compress the trapped air by approximately 40%. D-E) Once this is achieved, the spin speed is dropped back 
to a lower value, with a small portion of the sample remaining trapped with the PS, where the second DF 
valve is located. F-G) Once this DF valve is dissolved, the trapped air within the pneumatic stopped is 
released and sample will progress to the next reservoir. 
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Figure 5.6: – An illustration of a triple-test assay on the disc, with the 5-step assay protocol in triplicate; 
Load reservoir (1), mixing reservoir (2), analyte detection zone (3), Control analyte detection zone (4) and 
waste storage (5) (see Figure 5.2-Left). One third of a disc will be used per run with up to three separate 
analyte detections occurring on a loaded sample. A) Shows the portion of the disc used per run, with the 
loading reservoir. This reservoir delivers the sample to the outer microchannels, followed by metering into 
the central reservoir. B) The locations of the pneumatic stops, with DF valves both before and after (see 
Figure 5.5.C) the collective microfluidic channels (sample transportation and ventilation) throughout the 
disc highlighted. D) illustrates a single assay with the features described in A-C. 
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 Preparation of reservoir surface for bio-activation: 
 Before complete assembly of discs, the lower half (LH) of the discs, where antibody 
immobilisation was due to occur, were cleaned using a thorough surface cleaning 
process, which was then followed by O2 plasma treatment.  All the PMMA layers of the 
discs were initially cleaned in a class 1000 clean room using ultrasonication; A 2% (v/v) 
solution of Micro-90™ was used to remove oil, grease, resin and any biological material 
by ultrasonication at 50°C for 30 min. Subsequently, the PMMA layers discs were rinsed 
three times with deionised (DI) water and a 100% (v/v) solution of isopropanol. The 
PMMA discs were then rinsed a final time with DI water and dried using nitrogen. After 
cleaning, the LH of the discs were then assembled and placed in plastic bags for 
transportation to the O2 plasma cleaner. 
 Amine surface functionalisation of biosensor reservoir floor by 
liquid phase: 
 The LH of the discs were placed in the plasma cleaner (Harrick plasma, USA) to expose 
the PMMA surfaces to a microwave-induced O2 plasma. The operating pressure of the 
chamber was set using a scroll pump and a mass flow controller. The O2 was applied as 
a gas stream, regulated by the integrated mass flow controller and adjusted to 
approximately 1000 mT. The PMMA discs were exposed to the O2 plasma for 10 min. 
The detection reservoirs of the surface-activated discs were immediately coated in a 
solution of APTES to provide a binding bridge between the surface oxidation and 
hydroxylation (-OH groups) of the PMMA surface and the toxin conjugates of MC-
LR/DA/Anti-chicken (Control) antibodies; A 3% APTES solution was prepared in 98% 
ethanol to functionalise the PMMA disc reservoirs. The discs were then placed in a 15 
cm diameter petri dish with cover and incubated at room temperature for 1 h in a 
fumehood. After functionalisation, the discs were ultrasonically cleaned for 15 min (2x) 
using a solution of 98% ethanol. The discs were baked in an oven at 60°C for 2 h. If the 
temperature of the oven was set higher, significant cracking of the PMMA discs was 
noted. The discs were then cooled to room temperature before adding of the toxin 
conjugate/antibodies to surface.  
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 Toxin conjugate binding/Control antibody binding to biosensor 
surface: 
 The Alexa-430 labelled specific scFv were coated on the 2nd radially-aligned reservoirs, 
also referred to as the ‘incubation’ zone (see Figure 5.2). The sequential release of the 
liquid following incubation is required to resuspend antibody coated on the surface of 
the immobilisation zone, as this area is not functionalised prior to coating, the antibody 
is passively adsorbed onto the surface and resuspended following incubation with the 
solution. Toxin, representing both MC-LR and DA, conjugated to BSA (1 µg/mL), was 
prepared in PBS solution, where 100 µL was then added to each of the 3rd (radially) 
reservoirs, also referred to as the ‘test’ reservoir. Anti-chicken IgY (H+L) 100 µL, a 
commercial antibody from Gallus Immunotech Inc., Canada, was added to each of the 
4th radially-aligned reservoirs, also referred to as the ‘control’ reservoir (see Figure 5.2). 
The coated discs were stored at 4°C covered for 12 h. To prevent any non-specific 
binding occurring on the biosensor reservoir surface, the remaining activated amine 
sites were blocked by the addition of 200 μL of 3% BSA to each reservoir. This was left 
to block at 37°C for 1 hour. The blocking agent was aspirated and the prepared disc was 
ready for toxin determination. 
 Microfluidic disc characterisation: 
 The microfluidic discs were characterized on an in-house developed “spin stand” (40) 
as described by Kirby et al. (41) In short, centrifugation of the discs was controlled via 
computer operated spindle motor (Faulhaber Minimotor SA, Switzerland). A high 
sensitivity, short-exposure time camera (Pixelfly, PCO, Germany) and a stroboscopic 
light source (Drelloscop 3244, Drello, Germany) were combined and synchronized with 
the spindle motor using custom electronics to allow visualisation of hydrodynamic 
performance of the discs during centrifugation. Additionally, with the discs using 
manually activated microvalves, opening of the microvalves was achieved by pin 
puncture, allowing sample progression to occur. In summary, the disc was spun at 35 
Hz, followed stopping the disc and opening the sequential microvalve, with this cycle 
repeated until the liquid had successfully passed through each reservoir.  
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 Fluorescent microscope analysis: 
Fluorescent microscope images were captured using the Optika fluorescent Microscope 
(XDS-3 FL4 Inverted trinocular EPI fluorescence microscope HBO illumination system) 
combined with the Alexa-430-Fluor Filter (EOPT-39008), all supplied by Lennox Ireland.  
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 Development of a novel 
multi-analyte marine bio-sensor lab-
on-a-disc platform: A design pipeline 
from concept to actuality 
 
Chapter Foreword: 
This Chapter will act as an executive summary of the design strategies pertaining to the 
development of a multi-analyte centrifugal microfluidic platform for the MariaBox 
project. Presented to the author is the fragmented design strategy used in developing 
this platform, whereby an efficient and cost-effective testing of each stepwise is made 
possible through the development of low-complexity replica discs eventually being 
integrated together, once optimised. This strategy will cover a number of stages; 
conceptualisation, assay integration, microvalve development, integration with the 
MariaBox Platform and the final deployable outputs.  
Summary of the nature and extent of candidate’s work present in this chapter: 
First author, initiation, key ideas, input and management of biosensor development 
(collaboration with Dr. Jenny Fitzgerald, Dr. Caroline Murphy and Prof. Richard 
O’Kennedy), microvalves development (in collaboration with Prof. Jens Ducrée) and 
total system integration design strategies (in collaboration with Dr. Alessandro Giusti, 
Dr. Panayiotis Philimis, Dr. Rachele Isticato, Dr. Giuliana Donadio, Prof. Sabato D’Auria, 
Dr. Antonio Varriale, Dr. Maria Staiano, Dr. Anna Pennacchio, Prof. Kevin Thomas, Dr. 
Stephen J. Sayfritz), large scale fabrication, assisted in integration troubleshooting, 
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collection of all relevant ‘MARIABOX’ project information and analysis from partners, 
manuscript development and writing up. 
Summary of the nature and extent of work not performed by candidate present in this 
chapter:  
Methodology development for biosensor integration conducted primarily by Dr. Jenny 
Fitzgearld and Dr. Antonio Varriale. Heavy metal methodology developed by Dr. Giuliana 
Donadio. 
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 Abstract 
The development of microfluidic sensors as cost-effective strategies for environmental 
monitoring has been a primary goal for the platform since the 1980s. It has played a 
pivotal role in the downsizing of sample ranges and complex assay protocols used in 
analyte detection. This article aims to demonstrate the technical steps involved the 
designing, integrating and testing of biochemical assays on a centrifugal microfluidic 
platform for environmental applications, using MariaBox project as case in point. A 
gradual up-scaling design approach was used to allow development of the individual 
steps of the analytical assays on-chip, accommodating incremental testing. The concept 
to enable analysis of eight analytes on-chip simultaneously, with each requiring different 
assay methods, was the driver for the study. The final 8-analyte disc evolved through 
the testing process and emerged as a different, but effective design. The findings of the 
paper illustrate the complexities in developing a multi-analyte centrifugal microfluidic 
platform, and the incremental optimisation practices that should be employed. This will 
cover an initial conceptualisation, biosensor assay integration methods with surface 
modifications parameters used, microvalve development for synchronised assay 
execution, workarounds for integrations within the MariaBox system, and the final 
deployable outputs. 
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 Introduction 
The ideal criteria for environmental monitoring tools include; autonomous deployment, 
robust, quantitative and qualitative output, and cost-effectiveness. It is important to 
have a highly flexible monitoring platform which can process a large variety of analytes 
under different conditions. One such platform capable of this flexibility is the lab-on-a-
disc centrifugal platform (LOD) (1,2), a derivative of the lab-on-a-chip (LOC) (3–6) 
microfluidic platform.  
The flexibility of microfluidic platforms is primarily due to the significant advancement 
and more readily available micro-scale manufacturing technologies.(7) This has led to an 
exponential surge in many varying and novel applications to target the miniaturisation 
of laboratory-based techniques for conducting highly specific bio-chemical assay.(8) This 
is achieved through the combination of microfluidic features which can manipulate 
fluids, and their contents, with high precision; reservoirs for liquid storage, 
microchannels for liquid transport, microvalves for assay pause sequences, and 
transducing elements for detection. Advancement of each of these components is 
essential for platform success.(1,7,9) Common fluidic inputs can range from micro-litres 
(10-6) to atto-litres (10-18), depending on assay requirements. These low sample sizes 
correspond to a reduction in consumption of samples, reagents, materials, and 
detection times, whilst offering enhanced systematic detection resolution and 
sensitivity. Therefore, the overall associated development carbon footprint and cost of 
microfluidics, due to these advantages, is decreased.(10) 
In order to develop a centrifugal microfluidic platform for environmental monitoring, a 
number of factors must be considered; sample/reagent type/size, analyte 
characteristics, sample matrix, assay protocols, transduction method, targeted style of 
use (autonomous, handheld), usage (single, multiuse). With regards to detection 
strategy on centrifugal microfluidics, there are currently a myriad of transducing 
solutions currently employed in microfluidic platforms for biosensing (2) and 
electrochemical sensing (11). The key to developing a successful, multi-analyte 
environmental processing unit lies within the integration and adaptation of new and 
current microfluidic features and transducing elements in microfluidic platforms.(12) 
164 | P a g e  
 
The “Marine environmental in-situ Assessment and monitoring tool Box” (MariaBox) is 
a FP7 project (13), funded by the European Commission under the Horizon 2020 
framework, which was developed in response to a number of European directives 
outlining the priority of marine environmental protection;  
● “Strategies against pollution of water” - Article 16 of the Water Framework 
Directive (2000/60/EC) 
● “Establishing the list of priority substances in the field of water policy and 
amending Directive 2000/60/EC” – Commission Decision (2455/2001/EC) 
● “Laying down, pursuant to Directive (2000/60/EC) of the European Parliament 
and of the Council, technical specifications for chemical analysis and monitoring 
of water status.” - Commission directive (2009/90/EC)  
 
As such, the MariaBox autonomous sensing platform was designed to be used as a tool 
which could assist in the decision-making process behind the development of European 
strategy for the marine protection and exploitation. Incorporated within the MariaBox 
platform is an autonomous, wireless analytical device, capable of long-term, real-time 
in-situ water monitoring when integrated onto a buoy, a free-floating device or a ship. 
The device utilises a multi-analyte centrifugal microfluidic processing unit (mCPU), 
incorporating novel biosensors, as a detection strategy. The purpose of this paper is to 
outline the design strategy undertaken during the development of the microfluidic bio-
sensor disc from concept to delivery of the final 8-analyte disc.  
 
 Methodology 
 Chemical and biological reagents used 
 (3-Aminopropyl)triethoxysilane (APTES) (cat no. 440140), nickel powder (cat no. 
266981), ethanol, isopropanol and phosphate buffered saline (PBS) were all obtained 
from Sigma Aldrich, Ireland Limited, Arklow, County Wicklow, Ireland. 1-Ethyl-3-(3-
dimethylaminopropyl)carbodiimide bovine serum albumin (Imject EDC BSA) and 1-
Ethyl-3-(3-dimethylaminopropyl)carbodiimide keyhole limpet hemocyanin (Imject EDC 
KLH) spin conjugation kits were obtained from Fisher Scientific (UK). Alexa Fluor 430 
(Alexa-430) fluorescent kit (cat no. A10171) was obtained from Bio-Sciences Ltd., 
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Charlemont Terrace, Crofton Rd, Dún Laoghaire, Dublin, Ireland. MC-LR (cat no. ALX-
350-012-M001) was obtained from Enzo life sciences (UK) Ltd. Domoic acid polyclonal 
antibody was obtained from Abcam Ltd. Cambridge, United Kingdom. Donkey anti-
chicken IgY Fab was obtained from Gallus Immunotech (Antibodies-online GMBH). 
Chelex® 100 Resin (cat no. 1422822) was acquired from Bio-Rad Laboratories. 
 Microfluidic disc manufacturing 
The mCPUs were manufactured from poly(methyl methacrylate) (PMMA) sheets 
(ranging from ~0.5 - 2 mm in thickness) and “pressure sensitive adhesive” (PSA) sheets 
(ARseal™90880) (ranging from ~80 - 160 μm in thickness), sourced from Radionics™ and 
Adhesives Research™ respectively. The discs. Briefly, the PMMA and PSA sheets were 
laser- and knife-cut, respectively, where the layers were then intermittently stacked and 
pressure rolled. (14–16) 
 Microfluidic disc fluidic characterisation 
Fluidic actuation studies were performed an in-house developed “spin stand” (17), as 
described by (18). Briefly, discs centrifugation was achieved using a computer operated 
spindle motor (Faulhaber Minimotor SA, Switzerland), synchronized, using custom 
electronics, with a high sensitivity, short-exposure time camera (Pixelfly, PCO, Germany) 
and a stroboscopic light source (Drelloscop 3244, Drello, Germany) pairing.  
 Pre-storage of analyte conjugate and control on disc 
The Alexa-430 labelled analyte specific antibodies (anti-analyte) and chicken IgY 
antibodies were coated on the 2nd radially-aligned ‘incubation zone’ reservoir where 
100 μL of each antibody concentration was added (40 µg/mL). As this reservoir was not 
functionalised prior to coating, the anti-analyte was passively adsorbed onto the 
reservoir floor of the incubation zone. The sequential release of the analyte-containing 
sample was then required for antibody resuspension within this zone. Anti-analyte, 
conjugated to BSA (1 µg/mL) was prepared in a PBS solution, where 100 µL was then 
added to each of the 3rd radially-aligned ‘test’ reservoir (see Figure 6.1.a). 100 µL of a 
commercially available anti-chicken IgY (H+L), at approximately 10 µg/mL (Gallus 
Immunotech Inc., Canada), was added to each of the 4th radially-aligned ‘control’ 
reservoir (see Figure 6.1.a). The coated discs were stored at 4°C covered for 12 h. To 
avoid any non-specific binding from occurring on the biosensor reservoir floor, the 
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remaining activated amine sites were then subsequently blocked with 200 μL of 3% BSA 
(in PBS solution) added to each reservoir. The blocking agent was left to incubate at 37°C 
for 1 h, after which it was aspirated. Finally, the disc assembly was completed and the 
prepared disc was ready for toxin determination.  
 Biosensor integration 
 Surface modification 
This method allows activating the top of the surface with chemical groups able to react 
towards the COOH and/or NH2 residues present in the biomolecules. The surface 
derivatization was made through the incubation of 50 μL of 3% APTES in 98% Ethanol 
for 1 hour. The discs were placed in 15 cm diameter petri dishes to prevent the 3% APTES 
in EtOH from evaporating. The disc was then rinsed twice with 98% ethanol, baked at 
85°C oven for 2 hours and then allowed to cool before adding the analytes-conjugate. 
 Functionalization of the surface with analytes-conjugate. 
After the derivatization step, the surface is functionalized through two main steps. First, 
the analytes-conjugate (5μg/mL) was pre-incubated for 20 minutes in a solution of 5 
mM 1-ethyl-3-[3-dimethylaminopropyl] carbodiimide hydrochloride (EDC) and 5 mM N-
hydroxysuccinimide (NHS) in HEPES 20 mM pH 6.0 and after added (100μl) to each well 
and the disks are left coating at 4°C covered overnight. Then, the surface was washed 
three times with PBS buffer. The selected surface was derivatized first with the amino 
reactive group and then functionalized with specific analytes-conjugate, such as the pre-
developed glutamine-perfluorooctanoic acid (GlnBP-PFOA), glutamine-naphthalene 
(GlnBP-NAFTHA) and casein-camphechlor (Casein-CHOR). to prevent any non-specific 
binding occurring on the biosensor reservoir surface, the remaining activated amine 
sites were blocked by the addition of 200 μL of 3% of protein (BSA and/or OVA) to each 
reservoir. This was left to block at 37°C for 1 hour. The blocking agent was aspirated and 
the prepared disc is ready for analytes determination. The bio-functionalized surfaces 
were then characterized for their ability to selectively bind to the biological targets. 
 Heavy metals assay integration 
To conduct the total heavy metal assay, nickel-saturated Chelex 100 resin was added 
into the 3rd radially positioned reservoir until completely filled. The resin was prepared 
by re-suspending 50mg of resin in 500 Mm Nickel solution, followed by stirring for 20 
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min. This was followed by several washes in de-ionised water to remove any excess 
metal. 
 Manufacturing of a detection platform 
The assay detectability was conducted using a 3d printed fluorescence detector, as 
described by (19), as a proof of concept for the MariaBox fluorescence detection system. 
In summary, the final fluorescence detection reader was 3D-printed from acrylonitrile 
butadiene styrene (ABS) and incorporated a top-down detection configuration, inclusive 
of a 405 nm excitation LED (cat no. 713-4898, Radionics Ltd Ireland), a 475 nm long pass 
filter (cat no. 64-617, Edmund Optics Ltd) and a 420–675 nm photo-LED emission 
detector (cat no. 708-2813, Radionics Ltd Ireland). This was controlled using a 
programmable IC (Pololu Wixel, cat no. 785, Cool Components Ltd). 
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 Discussion 
 Analytes 
Eight different analytes (summarised in Table 7), four algal toxins and four priority 
pollutant analytes, were targeted. In the case of the algal toxins, pre-lysed samples of 
azaspiracid, domoic acid, microcystin (and structurally related variants), and saxitoxin 
(and derivatives) were required to be quantitively detected. While this was initially done 
manually before loading onto the disc, lysing on disc has been previously reported 
(20)(21) but was too complicated to achieve in the MariaBox mCPU also. Therefore the 
MariaBox platform incorporated a custom lysing instrument for sample handling prior 
to sample loading onto disc platform.(22) Targeted priority pollutant chemicals included 
camphechlor, naphthalene, perfluorooctanoic acid, and total heavy metals. A generic 
competitive inverse assay protocol, as described in Figure 6.1.a, was implemented for 
the fluorescence detection of all of the analytes, except for the total heavy metals which 
had minor deviations (Figure 6.1.b).  
 
Table 7: List of chemical pollutants and algal toxins initially targeted by the MariaBox centrifugal 
processing unit. 
 Category Analyte Partner Ref. 
C
h
em
ic
al
 p
o
llu
ta
n
ts
 
PAHs Naphthalene 
CNR - Consiglio 
Nazionale delle Ricerche 
- 
Pesticides Camphechlor 
CNR - Consiglio 
Nazionale delle Ricerche 
- 
PFCAs Perfluorooctanoic acid 
CNR - Consiglio 
Nazionale delle Ricerche 
(23) 
Total Heavy 
Metals 
Cu2+, Zn2+ 
University of Naples 
Federico II 
(24) 
     
A
lg
al
 t
o
xi
n
s 
Dinoflagellate, 
Alexandrium 
Saxitoxin and derivatives Dublin City University (19,22,25) 
Cyanobacteria 
Microcystin and 
structurally related 
variants. 
Dublin City University (19,22,25) 
Oscillatoria, 
Nostoc. 
Azaspiracid Dublin City University - 
Pseudo nitzschia 
sp. 
Domoic acid Dublin City University (19,22,25) 
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Figure 6.1: The inverse assay protocols used for fluorescence detection of both non-heavy metal analytes 
(A) and heavy metals (B), illustrated as a centrifugal microfluidic processing unit. 
1) A sample containing the analyte of interest is loaded. 2) The analyte-containing sample is incubated 
with a fluorescently-enabled ‘anti-analyte’ to form a complex. Also present in this reservoir is fluorescently-
enabled chicken antibodies to act as a control. 3.a) Any excess anti-analyte is then collected through 
interaction with the test biosensor for inverse quantification of analyte concentration. 3b) The metal-
containing complex is captured on the Chelex resin upon flow-through. Fluorescent measurement of this 
reservoir was used as a control mechanism for this assay. 4.a) The fluorescently-enabled chicken 
antibodies (control) interacts with the surface bound anti-chicken control antibody, confirming successful 
sample passthrough of test zone. 4.b) Any excess fluorescently-enabled anti-analyte is collected for inverse 
quantification of analyte concentration. 5) The sample holding the complex is then stored within the waste 
reservoir for dry measurement of the test and control reservoirs. 
 
The inverse assay protocol can be represented by a microfluidic structure consists of 
different reservoirs, with each reservoir acting as a functional assay step (Figure 6.1). 
On-disc, these reservoirs are in radial alignment and connected by microchannels, with 
connected to a separate ventilation system.  Depending of microfluidic structure 
complexity, multiple replicas are also possible on each disc. Below we summarise the 
operational steps that compose the final assay configuration, with the operational steps 
are similar in all versions of the discs used throughout the MariaBox final validations and 
demos. 
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1. The water sample is loaded into the first inner most reservoir. 
2. The water sample is then transported and incubated with Alexa-430 labelled 
specific antibody (anti-analyte), coated on the 2nd radially-aligned reservoirs, 
also referred to as the ‘incubation zone’. The liquid, following a 5-min incubation, 
resuspends the antibody coated on the surface.  
3. The liquid complex is then transported and incubated with the assay biosensor 
zone, also referred to as the ‘test zone’, for 10 min. For the chemical assays, in 
the test reservoirs, the analytes are conjugated to the carrier protein (50 μg/mL), 
prepared in PBS solution at pH 7.4. For the biological assays, the PBS is not 
required.  
4. Commercially available anti-chicken antibodies, which was previously bound to 
the control surface, interact with the fluorescently-enabled free chicken 
antibodies where a positive signal indicates correct sample-biosensor pass-over. 
5. The sample is then transported to a waste reservoir to allow dry reading of 
biosensor and control zones. 
This inverse assay demonstrates how a loaded sample interacts with anti-analytes, 
labelled with Alexa Fluor 430, and how excess of anti-analytes available are used for 
inverse quantification of analyte concentration. 
In the case of the detection of total heavy metals, the detection assay deviated slightly. 
Firstly, a nickel-saturated Chelex resin was added within the disc for heavy metals only. 
This particular assay also had a reduction in steps from five to four, as no waste reservoir 
was required (see Figure 6.1.b). The order of assay steps also differed slightly from the 
main five step assay, with the first steps of sample loading and peptide mixing remaining 
the same, but the 3rd step involved Chelex resin flow-through with test detection as step 
4. The fluorescent measurement of both the resin and the test zone was then used to 
approximate the fluorescent intensity ratio; i.e. the initial premix fluorescence of the 
protein should be the same intensity as the combined population of both the Chelex-
bound fluorescent protein and fluorescent protein remaining in the collected sample 
after pass-through. The control mechanism used is a summation of fluorescence 
intensity values from both the test and Chelex resin reservoirs, where a set threshold 
should be reached to confirm a valid test. 
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 Disc development process 
 Design and Manufacturing 
The discs were designed using CAD software, where a layer-by-layer, hand-assembled 
manufacturing approach was employed (Figure 6.2). This was determined to be the 
easiest method for rapid modifications; such as inclusion of additional layers, change of 
material, and compatibility with both laser and knife cutter instruments. Generally, the 
microfluidic discs were engineered from sheets of poly(methyl methacrylate) (PMMA) 
ranging from 2 mm to 0.5 mm in thickness, with interlocking layers of modified “pressure 
sensitive adhesive” (PSA) sheets (ARseal™90880), sourced from Radionics™ and 
Adhesives Research™ respectively.(14–16) The design and development strategy used 
encompassed five stages (Figure 6.3);  
• Conceptualisation –  The conceptualisation stage was used to set a target of 
expected platform outcome. It is a particularly important stage for ensuring 
efficient collaborations, particularly emphasising realistic objectives, whilst also 
focusing the initial platform configuration.  
 
• Assay integration – The assay integration stage is inclusive of designing, and 
optimising, of the fluidic actuation on-disc, modification and functionalisation of 
microfluidic features for conducting assay protocols, and the detectability of the 
assay results after completion.  
 
• Microvalve integration – The microfluidic valve stage substitutes manually 
actuated elements within the disc for autonomous strategies. This reduces the 
user interaction, as well as minimising the expertise level, required to use the 
platform.  
 
• System integration – The system integration stage offers potential collaborators 
to offer input into the design and development strategy for compatibility with 
their project elements. This could include minor modifications to the platform 
which could enhance the integration compatibility with the overall system, such 
as additional slots for autonomous manipulation, low complexity calibration 
replicas for rapid testing, and issue reporting.  
 
• Deployable outputs – The deployable output stage includes the testing and the 
optimisations of the final platforms, operating with all the integrated partner 
elements, within the targeted environment. 
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Figure 6.2: Layer-by-layer disc design approach using CAD software for ease of compatibility and rapid 
modification. 
Poly(methyl methacrylate) (PMMA) Layers (white), ranging from 0.5 - 2 mm in thickness, are interlocked 
with pressure sensitive adhesive (PSA) layers (black), ranging from 80 – 150 µm in thickness. The thickness 
dimensions of both the PMMA and PSA make them ideal for μl liquid storage, and capillary action 
transportation, respectively. 
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Figure 6.3: The design tree for the MariaBox centrifugal processing unit (mCPU).  
Illustrated here, are the design fragmentations based on the initial conceptualisation design. In order of 
development, assay integration was prioritised to give the partners a proof of concept for testing assay 
integration. Next, microvalve integration strategies were investigated to automate assay protocol. This 
was then followed by development and distribution of calibration and test discs to partners for 
compatibility troubleshooting with the MariaBox platform. Finally, any compatibility issues were rectified, 
with two final deployable mCPU variants for the MariaBox platform produced; 3-day, 3-analyte disc 
(Biological analytes only) and 3-day, 8-analyte disc (all analytes). 
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 Conceptualisation 
As there were a number of individual and international partners involved in the 
development MariaBox analyte detection strategy, identification and agreement of the 
minimum requirements for conducting each partner’s designated analyte detection 
protocols was conducted. This included specifically inputted liquid sample sizes required 
to conduct each assay (50 μL), the maximum number of assay steps (five) and the 
detection strategy (fluorescence spectroscopy). Based on these parameters, and in 
combination with the solutions presented by Lai et al.(26) and Lee et. al.(27), an initial 
conceptualisation of the MariaBox centrifugal processing unit (mCPU), encompassing 
the targeted analytes (shown in Table 7) detection assays was designed (Figure 6.4). A 
platform design tree (Figure 6.3) was designed, based on this mCPU concept, which was 
filled during the course of the study. 
 
Figure 6.4: Initial conceptualisation of the MariaBox centrifugal processing unit (mCPU). 
 In this initial concept, integration of the minimum requirements required to perform the detection assay 
protocols were prioritized over fluidic actuation and device cost-effectiveness. This design was not 
manufactured, but rather used as an end target goal, with the design fragmented into simpler microfluidic 
features for ease of manufacturing, reproducibility and cost-effectiveness. 
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   Assay integration  
Initial efforts were focused on simplification of the mCPU concept to a single assay form. 
V1.0, illustrated in Figure 6.5. This disc had the same manufacturing issues associated 
with the concept disc, such as thickness, expensive and no autonomous valving 
mechanism for assay automation. Therefore, by reducing the number of performable 
assays, the required thickness could be reduced with an expansion of reservoir in the x-
y plane.  
 
 
Figure 6.5: The single assay concept (v1.0).  
The microfeatures contained within the disc consists of vents (green), reservoirs (red), microvalves (blue), 
manual vent caps (green with dark green dot). Modifications from the previous version is illustrated by 
yellow.  
 Assay integration – fluidic actuation 
A low complexity, 3-to-5 step assay protocol for assessing liquid transfer between 
reservoirs on the disc was developed (Figure 6.6). In the first iteration (V1.1), liquid 
transportation between the 3 reservoirs unintentionally halted when rotational 
frequency was constant due to the pneumatic trapping of air halting sample 
progression. Therefore, the subsequent version (V1.2) was a modified in such that each 
reservoir had a separate ventilation mechanism, which was capped. Transfer between 
desired reservoirs was only achieved by rupturing the adjacent ventilation cap of the 
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desired reservoir manually. With the successful liquid actuation of this version, this was 
then further expanded from a 3-step assay protocol proof of concept to a 4- and 5-step 
assay protocol, in V1.3 and V1.4 respectively. However, due to the non-rounded 
reservoir shape, sample loss occurred in these versions also. Therefore, in V1.5, a 
rounded reservoir modification was implemented prevent sample loss during assay 
execution. 
 
 
Figure 6.6: The design refinement process of the initial assay development with manual microvalve 
mechanism (V1.1-1.5). 
The microfeatures contained within the disc consists of vents (green), reservoirs (red), microvalves (blue), 
manual vent caps (green with dark green dot). Modifications from the previous version is illustrated by 
yellow.  
 Assay integration – biosensor integration 
Modification of the PMMA surface was required in order to adhere a functionalisation 
complex for assay detection. The chemical based approach with EDC/NHS protocol (28), 
often used in SPR sensors, was modified in order to obtain active groups on the PMMA 
surface. These active groups are chemical molecules that react with the COOH and/or 
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NH2 residues present in the biomolecules. Then, the reactive group present on the 
surface, reacts with the biomolecules through a chemical EDC/NHS reaction. In 
particular, after the activation of the surface with the APTES, the conjugates were 
attached. In Figure 6.7, the flowchart of the reaction using the APTES-EDC/NHS protocol 
is shown. Initially, the PMMA surface is O2 plasma treated (Harrick plasma-USA, 1000 
mT for 10 mins on high settings) and reacted with APTES to produce a silanization of the 
surface. After the silanization procedure, an amino reactive group was available on the 
surface for reaction. Then, the analyte conjugate was pre-incubated, with a solution of 
EDC/NHS, and added to the disc surface. This allowed the obtaining of a stable and 
permanent binding of the conjugate to the surface. This process was not required for 
the heavy metals assay, as this step was replaced by the use of Chelex resin. 
 
 
Figure 6.7: Flowchart of the APTES-EDC/NHS surface functionalisation chemical method. 
 
 Assay integration – detectability 
Finally, this mCPU V1.5 was tested using the first detection platform (Figure 7-left), 
which presented misalignment issues with the detection platform. This was rectified 
through the addition of alignment holes and pillars, which were integrated in V1.6, and 
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the succeeding detection platform (Figure 7-right), respectively. The performance of the 
liquid actuation using a cap vent valving mechanism for the mCPU V1.6 was also 
previously demonstrated (19). For convenience and rapid assay optimisation studies, a 
chip and holder mechanism (Figure 6.8), replicating the 3rd and 4th reservoir (test and 
control assay zones) in the mCPU, was also produced. This chip platform offered ease of 
assay optimisation by being compatible for use with both the detection platform (Figure 
7-right) and a fluorescence microscope. This facilitated the optimisation and testing of 
the reservoir surface modification, whereby successfulness of an immobilised capture 
target could be determined. 
 
 
Figure 6.8: The detection optimised mCPU with manual microvalve mechanism (V1.6), and reservoir replica 
chip and holder for rapid biosensor integration. 
The microfeatures contained within the disc consists of vents (green), reservoirs (red), microvalves (blue), 
manual vent caps (green with dark green dot). Modifications from the previous version is illustrated by 
yellow. 
 
 Disc Testing 
Before a centrifugal microfluidic platform can be used in-situ, the platform must be 
rigorously tested and optimised to ensure correct assay execution. This assessment 
should include both a characterisation of the liquid actuation on disc and the assay 
detectability. The microfluidic platform fluidic performance was generally characterised 
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using a custom built “spin-stand” mechanism (17), as described by (18). In short, a high 
sensitivity, short-exposure time camera (Pixelfly, PCO, Germany) was paired with a 
stroboscopic light source (Drelloscop 3244, Drello, Germany), and synchronised with a 
spindle motor, was used in recording still images of the microfluidic platform whilst 
under centrifugation. 
The assay detectability was conducted using a custom-made, 3d-printed fluorescence 
detector system, as described by (19), as a proof of concept for the MariaBox 
fluorescence detection system. The first detection platform iteration (Figure 6.9-left) 
was manufactured to complement the mCPU V1.5. This in-house built fluorescence 
detection system, however, was flawed. Firstly, this detection strategy was designed 
similar to a compact disc reader, in that it operated a bottom-up detection method 
(Figure 7-left). It was found that the surface modification of the reservoir floor during 
the capture target immobilisation resulted in a major degradation of the optical 
transparency of the surface. Secondly, alignment with the detection elements proved 
very difficult, with a temporary ‘2-pin’ mechanism used to lock the disc in place. This set-
up was insufficiently rigid, whereby minor movement resulted in major fluctuations in 
the recorded optical signal. The final iteration (Figure 6.9-right) amended these issues. 
Firstly, the optical detection configuration was rotated to a top-down detection method, 
illustrated in (Figure 6.9-right), which vastly improved the maximum optical signal 
readout that was previously lost due to poor transmission through the bottom of the 
disc. Secondly, the alignment mechanism was upgraded from a ‘2-pin’ approach to a ‘6-
pillar’ strategy, whereby the disc holder had 6 extruded pillars which aligned with the 
array of circular holes present in the mCPU V1.6. The degree of freedom of this approach 
was minute, particularly in comparison to the ‘2-pin’ strategy. 
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Figure 6.9: The Evolution of the detection platform for the MariaBox centrifugal processing unit.  
The tested fluorescence detection strategies used on the MariaBox centrifugal processing unit (mCPU). A) 
The bottom-up approach used on the detection platform V1.0-2.0. This method proved inaccurate due to 
the loss in optical transparency due to surface modification of the reservoir floor during functionalisation. 
B) The top-down approach used in the detection platform V3.0. This configuration seemed unaffected by 
the functionalisation of the reservoir. 
 
The ability of this system (mCPU V1.6 and final detection platform) was previously 
characterised, with a 7.2 ng/mL limit of detection microcystin-LR (19). While the system 
was also optimised for MC-LR detection as a proof of concept, a limit of detection of 
both domoic acid and saxitoxin was also reported to be approximately 20 ng/mL and 50 
ng/mL, respectively, where it was predicted that further optimisations of the domoic 
acid and saxitoxin assays could have further reduced these limits of detections. 
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 Microvalve development 
With the assay integration on a proof of concept successful, development of appropriate 
microfluidic valving mechanisms was required to conduct autonomous assay execution. 
A number of microvalve strategies (Figure 6.10) were considered and tested to 
determining difficulty in application, reliability and ease of autonomous actuation in-
situ; 
a) The cap valve (19)  – With the success of the mCPU V1.6, the cap valve was 
designed to allow for the expansion of the number of test assays per disc with 
minimal additional microfeatures. However, as this approach was easy to apply 
and highly reliable, it was deemed that autonomous actuation in-situ would be 
too difficult. This was due to difficulties in integrating and operating a reliable 
puncturing mechanism in a turbulent marine environment, therefore this valve 
was not investigated beyond conceptualisation. 
 
b) Wax valve (29) – Through the use of a paraffin-graphite (1 g : 1.17 g) wax valve, 
in combination with a silver screen printed layer, an alternative to the cap valve 
(a) was developed, whereby the semi-conductive material would melt due to the 
ohmic heating effect. While this valve was successful, it was problematic to 
consistently integrate within the disc, guaranteeing contact between the screen-
printed layer and the valve, as well as ensuring the vent was completely closed, 
was difficult. This was amplified by the quantity of microvalve to be integrated 
per disc, whereby one was required for every reservoir.  
 
c) The wax valve multiplex – Due to the difficulties in integrating the wax valve 
within the disc, the wax valve multiplex solution was developed in an attempt to 
reduce the number of valves per disc, with a single valve actuating multiple 
reservoirs with the same radial positioning. This approach again was difficult to 
implement as the communal ventilation system also a sharing of initial sample 
loading inlets preventing pneumatic compression and sample progression 
halting. This was somewhat rectified by a resealing of the loading inlets, however 
as this would be difficult to achieve autonomously in-field, this approach was not 
further investigated. 
 
d) The hydrophobic valve – The use of a hydrophobic valve for halting liquid 
progression has been previously reported.(30,31) A hydrophobic valve strategy 
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was integrated by spray-coating the microfluidic channels using a sol-gel 
composite, similar to (32), whereby the in-house designed sol-gel recipe was 
paired with methylated fumed silica to achieve a hydrophobic coating (surface 
contact angle <130°). However, in this case, the hydrophobicity proved to 
promote liquid transportation over liquid halting. It was stipulated that this was 
caused by a non-uniform spreading of the coating of the reservoir due to the 
spray-coating procedure. 
 
e) The pneumatic valve for air actuation – A pneumatic compression valve was 
investigated whereby an air-tight, but water dissolvable, material (Solublon™) as 
an alternative to the cap valve (a), based on the event-trigger valving mechanism 
(33). In this method, a threshold centrifugal force is required for liquid 
progression to reach and compress a pneumatic chamber containing a 
dissolvable valve, whereby the opening this valve would uncap the ventilation 
for the subsequent reservoir and release pneumatic compression. This valve 
proved difficult to implement, as the centrifugal forces required to actuate the 
microvalve were too similar to the forces required for liquid transportation 
between reservoirs, making the valves highly unreliable in this configuration in 
high uncertainty of success. 
 
f) The pneumatic valve for liquid actuation (25) –  The pneumatic valve for liquid 
actuation was a variant, and less complex configuration to the pneumatic valve 
for air actuation (e). In this case, a standalone pneumatic chamber prevented 
liquid progression unless relatively high centrifugal forces were generated, with 
the need for capping of the ventilation system This case proved very successful 
and was used as the main valve for the deployable mCPU outputs. 
 
183 | P a g e  
 
 
Figure 6.10: The microvalve mechanisms investigated for autonomous assay execution. 
a) The cap valve (blue) was designed as an upscaled version of the mCPU V1.6 which also required external 
puncturing of the roof membrane. B) A paraffin-graphite wax valve (yellow), combined with a silver screen 
printed layer, was used as an alternative to the cap valve (a), whereby the semi-conductive material would 
melt due to the ohmic heating effect. C) The paraffin-graphite wax valve multiplex (yellow) was developed 
to amend the difficulties associated with (b), by attempting to use a single valve per multiple reservoirs at 
the same radial distance. d) A hydrophobic valve (orange) used to halt liquid progression. This valve was 
integrated by spray-coating the microfluidic channels using a sol-gel composite, similar to  (32), whereby 
the in-house designed sol-gel recipe was paired with methylated fumed silica to achieve a hydrophobic 
coating. E) The pneumatic valve (green) for air actuation utilised an air-tight, but water dissolvable, 
material as an alternative to the cap valve (a), whereby liquid progression would be halted until it reached 
the dissolvable valve, thus opening the valve. f) The pneumatic valve (green) for liquid actuation was an 
alternative and less complex configuration to the pneumatic valve for air actuation (e), whereby the 
ventilation system remained uncapped but an isolated pneumatic chamber prevented liquid progression 
unless relatively high centrifugal forces were generated.  
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 Integration of microfluidic platform with autonomous MariaBox 
platform 
With assay integration and a reliable microfluidic valving mechanism implemented, the 
MariaBox platform required calibration in order to correctly use the mCPU. As 
autonomous assay execution was handled on the mCPU, the MariaBox platform was 
only required to transport the disc to different zones within the system, rotate the disc 
using a specific test protocol, and fluorescently read the test and control reservoirs of 
the disc. Firstly, the central hole mCPU was slightly modified to allow interaction via a 
magnetic ball lifting mechanism as requested by the engineering partners (Figure 
6.11.a). This was to allow ease of transport and manipulation of the mCPU from a cold 
storage zone to the motor and fluorescence detection zone. Secondly, a full 
characterisation of the pneumatic valve for liquid actuation, at varying rotation 
frequencies and radial positions, was conducted (Figure 6.11.B). This was used in 
developing an accurate spin speed protocol to complement the autonomous assay 
execution cycle on the mCPU. Thirdly, a simple microfluidic platform was produced 
which could be completely loaded with a fluorophore-enriched liquid (Figure 6.11.C). 
This was used as a method for initial calibration the detection elements with the 
MariaBox platform without wasting the deployable mCPUs. 
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Figure 6.11: Modifications and calibration discs required for integration of microfluidic platform with 
autonomous MariaBox platform. 
A) Integration of an alignment slot in the mCPU for instalment of a magnetic ball lifting mechanism, as 
requested by the engineering partners. This was for easier manipulation and transportation of the mCPU 
inside of the MariaBox system. B) The microvalve characterisation disc. Using this disc, liquid actuation, at 
varying rotation frequencies and radial positions, was validated. This validation was then directly used in 
the generation of a specific spin speed protocol to complement the autonomous assay execution cycle on 
the mCPU. C) The fluorescence detection calibration disc. This disc was relatively simple microfluidic 
platform whereby the disc could be completely loaded with a fluorophore-enriched sample, for use as a 
sample for initial calibration the detection elements within the MariaBox platform, without the wastage 
of complex, deployable mCPUs. 
 
 Deployable outputs 
As disc storage was limited to approximately 26 concept mCPU discs, with a thickness of 
20mm each, seven replications of the multi-analyte detection strategy were initially 
included in the design to target the six-months (182 days) deployment duration required 
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of the MariaBox platform. It was found later however, that optimisation of the design 
towards a 3-day disc, as opposed to the conceptualised 7-day disc, reduced the disc 
thickness by ~65%, allowing for the storage of 69 discs within the same space, 
corresponding to an increase in potential test days to 207. Following this optimisation, 
the first deployable mCPU was produced the 3-day, triple-assay disc (3D3A) disc (Figure 
6.12), encompassing all of the successful discs from each of the stages prior. The 3A3D 
disc was used as an initial stage to bridge the gap between a single assay disc (mCPU 
v1.9) and the octuple-assay disc. This disc allowed the multiplex processing of a single 
sample for the conduction of three separate biological samples only, and is further 
described by (25). 
 
Figure 6.12: The deployable 3-day, 3 analyte (3D3A) MariaBox centrifugal processing unit. 
This was used as a bridging disc between the single assay disc mCPU 1.6 and the final octuple-assay disc 
(Figure 6.14). 1-3) The detection assays for Saxitoxin, microcystin, and domoic acid respectively. 
In summary, the sample is loaded, and metered between the second reservoir of the 
three separate assays. Using the pneumatic valve for liquid actuation, the sample 
conducted the remaining steps of the assay for the required duration. This mCPU 
verified fluorescence signal change proportional to the concentration of analytes 
present, however, as this disc had a 10 mm larger radius, it was not compatible for 
quantitative analysis using the detection platform (Figure 7-right) which could only be 
carried out using the MariaBox system. Unfortunately, the first tests were inconclusive 
due to partner distribution issues, whereby a whitening of the adhesive layers 
significantly degraded the optical clarity of the discs, resultantly saturating the optical 
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data results (Figure 6.13.left). This was rectified in the second generation of 3D3A discs, 
where whitening was reduced by removal of excess adhesive above and below reservoir 
zones, as well as increased rolling pressure in activating adhesive (Figure 6.13.right). 
 
 
Figure 6.13: Issues associated with the optical transparency of the discs during transportation. 
Right) significant whitening of the disc completely degraded the quality of the optical data, resulting in 
inconclusive results. Left) The rectified 3D3A disc, whereby whitening was reduced by removal of excess 
adhesive above and below reservoir zones, as well as increased rolling pressure in activating adhesive. 
During the testing of the 3D3A discs, and in order to meet the project end-date, the 3-
day, the octuple-assay (3D8A) disc (Figure 6.14) was simultaneously produced. This was 
an upscaled version of the 3D3A disc, where the reservoir size was maintained through 
upscaling, with a spatial reduction in the x-y plane accounted for by a 2 mm increase in 
disc thickness. This allowed the testable assay quantity to be increased from 9 to 24, 
with sufficient room for the pneumatic valve mechanism. However, the significant 
complexity associated with disc impeded the manufacturing time due to the manually 
achieved rapid prototyping approach used. The target goals of the project required 
distribution of these final 3D8A discs to be used in 3 separate MariaBox platforms, 
therefore only 6 discs, containing 3 iterations each, was available for each test site. As 
these systems also had not had the opportunity to be fully calibrated in the handling of 
these discs, but rather the lower complexity discs, an initial recalibration of the system 
prior to deployment was required. This further reduced the yield of data collected to 12 
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measurements per site, per day, whilst in autonomous deployment. This made it 
extremely difficult to assess which components (disc, optical system, mechanical 
system, electrical systems, computational system, etc…), if any, may have acted 
incorrectly whilst in the marine environment. This lack of component surveillance, 
combined with the low levels of analytes expected during the time of deployment 
(winter), particularly with regards to minimal toxin presence, further emphasised the 
additional validation required by the system. However, it is worth noting that significant 
steps have been made in development of a fully autonomous, in-situ deployable marine 
monitoring system, from conceptualisation to realisation, and had more time been 
available to conduct this additional validation, as well as the production of extra 3D8A 
mCPUs, it is believed that the end-target could have been achieved. 
 
 
Figure 6.14: The deployable 3-day, 8 analyte (3D8A) MariaBox centrifugal processing unit. 
This was the final realisation of the original concept, for the detection of all of the target analytes. 1-4.B) 
The detection assays for Saxitoxin, microcystin, azaspiracid, and domoic acid respectively. 1-4.C) The 
detection assays for naphthalene PFOS, Camphechlor, and total heavy metals respectively. 
 
 Summary and lessons learned 
There has had a number of successful outcomes and lessons learned from working on 
the highly complex and integrated MariaBox project. Whilst this report primarily 
discusses the design developments associated with the MariaBox mCPU, notable work 
which falls outside the scope of this report includes;  
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 The development of novel assay strategies for the detection of analytes which 
have not been detectable in-situ prior to this project. 
 The development of a highly integrated and deployable marine-monitoring 
system, inclusive of attachable peripheral sensors, with cloud-based networking 
for instantaneous data capture and processing. 
 The investigation into the requirement for deployable systems in marine-based 
environments, and the associated governmental legislation required for the 
correct installation and implementation of monitoring systems. 
 The accumulation of an interdisciplinary expertise networking consortium, 
inclusive of both academic, institutional and industrial, with future exploration 
of collaboration opportunities. 
With regards to microfluidic disc development for a highly challenging, long term 
deployment, a strategy from conceptual ion to realisation was developed. This was 
achieved through the development of a conceptual design, encompassing all of the 
required end target goals, which was then fragmented into simpler microfluidic discs for 
ease of manufacturing, reproducibility, simultaneous testing and optimisation of 
individual functional microfeatures, and cost-effectiveness. These simpler microfluidic 
discs, once optimised, could then be integrated together to gradually approach the 
requirements of the conceptual design. These fragment integration stages included; 
conceptualisation, assay integration, microvalve integration, partner compatibility and 
deployable outputs. A summary of the design changes for the mCPU during assay 
integration is summarised in Table 8. This table illustrates the lessons learned during 
each mCPU design iteration, with the optimal manually-actuated mCPU V1.6 could be 
used as a simple generic approach for alternative 5-step assay protocols, or further 
modified for the inclusion of more, or less, assay steps as required. Reservoir replica 
chips were also recommended for the rapid, cost-effective optimisation of the multi-
parameter surface functionalisation process. 
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Table 8: MariaBox centrifugal processing unit design log summary. 
Version Issue Design modifications 
V1.0 
Disc too thick for initial testing, no 
valving solution for automation 
Reduction in number of performable assays, wider 
reservoirs, thinner disc, automatic valving solution 
investigated 
V1.1 
Sample not progressing through 
reservoirs 
ventilation added to each reservoir 
V1.2 
Requires a control reservoir to be 
integrated, sample not stopping in 
reservoirs 
Control reservoir added, PSA used to cover each 
reservoir ventilation hole where popping allows 
progression: Manual valve (Vent) 
V1.3 
Anti-body mixing section required for 
powdered antibody storage 
Anti-body mixing reservoir added 
V1.4 
Sample loss more obvious with 
addition reservoirs 
Reservoirs rounded to reduce sample lose 
V1.5 
Alignment with detection difficult, 
bottom-up detection failing due to 
white PPT forming after surface 
modification 
Alignment holes added to disc, detection system 
converted to a top-down detection. 
V1.6 
Manufacturing time to slow at high 
cost for surface modification 
optimisation (~ 5 discs per week = 30 
tests per week at material wastage) 
Chip based replicas of test and control reservoirs 
created (~ 15 chips per day = 75 tests per week at 
low material wastage) 
Chip 
Chip no longer compatible with 
ToxiSense detection system for 
comparison with fluorescent 
microscope 
Chip holder accessory with alignment holes 
manufactured 
Chip Holder none none. 
 
A simple assay detection system, which would be representative of the final optical 
detection setup used in the MariaBox system, was developed to complement both the 
optimal mCPU and replica chip. A summary of the design changes for the detection 
platform during assay integration is summarised in Table 9.  While the end-target was a 
fully autonomous detection system, value was identified in the production of a portable, 
low-cost detection system. Therefore, a custom designed and 3d-printed detection 
platform was manufactured. During assay integration, however, it was notated that 
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optical transparency issues due to surface functionalisation impelled the orientation of 
the optical detection, with the ‘Top-down’ approach selected as the optimum detection 
configuration. 
 
Table 9: Detection platform design log summary. 
Version Issue Design modifications 
Bottom-
up 
Alignment of disc difficult and 
causing varying detection 
results, Surface modification of 
disc creating white PPT which 
detection optics must travel 
Alignment extrudes added, systems 
converted to a top-down detection 
system 
 
Top-down 
None None 
 
Finally, a summary of the disc production for the entire MariaBox project, which only 
included on-disc assay integration, is presented in Table 10. Clearly evident in Table 10, 
is the correlation between disc complexity, given by number of individual ‘layers with 
disc’, and the quantity of discs produced. Due to the manual manufacturing of the 
mCPUs, this trend became unavoidable. If this process was automated, significant 
improvement in the yield of produced discs is expected, but until such a procedure is 
implemented, it is recommended that this fragmented development strategy is 
implemented to minimise disc complexity and maximise testable disc yield.  
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Table 10: Microfluidic disc production summary during duration of MariaBox project. 
Disc model 
Layers 
within 
disc 
Dates Quantity 
Partner 
distributio
n 
Feedback from 
partners 
following usage of 
discs 
Modifications arising 
from feedback from 
tests done on discs by 
partners 
ToxiSense test 
design 
5 
2014-
2016 
50 
N/A - DCU 
solo 
testing 
Assay 
performance and 
quantification 
successful on the 
ToxiSense 
platform 
N/A 
3-Day discs 
(with toxin 
coated within 
the discs) 
10 Jan-17 3 CYRIC None N/A 
Lucifer yellow 
discs – 
developed by 
DCU to test the 
detection system 
in Cyprus 
10 Jan-17 2 CYRIC 
Brief summary of 
final results, 
request of 
alignment slot on 
disc 
Due to lack of results, 
analysis of results 
could not be carried 
out to decide further 
modifications, 
alignment slot 
incorporated 
3-Day discs 
(without toxin 
coated with the 
discs) 
10 
Mar-
17 
5 NIVA 
YES: 
Detection wells 
became whitened 
due oxidation of 
glue over 
detection wells 
during 
transportation 
Further optical 
enhancement of 
detection zones 
3-Day discs 
(without toxin 
coated with the 
discs)(Optically 
enhanced) 
10 
Oct-
17 
10 NIVA 
YES: 
Detection wells 
remained 
transparent for 
testing. 
Liquid traveling 
beyond detection 
zones before 
detection occurs. 
Clarification to 
partners that this was 
always the case and 
detection is supposed 
to occur after liquid 
has travelled to waste 
zone, therefore discs 
functioning correctly 
8-day discs (Full) 
calibration 
12 
Nov-
17 
3x2 (6) 
Galway, 
Barcelona, 
CYRIC 
Discs are leaking, 
sample not 
progressing 
correctly, 
Detection not 
functioning 
correctly 
Request of returned 
disc to assess why 
liquid is no longer 
correctly flowing, 
Detection zone 
verified by DCU. 
Detection issue with 
MariaBox. Suggested 
simplification of discs 
for characterising 
MariaBox 
performance with 
reading detection 
zone only. 
8-day discs (Full) 
Test pilot 
12 
Dec-
17 
3x4 (12) 
Galway, 
Barcelona, 
CYRIC 
N/A-System pilots 
not complete 
N/A 
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 Conclusion 
The development of microfluidic bio-sensors as cost-effective strategies for 
environmental monitoring has been a primary goal for the platform since the 1980s. It 
has played a pivotal role in the downsizing of sample ranges and complex assay 
protocols used in analyte detection. In order to develop a successful, highly integrated 
centrifugal microfluidic platform, from initial concept to final employed disc, for a large 
scale, interdisciplinary project, a number of design stages must be undertaken and 
optimised. Depending on the complexity of the project, autonomous multi-assay 
integration and execution studies may be required, with microvalve technology which 
allows minimal external interaction for maximum automation. In achieving this, 
compromises and assistance must be provided to project partners, such as modifications 
and/or calibration devices, in order to attain the proposed project target. Throughout 
this paper, the design and development strategy implemented in the MariaBox 
centrifugal processing unit was used as an example of how to develop a highly-
integrated, microfluidic centrifugal processing unit, from conceptualisation to 
realisation. As part of this, a concept-fragmentation strategy is demonstrated for the 
development and optimisation of single microfeature elements prior to amalgamation 
into a complete and fully integrated platform. The benefits of this approach allow the 
complete characterisation and optimisation of each microfeature required separately in 
a low-complexity, high production yield device. This approach also allows for maximised 
research output opportunities during the development process, whilst offering insight 
into the ‘most feasible’ selection practice for large-scale integration compatibility and 
success.  
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 Supplementary Information 
 Additionally, the design portfolio of the microfluidic discs and detection systems 
for assay integration has been included. 
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 Final Conclusion 
The development of low-cost sensors for the monitoring of the precious resource that 
is water is of critical importance worldwide. As these sensors reduce in cost, complexity 
and size, their ability to be implemented in large scale autonomous and/or hand-held 
networks allows for more frequent and extensive monitoring of environments. As 
outlined at the start of this thesis, the primary technical challenge of this thesis was the 
development of low-cost, microfluidic platforms for environmental water quality 
monitoring. The project was sponsored by the FP7 EU-Funded ‘MARIABOX project’, as 
part of the European Union Seventh Framework Program (grant agreement No: 
614088). Presented within this thesis, was the staged development process for achieving 
an autonomous, multi-assay detection strategy for environmental monitoring, through 
the use of centrifugal microfluidic platforms. Included within this development strategy 
are both the individual and integration advancements towards a successful, 
autonomous environmental sensor which has the potential to be used in-situ. 
 
As the MARIABOX project deliverables included the requirement to develop a 
microfluidic platform with eight separate on-board biosensors (four biological, four 
chemical). This platform was also required to be compatible with a deployable analytical 
system developed by external partners, in which contained modules of sample 
preparation and delivery, disc and reagent storage, detection capabilities, as well as 
network communications. To achieve this target, a conceptual fragmentation strategy 
was utilised, whereby an initial high-cost centrifugal platform was developed and 
simplified for the individual optimisation of microfluidic components. Therefore, as part 
of this project, a proof-of-concept toxin detection system was developed and tested. 
This generically designed platform demonstrated capability for detecting 3 of the 4 
separate toxins required by the MariaBox system. This platform was then further 
enhanced to include a simple, yet robust microvalve mechanism, allowing for 
simultaneous assay execution. This was then followed by further expansion of the 
platform for the inclusion of 8 separate analytes. 
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Centrifugal microfluidic technology was selected as the ideal sensor platform for hand-
held systems due to the current gap in research, adaptability of the platform and low 
cost of implementation and actuation. Requiring only a motor to propel a sample within 
a centrifugal microfluidic platform, complex assay protocols can be integrated within 
the platform through coupling with biosensing technology (1–3).  This platform 
therefore offers huge potential in the enhancement of current environmental 
monitoring strategy limitations; portability and in-situ capability, cost-effectiveness, 
generical design for multi-analyte detectability, and the minimal required end-user 
interaction. As part of this thesis, the basic principles observed in microfluidic systems 
were investigated, as well as the current detection methodologies for marine based 
environments was conducted, which was then used in the translation of popular Lab-
on-a-Chip technologies into centrifugal platforms.  
 
Initially, high priority marine toxins were selected as the analytes of interest, including 
microcystin-LR, domoic acid, saxitoxin and azaspiracid (4,5). While antibody generation 
and ‘off-chip’ assay performance studies were separately performed by Dr. Jenny 
Fitzgerald, the design and optimisation of the ‘on-chip’ fluidic handling was conducted 
by the author. As is evident in chapter six, the design stage received several optimisation 
iterations, which varied based on the fluidic, assay and detection performances, before 
the final toxin detection platform was realised and presented in chapter 3. In chapter 3, 
it was demonstrated that a limit of detection of 7.2 ng/mL, 20 ng/mL and 50 ng/mL for 
microcystin-LR, domoic acid and saxitoxin respectively could be achieved when the ‘on-
chip’ platform was integrated with the detection assays and paired with a low-cost 
fluorescence detection system. Considering the case of the microcystin detection assay, 
which received further optimisation, a detection limit of 7.2 ng/mL would be useful for 
monitoring bathing site, where a detectability of 20 ng/mL is required, but unfortunately 
it is well short of the required 1 ng/mL detection for drinking water. This shortage was 
determined to be due to the low-cost fluorescence detection system used, as it has been 
recently reported that alternative detection systems using similar assay protocols could 
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achieve < 1 ng/mL limits of detection for microcystin (6,7). However, in comparison with 
these systems, a reasonably similar detection response for microcystin-spiked water 
samples was noted. 
 
Following the assay integration on a low-cost centrifugal microfluidic platform, 
precedence switched to the lowering the minimum required user interaction through 
the inclusion of microvalves within the system. The importance of these microvalves lies 
with their ability to allow each assay step to occur both in the correct order and for their 
set allotted time. Four separate microvalve strategies were investigated for their 
performance and ease-of integration with the MARIABOX platform as demonstrated in 
chapter 6; Manually-actuated valves, Ohmic-heated wax valves, pneumatic dissolvable 
valves, and hydrophobic valves. Of these valves, hydrophobic valves proved the least 
predictable, which was expected to be primarily due to the rapid spray-coat application 
technique used, and in some cases, it assisted in the promotion liquid flow. The ohmic 
heated valves were also found to be quite promising, however integration of the valve 
within the centrifugal platform proved quite difficult and often resulted a degrading of 
the optical transparency of the platform resulting in diminished detectability. This valve 
also required an additional electronic plug-and-play device to heat the wax valves. This 
device would have also needed to be integrated within the final MARIABOX platform, 
which was deemed to be unattainable by the project consortium. The manually-
actuated valves used the same mechanism of preventative ventilation demonstrated in 
chapter 3, whereby a physical puncturing of the centrifugal platform surface released 
compressed air which was otherwise preventing liquid flow. However again, while this 
disc was highly successful and ideal for multiple-assay integration, it required an external 
puncturing mechanism similar to the laser abolition method previously reported (8), 
which again was determined to be too difficult to integrate within the final MARIABOX 
platform. Finally, the pneumatic dissolvable valves presented in chapter 4, became the 
compromise between microvalve actuation and integrability with the MARIABOX 
platform. As part of chapter 4, a complete characterisation of the pneumatic valve 
actuation was studied, whereby specific centrifugal forces would cause resultant 
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pneumatic compression within the microvalve. This principle was used to actuate each 
subsequent valve by the operation of a complementary disc rotational speed program. 
 
As was demonstrated in chapter 5, the toxin detection centrifugal microfluidic platform 
(chapter 3) and the pneumatic microvalve mechanism (chapter 4) were combined within 
a single microfluidic disc. Given that there is interest in the use of optical biosensors for 
simultaneous detection of multiple analytes (9), this platform was also scaled up further 
to allow for the detection of up to 3 separate toxins in triplicate, while in this case, only 
microcystin and domoic acid were assessed with a blank assay used as a negative test, 
with the positive control included within the assay itself. Due to the increase size of this 
platform, it could not be qualitatively assessed using the same the detection platform 
discussed in chapter 3 as it was too large, and the MARIABOX detection prototype for 
which it was designed was not functional at the time. Therefore, the disc was analysed 
using both a ‘spin-stand’ mechanism, for fluidic performance characterisation, and 
fluorescence microscopy, for assay performance characterisation. 
 
While this platform was demonstrated to be successful, as is shown in chapter 5, the 
scalability of the microvalve mechanism was difficult to achieve when the platform was 
further expanded to include triplicate detection of the eight separate MARIABOX target 
analytes, as discussed in chapter 6. This was due to the lack of autonomous tools 
available to assist with microvalve integration within the disc, thus leading to a more 
manually assembled platform than desired. The manufacturability of the final 
MARIABOX centrifugal platform was also impacted during the integration of this 
microvalve within the platform by way of a more complex, and significantly larger 
centrifugal platform. As a result, errors due to misalignment during assembly were more 
prominent and large-scale production of the platform for deployment proved difficult.  
However, while difficulties are commonplace during prototype development, which can 
often take up to 10 years to convert a prototype to an end-user commercial device, 
within this project, a deployable asset, from conceptualisation to realisation, with great 
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potential in the field of environmental monitoring has been realised within a four-year 
period, thanks to the culmination of efforts of the MARIABOX partnership.  
 
It is hoped that these investigations will assist in the decision-making process of future 
environmental monitoring platforms, offering insight into the development of 
deployable environmental sensors.  
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